<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-archivearticle1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Adv</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Adv</journal-id>
    <journal-id journal-id-type="publisher-id">sciadv</journal-id>
    <journal-id journal-id-type="hwp">advances</journal-id>
    <journal-title-group>
      <journal-title>Science Advances</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2375-2548</issn>
    <publisher>
      <publisher-name>American Association for the Advancement of Science</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9417173</article-id>
    <article-id pub-id-type="pmid">36026442</article-id>
    <article-id pub-id-type="publisher-id">abo6371</article-id>
    <article-id pub-id-type="doi">10.1126/sciadv.abo6371</article-id>
    <article-categories>
      <subj-group subj-group-type="article-type">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Biomedicine and Life Sciences</subject>
      </subj-group>
      <subj-group subj-group-type="legacy-article-type">
        <subject>SciAdv r-articles</subject>
      </subj-group>
      <subj-group subj-group-type="field">
        <subject>Cancer</subject>
        <subject>Human Genetics</subject>
      </subj-group>
      <subj-group subj-group-type="overline">
        <subject>Human Genetics</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Cancer-driving mutations are enriched in genic regions intolerant to germline variation</article-title>
      <alt-title alt-title-type="short-title">Population genetics of cancer-driving mutations</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8939-5445</contrib-id>
        <name>
          <surname>Vitsios</surname>
          <given-names>Dimitrios</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-data-curation/">Data curation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-formal-analysis/">Formal analysis</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-investigation/">Investigation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-project-administration/">Project administration</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-software/">Software</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-supervision/">Supervision</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Visualization" vocab-term-identifier="https://web.archive.org/web/20180313224017/http://dictionary.credit.niso.org/Contributor_Roles/Visualization">Visualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-original-draft/">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="cor1" ref-type="corresp">*</xref>
        <xref rid="afn1" ref-type="author-notes">†</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8965-0813</contrib-id>
        <name>
          <surname>Dhindsa</surname>
          <given-names>Ryan S.</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-formal-analysis/">Formal analysis</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-investigation/">Investigation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-software/">Software</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Visualization" vocab-term-identifier="https://web.archive.org/web/20180313224017/http://dictionary.credit.niso.org/Contributor_Roles/Visualization">Visualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-original-draft/">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff2" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="aff3" ref-type="aff">
          <sup>3</sup>
        </xref>
        <xref rid="aff4" ref-type="aff">
          <sup>4</sup>
        </xref>
        <xref rid="cor1" ref-type="corresp">*</xref>
        <xref rid="afn1" ref-type="author-notes">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0798-3479</contrib-id>
        <name>
          <surname>Matelska</surname>
          <given-names>Dorota</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-data-curation/">Data curation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-formal-analysis/">Formal analysis</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-software/">Software</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Visualization" vocab-term-identifier="https://web.archive.org/web/20180313224017/http://dictionary.credit.niso.org/Contributor_Roles/Visualization">Visualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-original-draft/">Writing - original draft</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mitchell</surname>
          <given-names>Jonathan</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zou</surname>
          <given-names>Xuequing</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Armenia</surname>
          <given-names>Joshua</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-data-curation/">Data curation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff5" ref-type="aff">
          <sup>5</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1756-7551</contrib-id>
        <name>
          <surname>Hu</surname>
          <given-names>Fengyuan</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-software/">Software</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Quanli</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-data-curation/">Data curation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-formal-analysis/">Formal analysis</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-software/">Software</role>
        <xref rid="aff2" ref-type="aff">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2733-3078</contrib-id>
        <name>
          <surname>Sidders</surname>
          <given-names>Ben</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-project-administration/">Project administration</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-supervision/">Supervision</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff5" ref-type="aff">
          <sup>5</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Harper</surname>
          <given-names>Andrew R.</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-supervision/">Supervision</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-original-draft/">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1527-961X</contrib-id>
        <name>
          <surname>Petrovski</surname>
          <given-names>Slavé</given-names>
        </name>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-conceptualization/">Conceptualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-funding-acquisition/">Funding acquisition</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-methodology/">Methodology</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-project-administration/">Project administration</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-resources/">Resources</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-supervision/">Supervision</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-validation/">Validation</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Visualization" vocab-term-identifier="https://web.archive.org/web/20180313224017/http://dictionary.credit.niso.org/Contributor_Roles/Visualization">Visualization</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-original-draft/">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="https://credit.niso.org/term/contributor-roles/" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/term/contributor-roles-writing-review-editing/">Writing - review &amp; editing</role>
        <xref rid="aff1" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="aff6" ref-type="aff">
          <sup>6</sup>
        </xref>
        <xref rid="cor1" ref-type="corresp">*</xref>
      </contrib>
      <aff id="aff1"><label><sup>1</sup></label>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</aff>
      <aff id="aff2"><label><sup>2</sup></label>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Waltham, MA, USA.</aff>
      <aff id="aff3"><label><sup>3</sup></label>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.</aff>
      <aff id="aff4"><label><sup>4</sup></label>Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX, USA.</aff>
      <aff id="aff5"><label><sup>5</sup></label>Bioinformatics and Data Science, Research, and Early Development, Oncology R&amp;D, AstraZeneca, Cambridge, UK.</aff>
      <aff id="aff6"><label><sup>6</sup></label>Department of Medicine, University of Melbourne, Austin Health, Melbourne, Victoria, Australia.</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Corresponding author. Email: <email xlink:href="dimitrios.vitsios@astrazeneca.com">dimitrios.vitsios@astrazeneca.com</email> (D.V.), <email xlink:href="ryan.dhindsa@astrazeneca.com">ryan.dhindsa@astrazeneca.com</email> (R.S.D.), <email xlink:href="slav.petrovski@astrazeneca.com">slav.petrovski@astrazeneca.com</email> (S.P.)</corresp>
      <fn id="afn1" fn-type="equal">
        <label>†</label>
        <p>These authors contributed equally to this work.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <month>8</month>
      <year>2022</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pub">
      <day>26</day>
      <month>8</month>
      <year>2022</year>
    </pub-date>
    <volume>8</volume>
    <issue>34</issue>
    <elocation-id>eabo6371</elocation-id>
    <history>
      <date date-type="received">
        <day>16</day>
        <month>2</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>12</day>
        <month>7</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).</copyright-statement>
      <copyright-year>2022</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense" start_date="2022-08-26">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-NonCommercial license</ext-link>, which permits use, distribution, and reproduction in any medium, so long as the resultant use is <bold>not</bold> for commercial advantage and provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="sciadv.abo6371.pdf"/>
    <abstract>
      <p>Large reference datasets of protein-coding variation in human populations have allowed us to determine which genes and genic subregions are intolerant to germline genetic variation. There is also a growing number of genes implicated in severe Mendelian diseases that overlap with genes implicated in cancer. We hypothesized that cancer-driving mutations might be enriched in genic subregions that are depleted of germline variation relative to somatic variation. We introduce a new metric, OncMTR (oncology missense tolerance ratio), which uses 125,748 exomes in the Genome Aggregation Database (gnomAD) to identify these genic subregions. We demonstrate that OncMTR can significantly predict driver mutations implicated in hematologic malignancies. Divergent OncMTR regions were enriched for cancer-relevant protein domains, and overlaying OncMTR scores on protein structures identified functionally important protein residues. Last, we performed a rare variant, gene-based collapsing analysis on an independent set of 394,694 exomes from the UK Biobank and find that OncMTR markedly improves genetic signals for hematologic malignancies.</p>
    </abstract>
    <abstract abstract-type="teaser">
      <p>Analysis of ~125,000 human exomes reveals that cancer-causing mutations accrue in regions where inherited mutations are depleted.</p>
    </abstract>
    <custom-meta-group>
      <custom-meta>
        <meta-name>Copyeditor</meta-name>
        <meta-value>Nicole Falcasantos</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec sec-type="introduction" disp-level="1">
    <title>INTRODUCTION</title>
    <p>The availability of large-scale human genetic variation reference datasets has revolutionized our ability to identify disease-causing mutations (<xref rid="R1" ref-type="bibr"><italic toggle="yes">1</italic></xref>, <xref rid="R2" ref-type="bibr"><italic toggle="yes">2</italic></xref>). Through the effective process of natural selection, variants with severe clinical outcomes are generally depleted in these datasets. We and others have leveraged this paradigm to develop intolerance metrics that quantify the extent to which natural selection constrains germline variation in genes and genic subregions (<xref rid="R3" ref-type="bibr"><italic toggle="yes">3</italic></xref>–<xref rid="R6" ref-type="bibr"><italic toggle="yes">6</italic></xref>). These methods have proven invaluable in prioritizing which of the roughly 20,000 protein-coding variants observed in any given individual are most likely to contribute to disease. Interpreting variants in the context of cancer suffers from similar challenges as interpreting germline variation: Cancer cells often carry thousands of somatic mutations, but only some of these drive the oncogenic process. Despite their success in prioritizing germline variants, population genetics–based approaches have yet to be applied in the context of distinguishing between somatic cancer driving mutations and neutral “passenger” mutations.</p>
    <p>Many developmental disorder-causing germline mutations occur in essential genic subregions, leading to dysfunction of crucial cellular biology pathways. We postulated that if these same mutations arise mitotically later in life, then they will not cause the same developmental disease due to more limited expression of the mutation but could have equally as profound impacts on cellular biology. Consistent with this, there are several examples whereby identical point mutations that cause severe developmental syndromes when mutated in the germ line cause cancer when mutated somatically (<xref rid="R7" ref-type="bibr"><italic toggle="yes">7</italic></xref>, <xref rid="R8" ref-type="bibr"><italic toggle="yes">8</italic></xref>), including identical mutations in <italic toggle="yes">PTEN</italic>, <italic toggle="yes">ASXL1</italic> (<xref rid="R9" ref-type="bibr"><italic toggle="yes">9</italic></xref>), <italic toggle="yes">EZH2</italic> (<xref rid="R10" ref-type="bibr"><italic toggle="yes">10</italic></xref>), and others (<xref rid="R11" ref-type="bibr"><italic toggle="yes">11</italic></xref>). Many of these genes are involved in cell proliferation, chromatin remodeling, genome maintenance, and signal transduction pathways. This convergence highlights a subset of genes in the human genome that are crucial to cell biology, whereby disruptive mutations can cause different clinical outcomes depending on their timing, localization, and cellular context.</p>
    <p>Here, we hypothesized that regions of genes that are under strong negative selection for germline variation but are exceptionally mitotically mutable would be enriched for variants that increase cancer risk. Identifying these genic subregions could help prioritize cancer-driving mutations. Here, we focus on missense variants as they are the most observed protein-coding variant class and are becoming increasingly clinically actionable (<xref rid="R12" ref-type="bibr"><italic toggle="yes">12</italic></xref>) but are also more difficult to interpret than protein-truncating annotated variants. We previously introduced the missense tolerance ratio (MTR), a sliding window–based approach that detects genetic subregions depleted of missense variation (<xref rid="R6" ref-type="bibr"><italic toggle="yes">6</italic></xref>). In this study, we extended this method to produce a score [OncMTR (oncology missense tolerance ratio)] to identify depleted of germline variation relative to somatic variation using exome data from 125,748 individuals in the Genome Aggregation Database (gnomAD) (<xref rid="R1" ref-type="bibr"><italic toggle="yes">1</italic></xref>). We demonstrate that OncMTR effectively predicts driver mutations of hematologic malignancies. We also use 394,694 UK Biobank (UKB) exomes to illustrate the utility of OncMTR in prioritizing variants in genetic discovery for cancer phenotypes. This work introduces a population genetics approach to identifying genic subregions enriched for cancer-related somatic missense mutations. We accompany our work with a web app that enables easy visualization of OncMTR scores for each protein-coding gene: <ext-link xlink:href="http://oncmtr.public.cgr.astrazeneca.com" ext-link-type="uri">http://oncmtr.public.cgr.astrazeneca.com</ext-link>.</p>
  </sec>
  <sec sec-type="results" disp-level="1">
    <title>RESULTS</title>
    <sec disp-level="2">
      <title>Putative somatic variants in gnomAD</title>
      <p>Population-level catalogs of human genetic variation allow for the investigation of selective constraint and mutational patterns in the exome. We used the gnomAD database of 125,748 human exomes to survey both germline and somatic variants (<xref rid="R1" ref-type="bibr"><italic toggle="yes">1</italic></xref>). Although the gnomAD variant calling pipeline was tuned to detect germline variation, we reasoned that we may also be able to identify somatic variants that reach a sufficiently high variant allele frequency to be detected through their germline variant caller. Inherited heterozygous germline variants are expected to have an allelic ratio close to 50%. We observed that the distribution of median allelic balance (AB_median) values for gnomAD variants followed a bimodal distribution, with one distribution centered around 50% and another smaller distribution centered around 20% (<xref rid="F1" ref-type="fig">Fig. 1A</xref>).</p>
      <fig position="float" id="F1" fig-type="image" specific-use="distribute">
        <label>Fig. 1.</label>
        <caption>
          <title>Defining the OncMTR score.</title>
          <p>(<bold>A</bold>) Bimodal distribution of median allelic balance values for heterozygous variants in the gnomAD database. This distribution refers to all gnomAD variants, consistent with gnomAD AB_median figures. We defined putative somatic variants as those with an AB_median ≤ 0.3 (dashed line). (<bold>B</bold>) The top figure demonstrates the MTR distribution of <italic toggle="yes">TP53</italic> when considering all missense variants (blue) and when restricted to only germline variants (i.e., AB_median &gt; 0.3; depicted in pink). We defined OncMTR as the difference between these two distributions (bottom). (<bold>C</bold>) OncMTR scores overlaid on the AlphaFold structure for TP53. The most intolerant region maps to the DNA binding domain of the protein, which is strongly enriched for mutations known to drive hematologic malignancies.</p>
        </caption>
        <graphic xlink:href="sciadv.abo6371-f1" position="float"/>
      </fig>
    </sec>
    <sec disp-level="2">
      <title>Defining OncMTR</title>
      <p>We previously introduced a sliding window–based metric, the MTR, which measures purifying selection on missense variation in genic subregions (<xref rid="R6" ref-type="bibr"><italic toggle="yes">6</italic></xref>). This score demonstrably detects crucial functional domains of proteins that can cause Mendelian disease when mutated in the germ line. Motivated by the overlap between mutations associated with Mendelian disease and cancer, we set out to create a cancer-relevant version of MTR (see Methods) that captures regions that are depleted of germline variation relative to somatic variation. In this study, we defined another variation of the MTR score, namely, MTR<sup>germline</sup>. In its construction, MTR<sup>germline</sup> is restricted to only those variants achieving an AB_median &gt; 0.3. Taking the well-known cancer gene <italic toggle="yes">TP53</italic> as an example, we can observe those genic subregions where the two MTR formulations diverged (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). We then define OncMTR as the difference between these two MTR formulations for each codon and using a 31-codon sliding window (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). Negative scores correspond to regions with the greatest divergence between germline intolerance and somatic variant enrichment. Overlaying OncMTR scores on the AlphaFold-predicted structure of TP53 (<xref rid="R13" ref-type="bibr"><italic toggle="yes">13</italic></xref>) illustrated that the strongest negative scores correspond to the DNA binding domain, which is the domain enriched for mutations known to drive hematologic malignancies (<xref rid="F1" ref-type="fig">Fig. 1C</xref>).</p>
    </sec>
    <sec disp-level="2">
      <title>Using OncMTR to prioritize driver mutations in hematologic malignancies</title>
      <p>Motivated by the positive proof of concept demonstrated for <italic toggle="yes">TP53</italic>, we next tested whether the MTR and MTR<sup>germline</sup> distributions differed across other oncogenes and tumor suppressor genes included in the Catalogue of Somatic Mutations in Cancer (COSMIC) Cancer Gene Census (CGC). The CGC is divided into two tiers, with tier 1 containing bona fide cancer genes (<italic toggle="yes">n</italic> = 556) and tier 2 containing genes that have strong indications of playing a role in cancer but with less expansive evidence than tier 1 (<italic toggle="yes">n</italic> = 137). The difference between MTR and MTR<sup>germline</sup> distributions per gene, calculated via cross-entropy, was significantly higher for tier 1 genes than a random selection of 556 non-CGC genes (<italic toggle="yes">P</italic> = 5.7 × 10<sup>−31</sup>), the remainder of the exome (<italic toggle="yes">P</italic> = 2.8 × 10<sup>−67</sup>), and tier 2 genes (<italic toggle="yes">P</italic> = 1.1 × 10<sup>−7</sup>) (<xref rid="F2" ref-type="fig">Fig. 2A</xref>). The cross-entropy was also significantly larger for tier 2 genes than the remaining genes in the exome (<italic toggle="yes">P</italic> = 2.6 × 10<sup>−4</sup>) (<xref rid="F2" ref-type="fig">Fig. 2A</xref>). We also compared the cross-entropy between genes annotated in IntOGen as loss of function (LoF) versus “activating” (i.e., gain of function) and explored the signals from the CGC tier 1 and 2 gene sets, excluding genes acting only through LoF mechanism (fig. S10). Overall, there is a significant difference between MTR and MTR<sup>germline</sup> distributions for all genes regardless of the mechanism of action of the mutational cancer driver genes, when compared against the rest of the exome. However, we observe that restricting analysis to genes with a gain-of-function mechanism (i.e., excluding those with LoF mechanism), there is a stronger enrichment signal compared to the rest of the exome or between activating and “LoF” gene sets. For example, IntOGen activating cross-entropy was more divergent from the rest of the exome than IntOGen LoF and with a significant difference (<italic toggle="yes">P</italic> = 0.01, Mann-Whitney <italic toggle="yes">U</italic> test; fig. S10A). The same pattern was observed for the CGC tier 1 and 2 datasets, although it was significant only for CGC tier 1 (<italic toggle="yes">P</italic> = 0.037 and <italic toggle="yes">P</italic> = 0.28, respectively, Mann-Whitney <italic toggle="yes">U</italic> test; fig. S10, B and C). Together, these results support the hypothesis that mitotically mutable genic subregions that are intolerant to germline variation are broadly relevant to cancer.</p>
      <fig position="float" id="F2" fig-type="image" specific-use="distribute">
        <label>Fig. 2.</label>
        <caption>
          <title>OncMTR regions are enriched for somatic variants associated with hematologic malignancies.</title>
          <p>(<bold>A</bold>) Cross-entropy between the distribution MTR and MTR<sup>germline</sup> distributions for COSMIC CGC genes, a random selection of genes, and the rest of the exome. (<bold>B</bold>) Receiver operator curve (ROC) depicting the ability of random forest models based on either the raw OncMTR score, the OncMTR transcript-level percentile scores (“Tx%”), and a joint model in discriminating between 546 unique leukemogenic variants and a random size-matched set of variants. (<bold>C</bold>) Mean ROC AUCs (with fivefold cross-validation) of logistic regression models based on raw OncMTR and other genome-wide scores in predicting variants involved in leukemia [same variant set as (B)]. The putatively neutral variant sets comprise a random, size- and transcript-matched selection of variants. OncMTR (mutrate) refers to the version of the OncMTR that considers the trimer mutability rates of each codon in its formulation. (<bold>D</bold>) The OncMTR distributions of driver mutations for hematologic malignancies versus solid tumors are derived from the Cancer Genome Interpreter.</p>
        </caption>
        <graphic xlink:href="sciadv.abo6371-f2" position="float"/>
      </fig>
      <p>Distinguishing between cancer-causing driver mutations and neutral passenger mutations remains a central challenge in cancer genomics. We thus tested whether OncMTR could help prioritize somatic mutations that cause hematologic malignancies. We found that the OncMTR scores of a previously defined list of 546 unique leukemogenic driver mutations (table S1) (<xref rid="R14" ref-type="bibr"><italic toggle="yes">14</italic></xref>) were significantly lower than a size-matched set of random variants (<italic toggle="yes">P</italic> = 2.97 × 10<sup>−86</sup>, Mann-Whitney <italic toggle="yes">U</italic> test; fig. S1A). A random forest model using OncMTR achieved an area under the receiving operator curve (AUC) of 0.74 in discriminating between these leukemogenic variants and the random set (<xref rid="F2" ref-type="fig">Fig. 2B</xref>). We also calculated transcript-level percentiles for the MTR scores, in which lower percentiles corresponded to lower OncMTR scores. The AUC or the OncMTR transcript percentiles was 0.76, and a combined model that incorporated both the raw OncMTR scores and transcript percentiles achieved an even higher AUC of 0.78 (<xref rid="F2" ref-type="fig">Fig. 2B</xref>).</p>
      <p>We next compared the performance of OncMTR with other population- and evolutionary-based scores, including CADD (<xref rid="R15" ref-type="bibr"><italic toggle="yes">15</italic></xref>), ncER (<xref rid="R16" ref-type="bibr"><italic toggle="yes">16</italic></xref>), LINSIGHT (<xref rid="R17" ref-type="bibr"><italic toggle="yes">17</italic></xref>), and phyloP (<xref rid="R18" ref-type="bibr"><italic toggle="yes">18</italic></xref>), in predicting these leukemogenic variants. Here, we defined the putatively neutral variant set as a random set that was both size- and transcript-matched with the leukemogenic set. Transcript matching ensures that we can detect the power of each score to distinguish driver from neutral mutations within the same genes, rather than with neutral variants in genes that may have different score profiles than the carrier genes. In comparing the mean AUC across fivefold cross-validation via logistic regression, OncMTR outperforms the other scores, achieving an AUC of 0.71, compared to AUCs of 0.61, 0.58, 0.52, and 0.50, achieved by ncER, LINSIGHT, CADD, and phyloP, respectively. This highlights OncMTR’s ability to capture orthogonal and previously unidentified information compared to existing scores in picking up leukemogenic variants, which were not a focus set of variants in the training and development of many existing variant effect scores.</p>
      <p>As constructed, OncMTR compares the ratio of observed missense variants to synonymous variants over an expected ratio. Because the expected number of mutations could be influenced by local sequence context, we also constructed a score that accounts for trimer mutability rate in its construction (“OncMTR-mutrate”; see Methods). OncMTR-mutrate was considerably correlated with the original (nonmutability rate–informed) version of OncMTR, achieving a Pearson’s correlation of 0.75 across all transcripts. We also assessed the predictive power of OncMTR-mutrate in classifying leukemogenic variants against a random size- and transcript-matched set of putative neutral variants. OncMTR-mutrate achieved an AUC of 0.69 compared to the original OncMTR that achieved an AUC 0.71 on the same dataset (<xref rid="F2" ref-type="fig">Fig. 2C</xref>). We also make the OncMTR-mutrate version of scores across all transcripts publicly available through the OncMTR Viewer web app (<ext-link xlink:href="http://oncmtr.public.cgr.astrazeneca.com" ext-link-type="uri">http://oncmtr.public.cgr.astrazeneca.com</ext-link>).</p>
      <p>To further assess the capacity of OncMTR to prioritize driver mutations, we trained random forest models with raw OncMTR scores using fivefold cross-validation. The mean AUC for predicting leukemogenic variants was 0.74 (fig. S2). We next compared the performance of OncMTR in distinguishing between a set of random variants and 200 established driver mutations implicated in acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), diffuse large B cell lymphoma (DLBCL), or multiple myeloma (MM), achieving an AUC of 0.65 (fig. S2) and having significantly disparate OncMTR distributions from each other (<italic toggle="yes">P</italic> = 4.89 × 10<sup>−5</sup>, Mann-Whitney <italic toggle="yes">U</italic> test; fig. 1B and table S2). Logistic regression–based classifiers achieved similar, albeit marginally lower, AUCs than the random forest models (with AUCs of 0.73 and 0.62 for the two variant sets, respectively), likely due to a small degree of nonlinear distribution of OncMTR scores (fig. S6). To determine which OncMTR cutoff could maximize sensitivity and specificity, we calculated the Youden index from each of the above learning tasks (see Methods). The optimal cutoff was identified as OncMTR &lt; −0.05. Together, these results demonstrate the utility of our population genetics–based approach in identifying genic subregions relevant to hematologic malignancies.</p>
      <p>Because the somatic mutations used to calculate OncMTR arose in the blood, we expected that OncMTR would more reliably prioritize driver mutations in hematologic malignancies than in solid tumors. As expected, the OncMTR scores of driver mutations implicated in heme malignancies were significantly lower (<italic toggle="yes">P</italic> = 2.53 × 10<sup>−9</sup>, Mann-Whitney <italic toggle="yes">U</italic> test; <xref rid="F2" ref-type="fig">Fig. 2D</xref>). More generally, we find that 7.2% of bases in hematological malignancy genes and 24.7% of the driver missense variants among them correspond to low OncMTR regions (&lt;−0.05). This is in comparison to 3.5% of bases in other genes in the genome (<italic toggle="yes">P</italic> = 2.50 × 10<sup>−182</sup> and <italic toggle="yes">P</italic> = 5.10 × 10<sup>−41</sup>, respectively, Fisher’s exact test). To determine whether OncMTR performs better for certain subtypes of heme malignancies, we compared OncMTR distributions of putative driver and passenger mutations identified in a recent comprehensive in silico saturation mutagenesis experiment (<xref rid="R19" ref-type="bibr"><italic toggle="yes">19</italic></xref>). This dataset includes simulated variants across three genes for CLL, nine genes for AML, two genes for non-Hodgkin lymphoma, five genes for lymphoma, six genes for MM, and two genes for ALL (table S10). The OncMTR scores of predicted driver mutations were significantly lower than those of passenger mutations for each cancer subtype, although we observed the strongest separation in CLL (<italic toggle="yes">P</italic> &lt; 2 × 10<sup>−308</sup>, Wilcoxon test) and AML (<italic toggle="yes">P</italic> = 1.4 × 10<sup>−155</sup>, Wilcoxon test) (fig. S3).</p>
      <p>We next assessed whether OncMTR can successfully distinguish between ClinVar pathogenic and benign somatic variants. Logistic regression classification between pathogenic and benign or random variants across all protein-coding genes reached an AUC of 0.60 and 0.58, respectively [<italic toggle="yes">P</italic> = 815 unique pathogenic versus <italic toggle="yes">B</italic> = 58 unique benign variants; a set <italic toggle="yes">R</italic> (random) of equal size to <italic toggle="yes">P</italic> was sampled to compile the random variants; see also Methods] (fig. S4). We next restricted the set of pathogenic somatic variants to those occurring in genes associated with hematologic malignancies and compared to benign or random variants. The AUC was 0.62 in distinguishing between pathogenic and benign variants in hematologic malignancy genes (<italic toggle="yes">P</italic> = 64 versus <italic toggle="yes">B</italic> = 20) and 0.67 when comparing to benign variants across the entire exome (<italic toggle="yes">P</italic> = 64 versus <italic toggle="yes">B</italic> = 58). The AUCs for pathogenic hematologic malignancy variants versus random variants were 0.61 for random variants restricted to heme genes (<italic toggle="yes">P</italic> = 64 versus <italic toggle="yes">R</italic> = 64) and 0.64 for random variants pulled from all protein-coding genes (<italic toggle="yes">P</italic> = 815 versus <italic toggle="yes">R</italic> = 815) (fig. S4). These results provide support to this blood-based sequencing version of OncMTR being more powerful in identifying pathogenic mutations implicated with heme malignancies.</p>
      <p>Last, to further explore OncMTR’s power to agnostically detect putative oncogenic regions, we scanned all protein-coding genes in ClinVar in search of transcripts that are preferentially enriched for ClinVar pathogenic somatic variants in regions with OncMTR scores at the bottom 20 percentile of the full OncMTR distribution (see Methods). We identified 101 such transcripts from 24 unique genes (<italic toggle="yes">P</italic> &lt; 0.05, Fisher’s exact test; table S11), with several known cancer driver genes captured, such as <italic toggle="yes">TP53</italic>, <italic toggle="yes">IDH1</italic>, <italic toggle="yes">ALK</italic>, and <italic toggle="yes">HNRNPA1</italic> (<xref rid="R20" ref-type="bibr"><italic toggle="yes">20</italic></xref>). Many of the top-ranked genes are implicated in hematologic malignancies, including <italic toggle="yes">MYC</italic>, <italic toggle="yes">MSH2</italic>, and <italic toggle="yes">FBXW7</italic> (fig. S5) (<xref rid="R21" ref-type="bibr"><italic toggle="yes">21</italic></xref>–<xref rid="R23" ref-type="bibr"><italic toggle="yes">23</italic></xref>).</p>
    </sec>
    <sec disp-level="2">
      <title>Genes carrying mutations implicated in both human Mendelian disease and cancer</title>
      <p>There have been an increasing number of observations, which germline mutations in certain genic regions cause severe Mendelian disease, whereas identical somatic mutations—occurring later in life and localized to specific tissue(s)—in these regions can cause cancer. Here, we examined OncMTR distributions for three genes implicated in both neurodevelopmental disease and adult leukemias: <italic toggle="yes">GNB1</italic>, <italic toggle="yes">NRAS</italic>, and <italic toggle="yes">DNMT3A</italic> (<xref rid="F3" ref-type="fig">Fig. 3, A to C</xref>, and table S4).</p>
      <fig position="float" id="F3" fig-type="image" specific-use="distribute">
        <label>Fig. 3.</label>
        <caption>
          <title>OncMTR distributions for genes implicated in both cancer and Mendelian disease.</title>
          <p>(<bold>A</bold> to <bold>C</bold>) OncMTR scores for <italic toggle="yes">GNB1</italic> (A), <italic toggle="yes">NRAS</italic> (B), and <italic toggle="yes">DNMT3A</italic> (C) with corresponding protein structures from Protein Data Bank (PDB) (for NRAS, PDB ID: 6zio) or predicted by AlphaFold (<xref rid="R13" ref-type="bibr"><italic toggle="yes">13</italic></xref>). Points on the OncMTR plots and spheres on the protein structures indicate pathogenic somatic mutations included in TopMED leukemogenic variant set. Red points indicate variants with OncMTR &lt; −0.05. Points with a pink outline indicate somatic leukemogenic variants that are also known to cause developmental delay (DD) when mutated de novo in the germ line. De novo mutations were aggregated from the Online Mendelian Inheritance in Man database. GDP, guanosine diphosphate.</p>
        </caption>
        <graphic xlink:href="sciadv.abo6371-f3" position="float"/>
      </fig>
      <p>Germline de novo mutations in <italic toggle="yes">GNB1</italic> cause a severe developmental syndrome characterized by intellectual disability and other variable features, including hypotonia, seizures, and poor growth (<xref rid="R8" ref-type="bibr"><italic toggle="yes">8</italic></xref>). Somatic mutations in this gene have been associated with ALL, CLL, and myelodysplastic syndrome (<xref rid="R24" ref-type="bibr"><italic toggle="yes">24</italic></xref>). Three of four somatic driver mutations in this gene overlap with de novo mutations implicated in developmental delay (p.Asp76Gly, p.Ile80Thr, and p.Ile80Asn) (<xref rid="F3" ref-type="fig">Fig. 3A</xref>) (<xref rid="R8" ref-type="bibr"><italic toggle="yes">8</italic></xref>). All four mutated residues reside in a low OncMTR region (OncMTR &lt; −0.05) of the gene, which corresponds to the Gβ protein surface that interacts with Gα subunits and downstream effectors (<xref rid="F3" ref-type="fig">Fig. 3A</xref>).</p>
      <p><italic toggle="yes">NRAS</italic> encodes a RAS protein with intrinsic guanosine triphosphatase activity that has been implicated in multiple hematologic and solid malignancies (<xref rid="R25" ref-type="bibr"><italic toggle="yes">25</italic></xref>). There are 28 somatic missense variants in this gene at four distinct amino acid positions associated with juvenile myelomonocytic leukemia and AML, and all are residing in low OncMTR regions (<xref rid="F3" ref-type="fig">Fig. 3B</xref>) (<xref rid="R14" ref-type="bibr"><italic toggle="yes">14</italic></xref>). Two of these mutations have also been reported as causal germline de novo mutations for Noonan syndrome, a developmental delay syndrome that includes congenital heart defects, short stature, and other features (p.Gly13Asp and p.Gly60Glu) (<xref rid="F3" ref-type="fig">Fig. 3B</xref>) (<xref rid="R26" ref-type="bibr"><italic toggle="yes">26</italic></xref>, <xref rid="R27" ref-type="bibr"><italic toggle="yes">27</italic></xref>).</p>
      <p><italic toggle="yes">DNMT3A</italic> encodes a DNA methyltransferase essential for DNA methylation during human embryogenesis and, when mutated somatically, increases risk of AML (<xref rid="R28" ref-type="bibr"><italic toggle="yes">28</italic></xref>). In a large study on clonal hematopoiesis of indeterminate potential (CHIP), <italic toggle="yes">DNMT3A</italic> was found to harbor the largest proportion of CHIP variants of all CHIP-associated genes (<xref rid="R29" ref-type="bibr"><italic toggle="yes">29</italic></xref>), suggesting that it is highly mitotically mutable. In line with this, the OncMTR distribution of this gene is highly enriched for negative values, even compared to <italic toggle="yes">GNB1</italic> and <italic toggle="yes">NRAS</italic> (<xref rid="F3" ref-type="fig">Fig. 3C</xref>). The R882 amino acid residue of <italic toggle="yes">DNMT3A</italic> corresponds to a DNA binding residue that is a major somatic mutation hotspot in CHIP and AML (<xref rid="R28" ref-type="bibr"><italic toggle="yes">28</italic></xref>). De novo germline mutations at this residue are associated with an overgrowth syndrome called Tatton-Brown-Rahman syndrome characterized by tall stature and impaired intellectual development (<xref rid="R30" ref-type="bibr"><italic toggle="yes">30</italic></xref>). Mutations at the R882 residue are thought to interfere with DNA binding, resulting in functional impairment of the protein and aberrant DNA methylation patterns (<xref rid="R31" ref-type="bibr"><italic toggle="yes">31</italic></xref>). As expected, we identify that the leukemogenic variants in this gene are enriched in low OncMTR regions (<xref rid="F3" ref-type="fig">Fig. 3C</xref>). Together, these results support the notion that some critically important genic subregions are exceptionally mitotically mutable, and mutations in these regions result in different phenotypic outcomes depending on timing and cellular context (<xref rid="R9" ref-type="bibr"><italic toggle="yes">9</italic></xref>).</p>
    </sec>
    <sec disp-level="2">
      <title>Enrichment of low OncMTR scores in protein domains</title>
      <p>One strength of the sliding window approach implemented in OncMTR is that its estimates are independent of biological boundaries, such as annotated protein domains, which are not always well annotated. However, it is known that cancer-causing missense mutations tend to cluster in certain functional domains. We thus tested whether Pfam domains and domain superfamilies were enriched for low OncMTR regions (defined as OncMTR &lt; −0.05). Across human protein-coding genes, low OncMTR regions were significantly enriched for several protein domains previously implicated in cancer, such as homeodomains (Bonferroni adjusted <italic toggle="yes">P</italic> = 4.9 × 10<sup>−46</sup>, Fisher’s exact test), protein kinase domains (Bonferroni adjusted <italic toggle="yes">P</italic> = 5.25 × 10<sup>−110</sup>, Fisher’s exact test), RING domains (Bonferroni adjusted <italic toggle="yes">P</italic> = 3.22 × 10<sup>−48</sup>, Fisher’s exact test), and others (<xref rid="F4" ref-type="fig">Fig. 4, A and B</xref>, and tables S5 and S6). Furthermore, we found that proteins that had functional domains enriched for low OncMTR scores are significantly enriched in genes with TOPMed leukemogenic variants and known cancer hotspots (<xref rid="F4" ref-type="fig">Fig. 4C</xref> and tables S1 to S3 and S7 to S9) (<xref rid="R32" ref-type="bibr"><italic toggle="yes">32</italic></xref>). Among these two lists of genes, zinc finger motifs were found to be the most strongly enriched for low OncMTR scores (most significant adjusted <italic toggle="yes">P</italic> = 2.3 × 10<sup>−52</sup> from the union list, based on Fisher’s exact test; <xref rid="F4" ref-type="fig">Fig. 4, D to F</xref>), in line with their well-established role in cancer development (<xref rid="R33" ref-type="bibr"><italic toggle="yes">33</italic></xref>). Although the calculation of OncMTR is agnostic to domain annotations, it independently identifies cancer-relevant functional genic subregions.</p>
      <fig position="float" id="F4" fig-type="image" specific-use="distribute">
        <label>Fig. 4.</label>
        <caption>
          <title>Overlap between OncMTR regions and protein domains.</title>
          <p>(<bold>A</bold>) Pfam protein domains most strongly enriched with low OncMTR regions (OncMTR &lt; −0.05). (<bold>B</bold>) Pfam clans most strongly enriched with low OncMTR regions. The DNA binding superfamily set was defined in a prior publication (<xref rid="R44" ref-type="bibr"><italic toggle="yes">44</italic></xref>). (<bold>C</bold>) Proportions of genes enriched with low OncMTR scores in annotated protein domains in various cancer-related gene sets: genes carrying TopMED leukemogenic variants, annotated cancer hotspots, and the union of these three lists. (<bold>D</bold> to <bold>F</bold>) The most abundant Pfam domains enriched with low OncMTR regions in proteins encoded by the labeled sets of cancer genes. Error bars in each panel represent 95% confidence intervals (CIs). <italic toggle="yes">P</italic> values were calculated with Fisher’s exact test and adjusted via Bonferroni correction. <italic toggle="yes">P</italic><sub>adj</sub>, adjusted <italic toggle="yes">P</italic> value.</p>
        </caption>
        <graphic xlink:href="sciadv.abo6371-f4" position="float"/>
      </fig>
      <p>As low OncMTR scores can indicate functionally important sites within proteins, we sought to understand whether low OncMTR regions residing outside of annotated protein domains were enriched for any functional motifs. We found that low OncMTR regions share characteristics with structurally disordered regions and were not enriched for currently known sequence motifs (fig. S9).</p>
      <p>Because of the high enrichment of protein domains within low OncMTR regions, we next explored whether OncMTR captures additional information orthogonal to the presence of a protein domain. To test this, we used a logistic regression classifier based on the presence or absence of a protein domain in predicting the leukemogenic variants. This classifier achieved an AUC of 0.62 (with fivefold cross-validation) as compared to the superior 0.71 achieved by OncMTR on the same dataset.</p>
    </sec>
    <sec disp-level="2">
      <title>Informing rare variant collapsing analysis with OncMTR</title>
      <p>With increasing adoption of next-generation sequencing to generate case-control cohorts, rare variant collapsing analysis has emerged as a powerful approach to detecting disease-associated genes for both rare and complex disorders. In this approach, the proportion of cases with a qualifying variant (QV) is compared to the proportion of controls with a QV in the same gene. We have previously shown that incorporating an MTR filter in defining QVs markedly improves rare variant collapsing analyses (<xref rid="R2" ref-type="bibr"><italic toggle="yes">2</italic></xref>). In that phenome-wide association study (PheWAS) on approximately 300,000 exomes in the UKB, the collapsing analyses detected seven genes associated with hematologic malignancies (<xref rid="R2" ref-type="bibr"><italic toggle="yes">2</italic></xref>). Here, we sought to test whether OncMTR would further improve collapsing analysis signals for hematologic malignancy associations by performing a collapsing analysis on 394,694 European exomes contained in the UKB focused on 1394 chapter IX (neoplasm) phenotypes. We defined a total of eight collapsing models with and without OncMTR filters (table S12). Imposing an OncMTR filter of −0.05 (i.e., only considering missense QVs that fall below this threshold) significantly increased the effect sizes of gene-phenotype associations (<italic toggle="yes">P</italic> &lt; 0.0001) for each model (<xref rid="F5" ref-type="fig">Fig. 5A</xref> and table S13). We observed genome-wide significant (<italic toggle="yes">P</italic> &lt; 1 × 10<sup>−8</sup>) associations between several heme malignancies and <italic toggle="yes">DNMT3A</italic>, <italic toggle="yes">FBXW7</italic>, <italic toggle="yes">IDH2</italic>, <italic toggle="yes">IGLL5</italic>, <italic toggle="yes">JAK2</italic>, <italic toggle="yes">SF3B1</italic>, <italic toggle="yes">SRSF2</italic>, <italic toggle="yes">TET2</italic>, and <italic toggle="yes">TP53</italic>; in certain cases, the effect sizes were 10-fold greater than without adopting the OncMTR filter (<xref rid="F5" ref-type="fig">Fig. 5B</xref>). We also found that the association between <italic toggle="yes">TP53</italic> and CLL only reached significance in models including our OncMTR filter; for example, in the “raredmg” model, this association had a <italic toggle="yes">P</italic> value of 1.2 × 10<sup>−7</sup> [odds ratio (OR) = 8.8; 95% confidence interval (CI): 4.8 to 16.0], whereas in the “raredmgoncmtr” model, the same association reached a <italic toggle="yes">P</italic> value of 3.4 × 10<sup>−10</sup> (OR = 33.2; 95% CI: 16.1 to 68.7). Thus, applying the OncMTR filter effectively reduces background variation in the setting of gene-level collapsing analysis for hematological malignancy phenotypes, and we advise future large-scale hematological malignancy discovery studies to consider adopting OncMTR filter for improved signal detection.</p>
      <fig position="float" id="F5" fig-type="image" specific-use="distribute">
        <label>Fig. 5.</label>
        <caption>
          <title>Collapsing analyses using OncMTR.</title>
          <p>(<bold>A</bold>) Effect sizes of gene-phenotype associations derived from a gene-level collapsing analysis performed on neoplasm phenotypes in 394,694 UKB exomes. “Flex” and “flexdmg” models include missense QVs with a gnomAD minor allele frequency (MAF) ≤ 0.1%. “Rare” and “raredmg” models include missense QVs with a gnomAD MAF ≤ 0.005%. “Flexdmg” and “raredmg” only consider missense variants with a REVEL score ≥ 0.5. Collapsing models are fully defined in table S12. (<bold>B</bold>) Changes in ORs observed for selected gene-phenotype associations. MDS, myelodysplastic syndrome.</p>
        </caption>
        <graphic xlink:href="sciadv.abo6371-f5" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="discussion" disp-level="1">
    <title>DISCUSSION</title>
    <p>Determining the clinical relevance of missense variants in oncogenes remains a central challenge in cancer genetics (<xref rid="R12" ref-type="bibr"><italic toggle="yes">12</italic></xref>, <xref rid="R32" ref-type="bibr"><italic toggle="yes">32</italic></xref>). Motivated by the observation that missense variants in certain genic subregions can cause severe Mendelian disease when mutated in the germline and cancer when mutated somatically, we introduced a population genetics–based framework called OncMTR to quantitate the divergence between germline constraint and somatic mutability across the human exome.</p>
    <p>First, we demonstrated that oncogenes are enriched for these critically important regions that do not tolerate germline missense variants but harbor somatic mutations. We then illustrated that OncMTR can effectively distinguish between leukemogenic driver mutations and passenger mutations. Although OncMTR is calculated using a sliding window without any input of domain annotations, we found that genic subregions that have low OncMTR scores are significantly enriched for protein domains known to be relevant to cancer. Illustrative of our hypothesis was the observation that identical point mutations implicated in both severe Mendelian disease and leukemia in the genes <italic toggle="yes">GNB1</italic>, <italic toggle="yes">NRAS</italic>, and <italic toggle="yes">DNMT3A</italic> occur in low OncMTR regions. Last, we found that incorporating OncMTR in a gene-level collapsing analysis on hematologic malignancy phenotypes using 394,694 UKB exomes improved the signal-to-noise ratio for detecting hematologic malignancy associations. We have also developed a web server for visualization of OncMTR scores for each human protein-coding gene: <ext-link xlink:href="http://oncmtr.public.cgr.astrazeneca.com" ext-link-type="uri">http://oncmtr.public.cgr.astrazeneca.com</ext-link>.</p>
    <p>Our findings have important implications for the disease biology of both severe Mendelian disorders and cancer. The convergence of genes and genic subregions between these two disease areas suggest that similar biological processes play a fundamental role in these two groups of phenotypes. Cellular proliferation, chromatin remodeling, cell migration, and other cancer-relevant processes have been implicated in neurodevelopmental diseases (<xref rid="R11" ref-type="bibr"><italic toggle="yes">11</italic></xref>, <xref rid="R34" ref-type="bibr"><italic toggle="yes">34</italic></xref>–<xref rid="R36" ref-type="bibr"><italic toggle="yes">36</italic></xref>). Furthermore, our work supports the notion that mutations in these genes have different phenotypic manifestations based on timing (i.e., zygote versus adulthood), localization (systemic versus hematological), and cellular context.</p>
    <p>There exist many other approaches that aim to predict which genes and genic subregions are relevant to cancer. Many of these methods consider nonrandom clustering patterns of somatic mutations in either the linear protein sequence or three-dimensional space (<xref rid="R37" ref-type="bibr"><italic toggle="yes">37</italic></xref>). OncMTR could improve the predictive performance of other, orthogonal driver mutation prediction approaches (<xref rid="R38" ref-type="bibr"><italic toggle="yes">38</italic></xref>), as a recent in silico saturation mutagenesis experiment demonstrated the strength of incorporating multiple lines of evidence in prioritizing driver mutations (<xref rid="R19" ref-type="bibr"><italic toggle="yes">19</italic></xref>).</p>
    <p>One limitation of OncMTR in its current formulation is that it does not reflect the broader range of solid tumor malignancies because it is based on somatic mutations observed in blood-based sequencing. The general framework introduced in this study could also be applied to tumor-normal sequence datasets when sample sizes for those datasets increase to comparable numbers. Other future work should also focus on extending OncMTR to the noncoding genome, as availability of population-level whole-genome sequencing data become available (<xref rid="R39" ref-type="bibr"><italic toggle="yes">39</italic></xref>, <xref rid="R40" ref-type="bibr"><italic toggle="yes">40</italic></xref>). Furthermore, we used gnomAD because it represents the largest collection of publicly available aggregated allele frequency data. However, gnomAD variants were all called using a germline variant caller. While we demonstrated that we could detect somatic variants in this database, we were likely limited to those that reached a sufficiently high variant allele frequency to be detected. Use of somatic variant callers adopted on these large-scale datasets could further improve the sensitivity of OncMTR.</p>
  </sec>
  <sec sec-type="methods" disp-level="1">
    <title>METHODS</title>
    <sec disp-level="2">
      <title>Reconstructing the MTR with 125,000 samples from gnomAD</title>
      <p>We first reconstruct the MTR using a cohort of 125,748 exomes from the gnomAD Consortium (v2, GRCh38 liftover). The formula for deriving the window-based MTR scores has been introduced in the original paper (<xref rid="R6" ref-type="bibr"><italic toggle="yes">6</italic></xref>)<disp-formula><mml:math id="m1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtext>MTR</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo> </mml:mo><mml:mfrac><mml:mrow><mml:mtext>missense</mml:mtext><mml:mo> </mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mtext>obs</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo> </mml:mo><mml:mtext>missense</mml:mtext><mml:mo> </mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mtext>obs</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:mtext>synonymous</mml:mtext><mml:mo> </mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mtext>obs</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:mo> </mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:mtext>missense</mml:mtext><mml:mo> </mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mtext>exp</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo> </mml:mo><mml:mtext>missense</mml:mtext><mml:mo> </mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mtext>exp</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:mtext>synonymous</mml:mtext><mml:mo> </mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mtext>exp</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mfrac></mml:mrow></mml:mrow></mml:math></disp-formula>where the numerator represents the observed proportion of missense variants among the total observed protein-coding variation. The numerator is then scaled by the same proportion computed from the collection of all possible protein-coding variants in the corresponding protein-coding window. A window size of 31 codons has been used for calculating MTR based on the gnomAD cohort, in agreement with the previously published score (<xref rid="R6" ref-type="bibr"><italic toggle="yes">6</italic></xref>).</p>
      <p>The expected proportion of missense variants in a given protein-coding window was calculated by annotating all possible variants of a protein-coding transcript with SnpEff 4.3t using GRCh38.92 as the reference annotation and assuming that all events were equally likely to occur. Annotation with SnpEff focused on single-nucleotide variants (SNVs) that were flagged as PASS variants in the original gnomAD release (v2). Variants annotated as “missense_variant” or “missense_variant&amp;splice_region_variant” by SnpEff represent the set of “missense” variants in the MTR formula. Variants annotated as “synonymous_variant,” “stop_retained_variant,” “splice_region_variant&amp;stop_retained_variant,” or “splice_region_variant&amp;synonymous_variant” by SnpEff were considered as the “synonymous” variants in the same formula.</p>
    </sec>
    <sec disp-level="2">
      <title>OncMTR score construction</title>
      <p>Using MTR as our basis, we construct the OncMTR score (i.e., Oncology MTR score) to capture protein-coding subregions that are depleted of germline variation relative to somatic variation. We observe that the total distribution of AB_median values across all gnomAD variants (<xref rid="F1" ref-type="fig">Fig. 1A</xref>) is bimodal, with the main peak centered close to 0.5 and a second one emerging for values approximately around 0.2. The AB_median metric represents the allelic ratio between the alleles for each variant, with values close to 0.5, reflecting an equal number of copies being inherited from each parent in heterozygous settings, while truly biological variants that approach zero increasingly reflect variants that more likely arose somatically.</p>
      <p>We leverage this observation to construct an alternative version of the original MTR score: excluding any putative somatic variants and using only germline variants from the gnomAD dataset. We achieve that by selecting only variants with AB_median &gt; 0.3, constructing the MTR<sup>germline</sup> version of the score. OncMTR is then defined as the difference of the original MTR score from the MTR<sup>germline</sup> version<disp-formula><mml:math id="m2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtext>OncMTR</mml:mtext><mml:mo>=</mml:mo><mml:msup><mml:mtext>MTR</mml:mtext><mml:mtext>germline</mml:mtext></mml:msup><mml:mo>−</mml:mo><mml:mtext>MTR</mml:mtext></mml:mrow></mml:mrow></mml:math></disp-formula></p>
      <p>Negative OncMTR values (i.e., MTR<sup>germline</sup> &lt; MTR) represent regions that are depleted of germline variation relative to somatic variation, thus allowing to highlight putative oncogenic subregions in protein-coding genes.</p>
    </sec>
    <sec disp-level="2">
      <title>Sensitivity analysis on the definition of putative somatic variants</title>
      <p>We base the selection of the AB_median cutoff for defining putative somatic variants on the empirical distribution of AB_median values, derived from the gnomAD dataset (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). Specifically, we observe a bimodal distribution, with the two peaks centered at p1: +0.186 and p2: +0.477 on the <italic toggle="yes">x</italic> axis. The middle point of the two peaks is at m: +0.332 (fig. S8A). To be more conservative with regards to characterizing variants as putative somatic, we initially suggest a cutoff slightly lower than the middle point of the two peaks, picking 0.30 as our starting cutoff value.</p>
      <p>Furthermore, we calculated additional versions of OncMTR scores resulting from different values of AB_median thresholds, specifically 0.20, 0.25, 0.28, 0.30, 0.32, and 0.35. Let us define OncMTR<italic toggle="yes"><sub>k</sub></italic> as the set of OncMTR scores calculated using <italic toggle="yes">k</italic> as the AB_median threshold across all canonical transcripts. We calculated the Pearson’s correlations for all available {OncMTR<italic toggle="yes"><sub>i</sub></italic>, OncMTR<italic toggle="yes"><sub>j</sub></italic>} pairs and observed that OncMTR<sub>0.30</sub> has a correlation of 0.86 and 0.88 with OncMTR<sub>0.28</sub> and OncMTR<sub>0.32</sub>, respectively, showing that the score remains very robust around the 0.30 threshold (fig. S8B). Correlation remains considerably high also with OncMTR<sub>0.25</sub> (<italic toggle="yes">r</italic> = 0.74), while it falls more rapidly when the threshold is shifted to the other direction (<italic toggle="yes">r</italic> = 0.68 with OncMTR<sub>0.35</sub>). That may indicate that increase of AB_median threshold above 0.32 leads to noticeable mixture of putative somatic and nonsomatic variants. On the basis of the above observations, we select 0.30 as the default AB_median cutoff to calculate OncMTR. We also report Pearson’s correlations between all {OncMTR<italic toggle="yes"><sub>i</sub></italic>, OncMTR<italic toggle="yes"><sub>j</sub></italic>} pairs for reference (fig. S8B).</p>
    </sec>
    <sec disp-level="2">
      <title>Compilation of variant sets</title>
      <p>We used a precompiled set of variants known to be drivers of hematologic malignancies in a total of 160 genes (<xref rid="R41" ref-type="bibr"><italic toggle="yes">41</italic></xref>). This list was generated from recurrent hematologic somatic mutations in the literature and COSMIC, excluding genes with a relatively high proportion of LoF germline mutations. A second, smaller precompiled list focused on genes that were recurrent drivers specifically for myeloid malignancies (<xref rid="R14" ref-type="bibr"><italic toggle="yes">14</italic></xref>). A third validation set included a list of annotated driver mutations provided through the IntOGen database (<xref rid="R42" ref-type="bibr"><italic toggle="yes">42</italic></xref>). We restricted this set to “tier 1” (highest confidence) driver mutations observed in hematologic malignancies, which included ALL, AML, CLL, DLBCL, and MM. To identify variants overlapping between hematologic malignancy and neurodevelopmental disease, we identified genes from the leukemogenic set that had entries in the Online Mendelian Inheritance in Man for both adult leukemias and neurodevelopmental disease, which included <italic toggle="yes">GNB1</italic>, <italic toggle="yes">DNMT3A</italic>, and <italic toggle="yes">NRAS</italic> (<xref rid="R43" ref-type="bibr"><italic toggle="yes">43</italic></xref>).</p>
    </sec>
    <sec disp-level="2">
      <title>Classification of oncogenic variant sets with OncMTR</title>
      <p>We have performed classification of different oncogenic variant sets (TOPMed leukemogenic and IntOGen drivers) against random variant sets of equal size. We use two supervised models for the binary classification task, logistic regression with “max_iter” = 1000 and a random forest classifier with “max_depth” = 2, to avoid overfitting on the training set. Each classification was performed as a fivefold cross-validation task, and the mean AUC from all folds is reported to reflect the total average performance of each learning task. The implementations of logistic regression and random forest were derived from the sklearn Python package (v0.22.1).</p>
      <p>We also estimated the optimal OncMTR cut point for each classification by calculating the Youden’s index from each learning task. The average Youden index from all classification tasks performed with logistic regression was <italic toggle="yes">Y</italic><sub>LR</sub> = −0.0409 (SD: 0.00126), while for random forest, it was <italic toggle="yes">Y</italic><sub>RF</sub> = −0.0614 (SD: 0.00057). The mean of the two averages of Youden indexes is −0.05115 or −0.05, after rounding it up to one decimal point for simplicity. We thus consider OncMTR values of less than −0.05 to have the most distinctive power.</p>
    </sec>
    <sec disp-level="2">
      <title>Identifying OncMTR regions significantly enriched for ClinVar somatic variants</title>
      <p>For this analysis, we use all ClinVar somatic variants (ORIGIN = 2) from the GRCh38 release (last accessed on 9 June 2019), focusing on those annotated as missense or synonymous. We consider as pathogenic variants those annotated as “Pathogenic” or “Likely_pathogenic” and as benign those annotated as “Benign” or “Likely_benign” (based on ClinVar). Classification between pathogenic and benign (or random) variant sets was performed with a logistic regression classifier with fivefold cross validation (sklearn, Python package v0.22.1). When restricting the classification to heme-implicated genes, we derived those gene sets based on the IntOGen annotation (table S10).</p>
      <p>To identify genes/transcripts across the exome that are preferentially enriched for ClinVar somatic pathogenic variants in regions with low OncMTR scores, we use Fisher’s exact test. Specifically, we scan across each transcript and identify what percentage of the codons in each transcript achieves an OncMTR score at the bottom 20 percentile of the full OncMTR distribution (across the entire transcript). Then, we check whether known pathogenic or likely pathogenic ClinVar missense variants preferentially land in these codons (i.e., corresponding to low OncMTR scores) compared to the rest of the transcript. We apply Fisher’s exact test to evaluate the enrichment of each set of regions, i.e., those with low OncMTR scores versus the rest of the transcript. Eventually, we rank each transcript based on the OR and significance of the Fisher’s exact test enrichments (table S11).</p>
    </sec>
    <sec disp-level="2">
      <title>Enrichment of low OncMTR scores in protein domains</title>
      <p>To describe the functional context of OncMTR, we calculated enrichment of constrained regions in protein domain families. Residues within each canonical transcript (as defined by UniProtKB) were divided into two classes on the basis of their corresponding OncMTR scores: less than −0.05 (constrained; as defined by Youden’s index) and greater or equal to −0.05 (relaxed). Domain and clan annotations for the human proteome were taken from the Pfam 34.0 database. DNA binding domains were pulled from a previous compendium (<xref rid="R44" ref-type="bibr"><italic toggle="yes">44</italic></xref>). The final set of the canonical human proteome consisted of 18,313 annotated proteins. Enrichments of the constrained regions in protein domains were tested with the Fisher’s exact test, followed by Bonferroni correction and with significance level of adjusted <italic toggle="yes">P</italic> value of 0.05.</p>
    </sec>
    <sec disp-level="2">
      <title>Analysis of low OncMTR regions outside of protein domains</title>
      <p>Low OncMTR scores can indicate functionally important protein regions. We analyzed whether any genes had low OncMTR regions (i.e., spanning at least 30 residues with OncMTR lower than −0.05) residing outside of protein domains, but we did not identify any unannotated regions that could constitute previously unknown domains. According to UniProt annotations, 38% of them (372 of 978 in total) overlap with predicted disordered regions.</p>
      <p>To find common sequence motifs that would be indicative of functionally important sites, we first obtained clusters of low OncMTR regions of similar sequences (using CD-HIT, at 60% sequence identity). We found only three clusters consisting of multiple (i.e., two) short sequences. To find sequence motifs shared within those clusters, we ran MEME searches, which did not return any significant motifs.</p>
      <p>Last, to show that those low OncMTR regions do not significantly differ from other regions outside of Pfam domains in terms of structural disorder, we analyzed their per-residue confidence scores [pLDDT (predicted local distance difference test)] derived from AlphaFold2 models (<xref rid="R13" ref-type="bibr"><italic toggle="yes">13</italic></xref>). In general, regions with lower pLDDT scores have a higher chance of being unstructured. As shown in fig. S9, pLDDTs for Pfam domains are significantly higher than for the regions outside of annotated domains.</p>
    </sec>
    <sec disp-level="2">
      <title>UKB collapsing analysis</title>
      <p>Collapsing analyses were performed using the 394,694 exomes available in the UKB cohort (<xref rid="R45" ref-type="bibr"><italic toggle="yes">45</italic></xref>). The UKB is a prospective study of approximately 500,000 participants aged 40 to 69 years old at time of recruitment. Participants were recruited in the United Kingdom between 2006 and 2010 and are continuously followed. The average age at recruitment for sequenced individuals was 56.5 years, and 54% of the sequenced cohort is of female genetic sex. Participant data include health records that are periodically updated by the UKB, self-reported survey information, linkage to death and cancer registries, collection of urine and blood biomarkers, imaging data, accelerometer data, and various other phenotypic end points. All study participants provided informed consent, and the UKB has approval from the North-West Multi-centre Research Ethics Committee (11/NW/0382).</p>
      <p>We performed a gene-based collapsing analysis on 1394 chapter IX (neoplasm) phenotypes adopting our previously described approach (<xref rid="R2" ref-type="bibr"><italic toggle="yes">2</italic></xref>). We implemented a total of eight dominant collapsing models with and without OncMTR filters (table S12). Using SnpEff (<xref rid="R46" ref-type="bibr"><italic toggle="yes">46</italic></xref>), we defined protein truncating variants (PTVs) as variants annotated as exon_loss_variant, frameshift_variant, start_lost, stop_gained, stop_lost, splice_acceptor_variant, splice_donor_variant, gene_fusion, bidirectional_gene_fusion, rare_amino_acid_variant, and transcript_ablation. We defined missense as follows: missense_variant_splice_region_variant and missense_variant. Nonsynonymous variants included the following: exon_loss_variant, frameshift_variant, start_lost, stop_gained, stop_lost, splice_acceptor_variant, splice_donor_variant, gene_fusion, bidirectional_gene_fusion, rare_amino_acid_variant, transcript_ablation, conservative_inframe_deletion, conservative_inframe_insertion, disruptive_inframe_insertion, disruptive_inframe_deletion, missense_variant_splice_region_variant, missense_variant, and protein_altering_variant. We derived allele frequencies from gnomAD (<xref rid="R1" ref-type="bibr"><italic toggle="yes">1</italic></xref>). The raredmg, raredmg_OncMTR, flexdmg, and flexdmg_oncMTR models incorporated a REVEL cutoff of REVEL ≥ 0.5 to restrict to putatively damaging missense variants (<xref rid="R47" ref-type="bibr"><italic toggle="yes">47</italic></xref>).</p>
      <p>To compute <italic toggle="yes">P</italic> values, the carriers of at least one QV in a gene were compared to the noncarriers. The difference in the proportion of cases and controls carrying QVs in a gene was tested using a Fisher’s exact two-sided test. Variants were required to pass the following quality control criteria: minimum coverage of 10×; annotation in consensus coding sequence (CCDS) transcripts (release 22; approximately 34 Mb); at most 80% alternate reads in homozygous genotypes; percent of alternate reads in heterozygous variants ≤0.25 and ≥0.8; binomial test of alternate allele proportion departure from 50% in heterozygous state <italic toggle="yes">P</italic> &gt; 1 × 10<sup>−6</sup>; genotype quality score (GQ) ≥ 20; Fisher’s strand bias score (FS) ≤ 200 (indels) ≤ 60 (SNVs); mapping quality score (MQ) ≥ 40; quality score (QUAL) ≥ 30; read position rank sum score (RPRS) ≥ −2; mapping quality rank sum score (MQRS) ≥ −8; DRAGEN variant status = PASS; the variant site achieved 10-fold coverage in ≤25% of gnomAD exomes; and if the variant was observed in gnomAD exomes, then the variant achieved exome <italic toggle="yes">z</italic> score ≤ −2.0 and exome MQ ≤ 30. We excluded 46 genes that we previously found associated with batch effects (<xref rid="R2" ref-type="bibr"><italic toggle="yes">2</italic></xref>).</p>
      <p>For all models, we applied the following quality control filters: minimum coverage of 10×; annotation in CCDS transcripts (release 22; approximately 34 Mb); at most 80% alternate reads in homozygous genotypes; percent of alternate reads in heterozygous variants ≤0.25 and ≥0.8; binomial test of alternate allele proportion departure from 50% in heterozygous state <italic toggle="yes">P</italic> &lt; 1 × 10<sup>−6</sup>; GQ ≤ 20; FS ≥ 200 (indels) ≥ 60 (SNVs); MQ ≤ 40; QUAL ≤30; read position rank sum score ≤ −2; MQRS ≤ −8; DRAGEN variant status = PASS; the variant site achieved 10-fold coverage in ≤25% of gnomAD exomes; and if the variant was observed in gnomAD exomes, then the variant achieved exome <italic toggle="yes">z</italic> score ≤ −2.0 and exome MQ ≤ 30. We excluded 46 genes that we previously found associated with batch effects 10.</p>
      <p>We defined the study-wide significance threshold as <italic toggle="yes">P</italic> &lt; 1 × 10<sup>−8</sup>. We have previously shown using an <italic toggle="yes">n</italic>-of-1 permutation approach and the empirical null synonymous model that this threshold corresponds to a false positive rate of 9 and 2, respectively, of ∼346.5 million tests for binary traits in the setting of a collapsing analysis PheWAS (<xref rid="R2" ref-type="bibr"><italic toggle="yes">2</italic></xref>).</p>
    </sec>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgments</title>
    <p>We thank L. Middleton for assistance in developing the OncMTR web portal. We thank O. Backhouse for useful discussions and feedback on this work.</p>
    <sec>
      <p><bold>Funding:</bold> We acknowledge that they received no funding in support of this research.</p>
    </sec>
    <sec>
      <p><bold>Author contributions:</bold> D.V., R.S.D., and S.P. designed the study. D.V., R.S.D., D.M., J.M., J.A., Q.W., B.S., A.R.H., and S.P. performed analyses and statistical interpretation. Q.W. and F.H. performed bioinformatic processing. D.V., R.S.D., and S.P. wrote the manuscript. D.V. and D.M. developed the web portal. D.V., R.S.D., D.M., J.M., X.Z., J.A., F.H., Q.W., B.S., A.R.H., and S.P. reviewed the manuscript.</p>
    </sec>
    <sec>
      <p><bold>Competing interests:</bold> D.V., R.S.D., D.M., J.M., X.Z., J.A., F.H., Q.W., B.S., A.R.H., and S.P. are current employees and/or stockholders of AstraZeneca. The authors declare that they have no other competing interests.</p>
    </sec>
    <sec>
      <p><bold>Data and materials availability:</bold> All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. OncMTR scores are publicly available through the online portal: <ext-link xlink:href="http://oncmtr.public.cgr.astrazeneca.com" ext-link-type="uri">http://oncmtr.public.cgr.astrazeneca.com</ext-link>. Code is publicly available on GitHub: <ext-link xlink:href="https://github.com/astrazeneca-cgr-publications/OncMTR" ext-link-type="uri">https://github.com/astrazeneca-cgr-publications/OncMTR</ext-link>. OncMTR scores and code are also available at a public Zenodo repository: <ext-link xlink:href="https://doi.org/10.5281/zenodo.6817251" ext-link-type="uri">https://doi.org/10.5281/zenodo.6817251</ext-link>. gnomAD data are accessible at <ext-link xlink:href="https://gnomad.broadinstitute.org" ext-link-type="uri">https://gnomad.broadinstitute.org</ext-link>. All whole-exome sequencing data described in this paper are publicly available to registered researchers through the UKB data access protocol. Exomes can be found in the UKB showcase portal: <ext-link xlink:href="https://biobank.ndph.ox.ac.uk/showcase/label.cgi?id=170" ext-link-type="uri">https://biobank.ndph.ox.ac.uk/showcase/label.cgi?id=170</ext-link>. Additional information about registration for access to the data is available at <ext-link xlink:href="http://www.ukbiobank.ac.uk/register-apply" ext-link-type="uri">www.ukbiobank.ac.uk/register-apply</ext-link>. Data for this study were obtained under resource application number 26041. Association statistics generated on this cohort are also publicly available through our AstraZeneca Centre for Genomics Research (CGR) PheWAS Portal: <ext-link xlink:href="http://azphewas.com" ext-link-type="uri">http://azphewas.com</ext-link>.</p>
    </sec>
  </ack>
  <sec sec-type="supplementary-material">
    <title>Supplementary Materials</title>
    <sec>
      <title>This PDF file includes:</title>
      <supplementary-material position="float" content-type="local-data">
        <caption>
          <p>Figs. S1 to S10</p>
        </caption>
        <media xlink:href="sciadv.abo6371_sm.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <sec>
      <title>Other Supplementary Material for this manuscript includes the following:</title>
      <supplementary-material position="float" content-type="local-data">
        <caption>
          <p>Tables S1 to S13</p>
        </caption>
        <media xlink:href="sciadv.abo6371_tables_s1_to_s13.zip">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </sec>
  <sec>
    <p>
      <ext-link xlink:href="https://en.bio-protocol.org/cjrap.aspx?eid=10.1126/sciadv.abo6371" ext-link-type="uri">View/request a protocol for this paper from <italic toggle="yes">Bio-protocol</italic>.</ext-link>
    </p>
  </sec>
  <ref-list>
    <title>REFERENCES AND NOTES</title>
    <ref id="R1">
      <label>1</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K. J.</given-names><surname>Karczewski</surname></string-name>, <string-name><given-names>L. C.</given-names><surname>Francioli</surname></string-name>, <string-name><given-names>G.</given-names><surname>Tiao</surname></string-name>, <string-name><given-names>B. B.</given-names><surname>Cummings</surname></string-name>, <string-name><given-names>J.</given-names><surname>Alföldi</surname></string-name>, <string-name><given-names>Q.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>R. L.</given-names><surname>Collins</surname></string-name>, <string-name><given-names>K. M.</given-names><surname>Laricchia</surname></string-name>, <string-name><given-names>A.</given-names><surname>Ganna</surname></string-name>, <string-name><given-names>D. P.</given-names><surname>Birnbaum</surname></string-name>, <string-name><given-names>L. D.</given-names><surname>Gauthier</surname></string-name>, <string-name><given-names>H.</given-names><surname>Brand</surname></string-name>, <string-name><given-names>M.</given-names><surname>Solomonson</surname></string-name>, <string-name><given-names>N. A.</given-names><surname>Watts</surname></string-name>, <string-name><given-names>D.</given-names><surname>Rhodes</surname></string-name>, <string-name><given-names>M.</given-names><surname>Singer-Berk</surname></string-name>, <string-name><given-names>E. M.</given-names><surname>England</surname></string-name>, <string-name><given-names>E. G.</given-names><surname>Seaby</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Kosmicki</surname></string-name>, <string-name><given-names>R. K.</given-names><surname>Walters</surname></string-name>, <string-name><given-names>K.</given-names><surname>Tashman</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Farjoun</surname></string-name>, <string-name><given-names>E.</given-names><surname>Banks</surname></string-name>, <string-name><given-names>T.</given-names><surname>Poterba</surname></string-name>, <string-name><given-names>A.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>C.</given-names><surname>Seed</surname></string-name>, <string-name><given-names>N.</given-names><surname>Whiffin</surname></string-name>, <string-name><given-names>J. X.</given-names><surname>Chong</surname></string-name>, <string-name><given-names>K. E.</given-names><surname>Samocha</surname></string-name>, <string-name><given-names>E.</given-names><surname>Pierce-Hoffman</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Zappala</surname></string-name>, <string-name><given-names>A. H.</given-names><surname>O’Donnell-Luria</surname></string-name>, <string-name><given-names>E. V.</given-names><surname>Minikel</surname></string-name>, <string-name><given-names>B.</given-names><surname>Weisburd</surname></string-name>, <string-name><given-names>M.</given-names><surname>Lek</surname></string-name>, <string-name><given-names>J. S.</given-names><surname>Ware</surname></string-name>, <string-name><given-names>C.</given-names><surname>Vittal</surname></string-name>, <string-name><given-names>I. M.</given-names><surname>Armean</surname></string-name>, <string-name><given-names>L.</given-names><surname>Bergelson</surname></string-name>, <string-name><given-names>K.</given-names><surname>Cibulskis</surname></string-name>, <string-name><given-names>K. M.</given-names><surname>Connolly</surname></string-name>, <string-name><given-names>M.</given-names><surname>Covarrubias</surname></string-name>, <string-name><given-names>S.</given-names><surname>Donnelly</surname></string-name>, <string-name><given-names>S.</given-names><surname>Ferriera</surname></string-name>, <string-name><given-names>S.</given-names><surname>Gabriel</surname></string-name>, <string-name><given-names>J.</given-names><surname>Gentry</surname></string-name>, <string-name><given-names>N.</given-names><surname>Gupta</surname></string-name>, <string-name><given-names>T.</given-names><surname>Jeandet</surname></string-name>, <string-name><given-names>D.</given-names><surname>Kaplan</surname></string-name>, <string-name><given-names>C.</given-names><surname>Llanwarne</surname></string-name>, <string-name><given-names>R.</given-names><surname>Munshi</surname></string-name>, <string-name><given-names>S.</given-names><surname>Novod</surname></string-name>, <string-name><given-names>N.</given-names><surname>Petrillo</surname></string-name>, <string-name><given-names>D.</given-names><surname>Roazen</surname></string-name>, <string-name><given-names>V.</given-names><surname>Ruano-Rubio</surname></string-name>, <string-name><given-names>A.</given-names><surname>Saltzman</surname></string-name>, <string-name><given-names>M.</given-names><surname>Schleicher</surname></string-name>, <string-name><given-names>J.</given-names><surname>Soto</surname></string-name>, <string-name><given-names>K.</given-names><surname>Tibbetts</surname></string-name>, <string-name><given-names>C.</given-names><surname>Tolonen</surname></string-name>, <string-name><given-names>G.</given-names><surname>Wade</surname></string-name>, <string-name><given-names>M. E.</given-names><surname>Talkowski</surname></string-name>; <collab>Genome Aggregation Database Consortium</collab>, <string-name><given-names>C. A.</given-names><surname>Aguilar Salinas</surname></string-name>, <string-name><given-names>T.</given-names><surname>Ahmad</surname></string-name>, <string-name><given-names>C. M.</given-names><surname>Albert</surname></string-name>, <string-name><given-names>D.</given-names><surname>Ardissino</surname></string-name>, <string-name><given-names>G.</given-names><surname>Atzmon</surname></string-name>, <string-name><given-names>J.</given-names><surname>Barnard</surname></string-name>, <string-name><given-names>L.</given-names><surname>Beaugerie</surname></string-name>, <string-name><given-names>E. J.</given-names><surname>Benjamin</surname></string-name>, <string-name><given-names>M.</given-names><surname>Boehnke</surname></string-name>, <string-name><given-names>L. L.</given-names><surname>Bonnycastle</surname></string-name>, <string-name><given-names>E. P.</given-names><surname>Bottinger</surname></string-name>, <string-name><given-names>D. W.</given-names><surname>Bowden</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Bown</surname></string-name>, <string-name><given-names>J. C.</given-names><surname>Chambers</surname></string-name>, <string-name><given-names>J. C.</given-names><surname>Chan</surname></string-name>, <string-name><given-names>D.</given-names><surname>Chasman</surname></string-name>, <string-name><given-names>J.</given-names><surname>Cho</surname></string-name>, <string-name><given-names>M. K.</given-names><surname>Chung</surname></string-name>, <string-name><given-names>B.</given-names><surname>Cohen</surname></string-name>, <string-name><given-names>A.</given-names><surname>Correa</surname></string-name>, <string-name><given-names>D.</given-names><surname>Dabelea</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Daly</surname></string-name>, <string-name><given-names>D.</given-names><surname>Darbar</surname></string-name>, <string-name><given-names>R.</given-names><surname>Duggirala</surname></string-name>, <string-name><given-names>J.</given-names><surname>Dupuis</surname></string-name>, <string-name><given-names>P. T.</given-names><surname>Ellinor</surname></string-name>, <string-name><given-names>R.</given-names><surname>Elosua</surname></string-name>, <string-name><given-names>J.</given-names><surname>Erdmann</surname></string-name>, <string-name><given-names>T.</given-names><surname>Esko</surname></string-name>, <string-name><given-names>M.</given-names><surname>Färkkilä</surname></string-name>, <string-name><given-names>J.</given-names><surname>Florez</surname></string-name>, <string-name><given-names>A.</given-names><surname>Franke</surname></string-name>, <string-name><given-names>G.</given-names><surname>Getz</surname></string-name>, <string-name><given-names>B.</given-names><surname>Glaser</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Glatt</surname></string-name>, <string-name><given-names>D.</given-names><surname>Goldstein</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gonzalez</surname></string-name>, <string-name><given-names>L.</given-names><surname>Groop</surname></string-name>, <string-name><given-names>C.</given-names><surname>Haiman</surname></string-name>, <string-name><given-names>C.</given-names><surname>Hanis</surname></string-name>, <string-name><given-names>M.</given-names><surname>Harms</surname></string-name>, <string-name><given-names>M.</given-names><surname>Hiltunen</surname></string-name>, <string-name><given-names>M. M.</given-names><surname>Holi</surname></string-name>, <string-name><given-names>C. M.</given-names><surname>Hultman</surname></string-name>, <string-name><given-names>M.</given-names><surname>Kallela</surname></string-name>, <string-name><given-names>J.</given-names><surname>Kaprio</surname></string-name>, <string-name><given-names>S.</given-names><surname>Kathiresan</surname></string-name>, <string-name><given-names>B. J.</given-names><surname>Kim</surname></string-name>, <string-name><given-names>Y. J.</given-names><surname>Kim</surname></string-name>, <string-name><given-names>G.</given-names><surname>Kirov</surname></string-name>, <string-name><given-names>J.</given-names><surname>Kooner</surname></string-name>, <string-name><given-names>S.</given-names><surname>Koskinen</surname></string-name>, <string-name><given-names>H. M.</given-names><surname>Krumholz</surname></string-name>, <string-name><given-names>S.</given-names><surname>Kugathasan</surname></string-name>, <string-name><given-names>S. H.</given-names><surname>Kwak</surname></string-name>, <string-name><given-names>M.</given-names><surname>Laakso</surname></string-name>, <string-name><given-names>T.</given-names><surname>Lehtimäki</surname></string-name>, <string-name><given-names>R. J. F.</given-names><surname>Loos</surname></string-name>, <string-name><given-names>S. A.</given-names><surname>Lubitz</surname></string-name>, <string-name><given-names>R. C. W.</given-names><surname>Ma</surname></string-name>, <string-name><given-names>D. G.</given-names><surname>MacArthur</surname></string-name>, <string-name><given-names>J.</given-names><surname>Marrugat</surname></string-name>, <string-name><given-names>K. M.</given-names><surname>Mattila</surname></string-name>, <string-name><given-names>S.</given-names><surname>McCarroll</surname></string-name>, <string-name><given-names>M. I.</given-names><surname>McCarthy</surname></string-name>, <string-name><given-names>D.</given-names><surname>McGovern</surname></string-name>, <string-name><given-names>R.</given-names><surname>McPherson</surname></string-name>, <string-name><given-names>J. B.</given-names><surname>Meigs</surname></string-name>, <string-name><given-names>O.</given-names><surname>Melander</surname></string-name>, <string-name><given-names>A.</given-names><surname>Metspalu</surname></string-name>, <string-name><given-names>B. M.</given-names><surname>Neale</surname></string-name>, <string-name><given-names>P. M.</given-names><surname>Nilsson</surname></string-name>, <string-name><given-names>M. C.</given-names><surname>O’Donovan</surname></string-name>, <string-name><given-names>D.</given-names><surname>Ongur</surname></string-name>, <string-name><given-names>L.</given-names><surname>Orozco</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Owen</surname></string-name>, <string-name><given-names>C. N. A.</given-names><surname>Palmer</surname></string-name>, <string-name><given-names>A.</given-names><surname>Palotie</surname></string-name>, <string-name><given-names>K. S.</given-names><surname>Park</surname></string-name>, <string-name><given-names>C.</given-names><surname>Pato</surname></string-name>, <string-name><given-names>A. E.</given-names><surname>Pulver</surname></string-name>, <string-name><given-names>N.</given-names><surname>Rahman</surname></string-name>, <string-name><given-names>A. M.</given-names><surname>Remes</surname></string-name>, <string-name><given-names>J. D.</given-names><surname>Rioux</surname></string-name>, <string-name><given-names>S.</given-names><surname>Ripatti</surname></string-name>, <string-name><given-names>D. M.</given-names><surname>Roden</surname></string-name>, <string-name><given-names>D.</given-names><surname>Saleheen</surname></string-name>, <string-name><given-names>V.</given-names><surname>Salomaa</surname></string-name>, <string-name><given-names>N. J.</given-names><surname>Samani</surname></string-name>, <string-name><given-names>J.</given-names><surname>Scharf</surname></string-name>, <string-name><given-names>H.</given-names><surname>Schunkert</surname></string-name>, <string-name><given-names>M. B.</given-names><surname>Shoemaker</surname></string-name>, <string-name><given-names>P.</given-names><surname>Sklar</surname></string-name>, <string-name><given-names>H.</given-names><surname>Soininen</surname></string-name>, <string-name><given-names>H.</given-names><surname>Sokol</surname></string-name>, <string-name><given-names>T.</given-names><surname>Spector</surname></string-name>, <string-name><given-names>P. F.</given-names><surname>Sullivan</surname></string-name>, <string-name><given-names>J.</given-names><surname>Suvisaari</surname></string-name>, <string-name><given-names>E. S.</given-names><surname>Tai</surname></string-name>, <string-name><given-names>Y. Y.</given-names><surname>Teo</surname></string-name>, <string-name><given-names>T.</given-names><surname>Tiinamaija</surname></string-name>, <string-name><given-names>M.</given-names><surname>Tsuang</surname></string-name>, <string-name><given-names>D.</given-names><surname>Turner</surname></string-name>, <string-name><given-names>T.</given-names><surname>Tusie-Luna</surname></string-name>, <string-name><given-names>E.</given-names><surname>Vartiainen</surname></string-name>, <string-name><given-names>M. P.</given-names><surname>Vawter</surname></string-name>, <string-name><given-names>J. S.</given-names><surname>Ware</surname></string-name>, <string-name><given-names>H.</given-names><surname>Watkins</surname></string-name>, <string-name><given-names>R. K.</given-names><surname>Weersma</surname></string-name>, <string-name><given-names>M.</given-names><surname>Wessman</surname></string-name>, <string-name><given-names>J. G.</given-names><surname>Wilson</surname></string-name>, <string-name><given-names>R. J.</given-names><surname>Xavier</surname></string-name>, <string-name><given-names>B. M.</given-names><surname>Neale</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Daly</surname></string-name>, <string-name><given-names>D. G.</given-names><surname>MacArthur</surname></string-name></person-group>, 
<article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title>. <source>Nature</source><volume>581</volume>, 
<fpage>434</fpage>–<lpage>443</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32461654</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Q.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>R. S.</given-names><surname>Dhindsa</surname></string-name>, <string-name><given-names>K.</given-names><surname>Carss</surname></string-name>, <string-name><given-names>A. R.</given-names><surname>Harper</surname></string-name>, <string-name><given-names>A.</given-names><surname>Nag</surname></string-name>, <string-name><given-names>I.</given-names><surname>Tachmazidou</surname></string-name>, <string-name><given-names>D.</given-names><surname>Vitsios</surname></string-name>, <string-name><given-names>S. V. V.</given-names><surname>Deevi</surname></string-name>, <string-name><given-names>A.</given-names><surname>Mackay</surname></string-name>, <string-name><given-names>D.</given-names><surname>Muthas</surname></string-name>, <string-name><given-names>M.</given-names><surname>Hühn</surname></string-name>, <string-name><given-names>S.</given-names><surname>Monkley</surname></string-name>, <string-name><given-names>H.</given-names><surname>Olsson</surname></string-name>; <collab>Astra Zeneca Genomics Initiative</collab>, <string-name><given-names>S.</given-names><surname>Wasilewski</surname></string-name>, <string-name><given-names>K. R.</given-names><surname>Smith</surname></string-name>, <string-name><given-names>R.</given-names><surname>March</surname></string-name>, <string-name><given-names>A.</given-names><surname>Platt</surname></string-name>, <string-name><given-names>C.</given-names><surname>Haefliger</surname></string-name>, <string-name><given-names>S.</given-names><surname>Petrovski</surname></string-name></person-group>, 
<article-title>Rare variant contribution to human disease in 281,104 UK Biobank exomes</article-title>. <source>Nature</source><volume>597</volume>, 
<fpage>527</fpage>–<lpage>532</lpage> (<year>2021</year>).<pub-id pub-id-type="pmid">34375979</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>R. S.</given-names><surname>Dhindsa</surname></string-name>, <string-name><given-names>B. R.</given-names><surname>Copeland</surname></string-name>, <string-name><given-names>A. M.</given-names><surname>Mustoe</surname></string-name>, <string-name><given-names>D. B.</given-names><surname>Goldstein</surname></string-name></person-group>, 
<article-title>Natural selection shapes codon usage in the human genome</article-title>. <source>Am. J. Hum. Genet.</source><volume>107</volume>, 
<fpage>83</fpage>–<lpage>95</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32516569</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names><surname>Petrovski</surname></string-name>, <string-name><given-names>Q.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>E. L.</given-names><surname>Heinzen</surname></string-name>, <string-name><given-names>A. S.</given-names><surname>Allen</surname></string-name>, <string-name><given-names>D. B.</given-names><surname>Goldstein</surname></string-name></person-group>, 
<article-title>Genic Intolerance to functional variation and the interpretation of personal genomes</article-title>. <source>PLOS Genet.</source><volume>9</volume>, 
<fpage>e1003709</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23990802</pub-id></mixed-citation>
    </ref>
    <ref id="R5">
      <label>5</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K. E.</given-names><surname>Samocha</surname></string-name>, <string-name><given-names>E. B.</given-names><surname>Robinson</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Sanders</surname></string-name>, <string-name><given-names>C.</given-names><surname>Stevens</surname></string-name>, <string-name><given-names>A.</given-names><surname>Sabo</surname></string-name>, <string-name><given-names>L. M.</given-names><surname>McGrath</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Kosmicki</surname></string-name>, <string-name><given-names>K.</given-names><surname>Rehnström</surname></string-name>, <string-name><given-names>S.</given-names><surname>Mallick</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kirby</surname></string-name>, <string-name><given-names>D. P.</given-names><surname>Wall</surname></string-name>, <string-name><given-names>D. G.</given-names><surname>MacArthur</surname></string-name>, <string-name><given-names>S. B.</given-names><surname>Gabriel</surname></string-name>, <string-name><given-names>M.</given-names><surname>DePristo</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Purcell</surname></string-name>, <string-name><given-names>A.</given-names><surname>Palotie</surname></string-name>, <string-name><given-names>E.</given-names><surname>Boerwinkle</surname></string-name>, <string-name><given-names>J. D.</given-names><surname>Buxbaum</surname></string-name>, <string-name><given-names>E. H.</given-names><surname>Cook</surname><suffix>Jr.</suffix></string-name>, <string-name><given-names>R. A.</given-names><surname>Gibbs</surname></string-name>, <string-name><given-names>G. D.</given-names><surname>Schellenberg</surname></string-name>, <string-name><given-names>J. S.</given-names><surname>Sutcliffe</surname></string-name>, <string-name><given-names>B.</given-names><surname>Devlin</surname></string-name>, <string-name><given-names>K.</given-names><surname>Roeder</surname></string-name>, <string-name><given-names>B. M.</given-names><surname>Neale</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Daly</surname></string-name></person-group>, 
<article-title>A framework for the interpretation of de novo mutation in human disease</article-title>. <source>Nat. Genet.</source><volume>46</volume>, 
<fpage>944</fpage>–<lpage>950</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25086666</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.</given-names><surname>Traynelis</surname></string-name>, <string-name><given-names>M.</given-names><surname>Silk</surname></string-name>, <string-name><given-names>Q.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>S. F.</given-names><surname>Berkovic</surname></string-name>, <string-name><given-names>L.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>D. B.</given-names><surname>Ascher</surname></string-name>, <string-name><given-names>D. J.</given-names><surname>Balding</surname></string-name>, <string-name><given-names>S.</given-names><surname>Petrovski</surname></string-name></person-group>, 
<article-title>Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation</article-title>. <source>Genome Res.</source><volume>27</volume>, 
<fpage>1715</fpage>–<lpage>1729</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28864458</pub-id></mixed-citation>
    </ref>
    <ref id="R7">
      <label>7</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A.</given-names><surname>Hoischen</surname></string-name>, <string-name><given-names>N.</given-names><surname>Krumm</surname></string-name>, <string-name><given-names>E. E.</given-names><surname>Eichler</surname></string-name></person-group>, 
<article-title>Prioritization of neurodevelopmental disease genes by discovery of new mutations</article-title>. <source>Nat. Neurosci.</source><volume>17</volume>, 
<fpage>764</fpage>–<lpage>772</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24866042</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names><surname>Petrovski</surname></string-name>, <string-name><given-names>S.</given-names><surname>Küry</surname></string-name>, <string-name><given-names>C. T.</given-names><surname>Myers</surname></string-name>, <string-name><given-names>K.</given-names><surname>Anyane-Yeboa</surname></string-name>, <string-name><given-names>B.</given-names><surname>Cogné</surname></string-name>, <string-name><given-names>M.</given-names><surname>Bialer</surname></string-name>, <string-name><given-names>F.</given-names><surname>Xia</surname></string-name>, <string-name><given-names>P.</given-names><surname>Hemati</surname></string-name>, <string-name><given-names>J.</given-names><surname>Riviello</surname></string-name>, <string-name><given-names>M.</given-names><surname>Mehaffey</surname></string-name>, <string-name><given-names>T.</given-names><surname>Besnard</surname></string-name>, <string-name><given-names>E.</given-names><surname>Becraft</surname></string-name>, <string-name><given-names>A.</given-names><surname>Wadley</surname></string-name>, <string-name><given-names>A. R.</given-names><surname>Politi</surname></string-name>, <string-name><given-names>S.</given-names><surname>Colombo</surname></string-name>, <string-name><given-names>X.</given-names><surname>Zhu</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Ren</surname></string-name>, <string-name><given-names>I.</given-names><surname>Andrews</surname></string-name>, <string-name><given-names>T.</given-names><surname>Dudding-Byth</surname></string-name>, <string-name><given-names>A. L.</given-names><surname>Schneider</surname></string-name>, <string-name><given-names>G.</given-names><surname>Wallace</surname></string-name>; <collab>University of Washington Center for Mendelian Genomics</collab>, <string-name><given-names>A. B. I.</given-names><surname>Rosen</surname></string-name>, <string-name><given-names>S.</given-names><surname>Schelley</surname></string-name>, <string-name><given-names>G. M.</given-names><surname>Enns</surname></string-name>, <string-name><given-names>P.</given-names><surname>Corre</surname></string-name>, <string-name><given-names>J.</given-names><surname>Dalton</surname></string-name>, <string-name><given-names>S.</given-names><surname>Mercier</surname></string-name>, <string-name><given-names>X.</given-names><surname>Latypova</surname></string-name>, <string-name><given-names>S.</given-names><surname>Schmitt</surname></string-name>, <string-name><given-names>E.</given-names><surname>Guzman</surname></string-name>, <string-name><given-names>C.</given-names><surname>Moore</surname></string-name>, <string-name><given-names>L.</given-names><surname>Bier</surname></string-name>, <string-name><given-names>E. L.</given-names><surname>Heinzen</surname></string-name>, <string-name><given-names>P.</given-names><surname>Karachunski</surname></string-name>, <string-name><given-names>N.</given-names><surname>Shur</surname></string-name>, <string-name><given-names>T.</given-names><surname>Grebe</surname></string-name>, <string-name><given-names>A.</given-names><surname>Basinger</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Nguyen</surname></string-name>, <string-name><given-names>S.</given-names><surname>Bézieau</surname></string-name>, <string-name><given-names>K.</given-names><surname>Wierenga</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Bernstein</surname></string-name>, <string-name><given-names>I. E.</given-names><surname>Scheffer</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Rosenfeld</surname></string-name>, <string-name><given-names>H. C.</given-names><surname>Mefford</surname></string-name>, <string-name><given-names>B.</given-names><surname>Isidor</surname></string-name>, <string-name><given-names>D. B.</given-names><surname>Goldstein</surname></string-name></person-group>, 
<article-title>Germline de novo mutations in GNB1 cause severe neurodevelopmental disability, hypotonia, and seizures</article-title>. <source>Am. J. Hum. Genet.</source><volume>98</volume>, 
<fpage>1001</fpage>–<lpage>1010</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27108799</pub-id></mixed-citation>
    </ref>
    <ref id="R9">
      <label>9</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A.</given-names><surname>Hoischen</surname></string-name>, <string-name><given-names>B. W. M.</given-names><surname>van Bon</surname></string-name>, <string-name><given-names>B.</given-names><surname>Rodríguez-Santiago</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gilissen</surname></string-name>, <string-name><given-names>L. E. L. M.</given-names><surname>Vissers</surname></string-name>, <string-name><given-names>P.</given-names><surname>de Vries</surname></string-name>, <string-name><given-names>I.</given-names><surname>Janssen</surname></string-name>, <string-name><given-names>B.</given-names><surname>van Lier</surname></string-name>, <string-name><given-names>R.</given-names><surname>Hastings</surname></string-name>, <string-name><given-names>S. F.</given-names><surname>Smithson</surname></string-name>, <string-name><given-names>R.</given-names><surname>Newbury-Ecob</surname></string-name>, <string-name><given-names>S.</given-names><surname>Kjaergaard</surname></string-name>, <string-name><given-names>J.</given-names><surname>Goodship</surname></string-name>, <string-name><given-names>R.</given-names><surname>McGowan</surname></string-name>, <string-name><given-names>D.</given-names><surname>Bartholdi</surname></string-name>, <string-name><given-names>A.</given-names><surname>Rauch</surname></string-name>, <string-name><given-names>M.</given-names><surname>Peippo</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Cobben</surname></string-name>, <string-name><given-names>D.</given-names><surname>Wieczorek</surname></string-name>, <string-name><given-names>G.</given-names><surname>Gillessen-Kaesbach</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Veltman</surname></string-name>, <string-name><given-names>H. G.</given-names><surname>Brunner</surname></string-name>, <string-name><given-names>B. B. B. A.</given-names><surname>de Vries</surname></string-name></person-group>, 
<article-title>De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome</article-title>. <source>Nat. Genet.</source><volume>43</volume>, 
<fpage>729</fpage>–<lpage>731</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21706002</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>W. T.</given-names><surname>Gibson</surname></string-name>, <string-name><given-names>R. L.</given-names><surname>Hood</surname></string-name>, <string-name><given-names>S. H.</given-names><surname>Zhan</surname></string-name>, <string-name><given-names>D. E.</given-names><surname>Bulman</surname></string-name>, <string-name><given-names>A. P.</given-names><surname>Fejes</surname></string-name>, <string-name><given-names>R.</given-names><surname>Moore</surname></string-name>, <string-name><given-names>A. J.</given-names><surname>Mungall</surname></string-name>, <string-name><given-names>P.</given-names><surname>Eydoux</surname></string-name>, <string-name><given-names>R.</given-names><surname>Babul-Hirji</surname></string-name>, <string-name><given-names>J.</given-names><surname>An</surname></string-name>, <string-name><given-names>M. A.</given-names><surname>Marra</surname></string-name>; <collab>FORGE Canada Consortium</collab>, <string-name><given-names>D.</given-names><surname>Chitayat</surname></string-name>, <string-name><given-names>K. M.</given-names><surname>Boycott</surname></string-name>, <string-name><given-names>D. D.</given-names><surname>Weaver</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Jones</surname></string-name></person-group>, 
<article-title>Mutations in EZH2 cause weaver syndrome</article-title>. <source>Am. J. Hum. Genet.</source><volume>90</volume>, 
<fpage>110</fpage>–<lpage>118</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22177091</pub-id></mixed-citation>
    </ref>
    <ref id="R11">
      <label>11</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.</given-names><surname>Kaplanis</surname></string-name>, <string-name><given-names>K. E.</given-names><surname>Samocha</surname></string-name>, <string-name><given-names>L.</given-names><surname>Wiel</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Zhang</surname></string-name>, <string-name><given-names>K. J.</given-names><surname>Arvai</surname></string-name>, <string-name><given-names>R. Y.</given-names><surname>Eberhardt</surname></string-name>, <string-name><given-names>G.</given-names><surname>Gallone</surname></string-name>, <string-name><given-names>S. H.</given-names><surname>Lelieveld</surname></string-name>, <string-name><given-names>H. C.</given-names><surname>Martin</surname></string-name>, <string-name><given-names>J. F.</given-names><surname>McRae</surname></string-name>, <string-name><given-names>P. J.</given-names><surname>Short</surname></string-name>, <string-name><given-names>R. I.</given-names><surname>Torene</surname></string-name>, <string-name><given-names>E.</given-names><surname>de Boer</surname></string-name>, <string-name><given-names>P.</given-names><surname>Danecek</surname></string-name>, <string-name><given-names>E. J.</given-names><surname>Gardner</surname></string-name>, <string-name><given-names>N.</given-names><surname>Huang</surname></string-name>, <string-name><given-names>J.</given-names><surname>Lord</surname></string-name>, <string-name><given-names>I.</given-names><surname>Martincorena</surname></string-name>, <string-name><given-names>R.</given-names><surname>Pfundt</surname></string-name>, <string-name><given-names>M. R. F.</given-names><surname>Reijnders</surname></string-name>, <string-name><given-names>A.</given-names><surname>Yeung</surname></string-name>, <string-name><given-names>H. G.</given-names><surname>Yntema</surname></string-name>; <collab>Deciphering Developmental Disorders Study</collab>, <string-name><given-names>S.</given-names><surname>Borras</surname></string-name>, <string-name><given-names>C.</given-names><surname>Clark</surname></string-name>, <string-name><given-names>J.</given-names><surname>Dean</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Miedzybrodzka</surname></string-name>, <string-name><given-names>A.</given-names><surname>Ross</surname></string-name>, <string-name><given-names>S.</given-names><surname>Tennant</surname></string-name>, <string-name><given-names>T.</given-names><surname>Dabir</surname></string-name>, <string-name><given-names>D.</given-names><surname>Donnelly</surname></string-name>, <string-name><given-names>M.</given-names><surname>Humphreys</surname></string-name>, <string-name><given-names>A.</given-names><surname>Magee</surname></string-name>, <string-name><given-names>V.</given-names><surname>McConnell</surname></string-name>, <string-name><given-names>S.</given-names><surname>McKee</surname></string-name>, <string-name><given-names>S.</given-names><surname>McNerlan</surname></string-name>, <string-name><given-names>P. J.</given-names><surname>Morrison</surname></string-name>, <string-name><given-names>G.</given-names><surname>Rea</surname></string-name>, <string-name><given-names>F.</given-names><surname>Stewart</surname></string-name>, <string-name><given-names>T.</given-names><surname>Cole</surname></string-name>, <string-name><given-names>N.</given-names><surname>Cooper</surname></string-name>, <string-name><given-names>L.</given-names><surname>Cooper-Charles</surname></string-name>, <string-name><given-names>H.</given-names><surname>Cox</surname></string-name>, <string-name><given-names>L.</given-names><surname>Islam</surname></string-name>, <string-name><given-names>J.</given-names><surname>Jarvis</surname></string-name>, <string-name><given-names>R.</given-names><surname>Keelagher</surname></string-name>, <string-name><given-names>D.</given-names><surname>Lim</surname></string-name>, <string-name><given-names>D.</given-names><surname>McMullan</surname></string-name>, <string-name><given-names>J.</given-names><surname>Morton</surname></string-name>, <string-name><given-names>S.</given-names><surname>Naik</surname></string-name>, <string-name><given-names>M.</given-names><surname>O’Driscoll</surname></string-name>, <string-name><given-names>K. R.</given-names><surname>Ong</surname></string-name>, <string-name><given-names>D.</given-names><surname>Osio</surname></string-name>, <string-name><given-names>N.</given-names><surname>Ragge</surname></string-name>, <string-name><given-names>S.</given-names><surname>Turton</surname></string-name>, <string-name><given-names>J.</given-names><surname>Vogt</surname></string-name>, <string-name><given-names>D.</given-names><surname>Williams</surname></string-name>, <string-name><given-names>S.</given-names><surname>Bodek</surname></string-name>, <string-name><given-names>A.</given-names><surname>Donaldson</surname></string-name>, <string-name><given-names>A.</given-names><surname>Hills</surname></string-name>, <string-name><given-names>K.</given-names><surname>Low</surname></string-name>, <string-name><given-names>R.</given-names><surname>Newbury-Ecob</surname></string-name>, <string-name><given-names>A. M.</given-names><surname>Norman</surname></string-name>, <string-name><given-names>E.</given-names><surname>Roberts</surname></string-name>, <string-name><given-names>I.</given-names><surname>Scurr</surname></string-name>, <string-name><given-names>S.</given-names><surname>Smithson</surname></string-name>, <string-name><given-names>M.</given-names><surname>Tooley</surname></string-name>, <string-name><given-names>S.</given-names><surname>Abbs</surname></string-name>, <string-name><given-names>R.</given-names><surname>Armstrong</surname></string-name>, <string-name><given-names>C.</given-names><surname>Dunn</surname></string-name>, <string-name><given-names>S.</given-names><surname>Holden</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Park</surname></string-name>, <string-name><given-names>J.</given-names><surname>Paterson</surname></string-name>, <string-name><given-names>L.</given-names><surname>Raymond</surname></string-name>, <string-name><given-names>E.</given-names><surname>Reid</surname></string-name>, <string-name><given-names>R.</given-names><surname>Sandford</surname></string-name>, <string-name><given-names>I.</given-names><surname>Simonic</surname></string-name>, <string-name><given-names>M.</given-names><surname>Tischkowitz</surname></string-name>, <string-name><given-names>G.</given-names><surname>Woods</surname></string-name>, <string-name><given-names>L.</given-names><surname>Bradley</surname></string-name>, <string-name><given-names>J.</given-names><surname>Comerford</surname></string-name>, <string-name><given-names>A.</given-names><surname>Green</surname></string-name>, <string-name><given-names>S.</given-names><surname>Lynch</surname></string-name>, <string-name><given-names>S.</given-names><surname>McQuaid</surname></string-name>, <string-name><given-names>B.</given-names><surname>Mullaney</surname></string-name>, <string-name><given-names>J.</given-names><surname>Berg</surname></string-name>, <string-name><given-names>D.</given-names><surname>Goudie</surname></string-name>, <string-name><given-names>E.</given-names><surname>Mavrak</surname></string-name>, <string-name><given-names>J.</given-names><surname>McLean</surname></string-name>, <string-name><given-names>C.</given-names><surname>McWilliam</surname></string-name>, <string-name><given-names>E.</given-names><surname>Reavey</surname></string-name>, <string-name><given-names>T.</given-names><surname>Azam</surname></string-name>, <string-name><given-names>E.</given-names><surname>Cleary</surname></string-name>, <string-name><given-names>A.</given-names><surname>Jackson</surname></string-name>, <string-name><given-names>W.</given-names><surname>Lam</surname></string-name>, <string-name><given-names>A.</given-names><surname>Lampe</surname></string-name>, <string-name><given-names>D.</given-names><surname>Moore</surname></string-name>, <string-name><given-names>M.</given-names><surname>Porteous</surname></string-name>, <string-name><given-names>E.</given-names><surname>Baple</surname></string-name>, <string-name><given-names>J.</given-names><surname>Baptista</surname></string-name>, <string-name><given-names>C.</given-names><surname>Brewer</surname></string-name>, <string-name><given-names>B.</given-names><surname>Castle</surname></string-name>, <string-name><given-names>E.</given-names><surname>Kivuva</surname></string-name>, <string-name><given-names>M.</given-names><surname>Owens</surname></string-name>, <string-name><given-names>J.</given-names><surname>Rankin</surname></string-name>, <string-name><given-names>C.</given-names><surname>Shaw-Smith</surname></string-name>, <string-name><given-names>C.</given-names><surname>Turner</surname></string-name>, <string-name><given-names>P.</given-names><surname>Turnpenny</surname></string-name>, <string-name><given-names>C.</given-names><surname>Tysoe</surname></string-name>, <string-name><given-names>T.</given-names><surname>Bradley</surname></string-name>, <string-name><given-names>R.</given-names><surname>Davidson</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gardiner</surname></string-name>, <string-name><given-names>S.</given-names><surname>Joss</surname></string-name>, <string-name><given-names>E.</given-names><surname>Kinning</surname></string-name>, <string-name><given-names>C.</given-names><surname>Longman</surname></string-name>, <string-name><given-names>R.</given-names><surname>McGowan</surname></string-name>, <string-name><given-names>V.</given-names><surname>Murday</surname></string-name>, <string-name><given-names>D.</given-names><surname>Pilz</surname></string-name>, <string-name><given-names>E.</given-names><surname>Tobias</surname></string-name>, <string-name><given-names>M.</given-names><surname>Whiteford</surname></string-name>, <string-name><given-names>N.</given-names><surname>Williams</surname></string-name>, <string-name><given-names>A.</given-names><surname>Barnicoat</surname></string-name>, <string-name><given-names>E.</given-names><surname>Clement</surname></string-name>, <string-name><given-names>F.</given-names><surname>Faravelli</surname></string-name>, <string-name><given-names>J.</given-names><surname>Hurst</surname></string-name>, <string-name><given-names>L.</given-names><surname>Jenkins</surname></string-name>, <string-name><given-names>W.</given-names><surname>Jones</surname></string-name>, <string-name><given-names>V. K. A.</given-names><surname>Kumar</surname></string-name>, <string-name><given-names>M.</given-names><surname>Lees</surname></string-name>, <string-name><given-names>S.</given-names><surname>Loughlin</surname></string-name>, <string-name><given-names>A.</given-names><surname>Male</surname></string-name>, <string-name><given-names>D.</given-names><surname>Morrogh</surname></string-name>, <string-name><given-names>E.</given-names><surname>Rosser</surname></string-name>, <string-name><given-names>R.</given-names><surname>Scott</surname></string-name>, <string-name><given-names>L.</given-names><surname>Wilson</surname></string-name>, <string-name><given-names>A.</given-names><surname>Beleza</surname></string-name>, <string-name><given-names>C.</given-names><surname>Deshpande</surname></string-name>, <string-name><given-names>F.</given-names><surname>Flinter</surname></string-name>, <string-name><given-names>M.</given-names><surname>Holder</surname></string-name>, <string-name><given-names>M.</given-names><surname>Irving</surname></string-name>, <string-name><given-names>L.</given-names><surname>Izatt</surname></string-name>, <string-name><given-names>D.</given-names><surname>Josifova</surname></string-name>, <string-name><given-names>S.</given-names><surname>Mohammed</surname></string-name>, <string-name><given-names>A.</given-names><surname>Molenda</surname></string-name>, <string-name><given-names>L.</given-names><surname>Robert</surname></string-name>, <string-name><given-names>W.</given-names><surname>Roworth</surname></string-name>, <string-name><given-names>D.</given-names><surname>Ruddy</surname></string-name>, <string-name><given-names>M.</given-names><surname>Ryten</surname></string-name>, <string-name><given-names>S.</given-names><surname>Yau</surname></string-name>, <string-name><given-names>C.</given-names><surname>Bennett</surname></string-name>, <string-name><given-names>M.</given-names><surname>Blyth</surname></string-name>, <string-name><given-names>J.</given-names><surname>Campbell</surname></string-name>, <string-name><given-names>A.</given-names><surname>Coates</surname></string-name>, <string-name><given-names>A.</given-names><surname>Dobbie</surname></string-name>, <string-name><given-names>S.</given-names><surname>Hewitt</surname></string-name>, <string-name><given-names>E.</given-names><surname>Hobson</surname></string-name>, <string-name><given-names>E.</given-names><surname>Jackson</surname></string-name>, <string-name><given-names>R.</given-names><surname>Jewell</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kraus</surname></string-name>, <string-name><given-names>K.</given-names><surname>Prescott</surname></string-name>, <string-name><given-names>E.</given-names><surname>Sheridan</surname></string-name>, <string-name><given-names>J.</given-names><surname>Thomson</surname></string-name>, <string-name><given-names>K.</given-names><surname>Bradshaw</surname></string-name>, <string-name><given-names>A.</given-names><surname>Dixit</surname></string-name>, <string-name><given-names>J.</given-names><surname>Eason</surname></string-name>, <string-name><given-names>R.</given-names><surname>Haines</surname></string-name>, <string-name><given-names>R.</given-names><surname>Harrison</surname></string-name>, <string-name><given-names>S.</given-names><surname>Mutch</surname></string-name>, <string-name><given-names>A.</given-names><surname>Sarkar</surname></string-name>, <string-name><given-names>C.</given-names><surname>Searle</surname></string-name>, <string-name><given-names>N.</given-names><surname>Shannon</surname></string-name>, <string-name><given-names>A.</given-names><surname>Sharif</surname></string-name>, <string-name><given-names>M.</given-names><surname>Suri</surname></string-name>, <string-name><given-names>P.</given-names><surname>Vasudevan</surname></string-name>, <string-name><given-names>N.</given-names><surname>Canham</surname></string-name>, <string-name><given-names>I.</given-names><surname>Ellis</surname></string-name>, <string-name><given-names>L.</given-names><surname>Greenhalgh</surname></string-name>, <string-name><given-names>E.</given-names><surname>Howard</surname></string-name>, <string-name><given-names>V.</given-names><surname>Stinton</surname></string-name>, <string-name><given-names>A.</given-names><surname>Swale</surname></string-name>, <string-name><given-names>A.</given-names><surname>Weber</surname></string-name>, <string-name><given-names>S.</given-names><surname>Banka</surname></string-name>, <string-name><given-names>C.</given-names><surname>Breen</surname></string-name>, <string-name><given-names>T.</given-names><surname>Briggs</surname></string-name>, <string-name><given-names>E.</given-names><surname>Burkitt-Wright</surname></string-name>, <string-name><given-names>K.</given-names><surname>Chandler</surname></string-name>, <string-name><given-names>J.</given-names><surname>Clayton-Smith</surname></string-name>, <string-name><given-names>D.</given-names><surname>Donnai</surname></string-name>, <string-name><given-names>S.</given-names><surname>Douzgou</surname></string-name>, <string-name><given-names>L.</given-names><surname>Gaunt</surname></string-name>, <string-name><given-names>E.</given-names><surname>Jones</surname></string-name>, <string-name><given-names>B.</given-names><surname>Kerr</surname></string-name>, <string-name><given-names>C.</given-names><surname>Langley</surname></string-name>, <string-name><given-names>K.</given-names><surname>Metcalfe</surname></string-name>, <string-name><given-names>A.</given-names><surname>Smith</surname></string-name>, <string-name><given-names>R.</given-names><surname>Wright</surname></string-name>, <string-name><given-names>D.</given-names><surname>Bourn</surname></string-name>, <string-name><given-names>J.</given-names><surname>Burn</surname></string-name>, <string-name><given-names>R.</given-names><surname>Fisher</surname></string-name>, <string-name><given-names>S.</given-names><surname>Hellens</surname></string-name>, <string-name><given-names>A.</given-names><surname>Henderson</surname></string-name>, <string-name><given-names>T.</given-names><surname>Montgomery</surname></string-name>, <string-name><given-names>M.</given-names><surname>Splitt</surname></string-name>, <string-name><given-names>V.</given-names><surname>Straub</surname></string-name>, <string-name><given-names>M.</given-names><surname>Wright</surname></string-name>, <string-name><given-names>S.</given-names><surname>Zwolinski</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Allen</surname></string-name>, <string-name><given-names>B.</given-names><surname>Bernhard</surname></string-name>, <string-name><given-names>A.</given-names><surname>Brady</surname></string-name>, <string-name><given-names>C.</given-names><surname>Brooks</surname></string-name>, <string-name><given-names>L.</given-names><surname>Busby</surname></string-name>, <string-name><given-names>V.</given-names><surname>Clowes</surname></string-name>, <string-name><given-names>N.</given-names><surname>Ghali</surname></string-name>, <string-name><given-names>S.</given-names><surname>Holder</surname></string-name>, <string-name><given-names>R.</given-names><surname>Ibitoye</surname></string-name>, <string-name><given-names>E.</given-names><surname>Wakeling</surname></string-name>, <string-name><given-names>E.</given-names><surname>Blair</surname></string-name>, <string-name><given-names>J.</given-names><surname>Carmichael</surname></string-name>, <string-name><given-names>D.</given-names><surname>Cilliers</surname></string-name>, <string-name><given-names>S.</given-names><surname>Clasper</surname></string-name>, <string-name><given-names>R.</given-names><surname>Gibbons</surname></string-name>, <string-name><given-names>U.</given-names><surname>Kini</surname></string-name>, <string-name><given-names>T.</given-names><surname>Lester</surname></string-name>, <string-name><given-names>A.</given-names><surname>Nemeth</surname></string-name>, <string-name><given-names>J.</given-names><surname>Poulton</surname></string-name>, <string-name><given-names>S.</given-names><surname>Price</surname></string-name>, <string-name><given-names>D.</given-names><surname>Shears</surname></string-name>, <string-name><given-names>H.</given-names><surname>Stewart</surname></string-name>, <string-name><given-names>A.</given-names><surname>Wilkie</surname></string-name>, <string-name><given-names>S.</given-names><surname>Albaba</surname></string-name>, <string-name><given-names>D.</given-names><surname>Baker</surname></string-name>, <string-name><given-names>M.</given-names><surname>Balasubramanian</surname></string-name>, <string-name><given-names>D.</given-names><surname>Johnson</surname></string-name>, <string-name><given-names>M.</given-names><surname>Parker</surname></string-name>, <string-name><given-names>O.</given-names><surname>Quarrell</surname></string-name>, <string-name><given-names>A.</given-names><surname>Stewart</surname></string-name>, <string-name><given-names>J.</given-names><surname>Willoughby</surname></string-name>, <string-name><given-names>C.</given-names><surname>Crosby</surname></string-name>, <string-name><given-names>F.</given-names><surname>Elmslie</surname></string-name>, <string-name><given-names>T.</given-names><surname>Homfray</surname></string-name>, <string-name><given-names>H.</given-names><surname>Jin</surname></string-name>, <string-name><given-names>N.</given-names><surname>Lahiri</surname></string-name>, <string-name><given-names>S.</given-names><surname>Mansour</surname></string-name>, <string-name><given-names>K.</given-names><surname>Marks</surname></string-name>, <string-name><given-names>M.</given-names><surname>McEntagart</surname></string-name>, <string-name><given-names>A.</given-names><surname>Saggar</surname></string-name>, <string-name><given-names>K.</given-names><surname>Tatton-Brown</surname></string-name>, <string-name><given-names>R.</given-names><surname>Butler</surname></string-name>, <string-name><given-names>A.</given-names><surname>Clarke</surname></string-name>, <string-name><given-names>S.</given-names><surname>Corrin</surname></string-name>, <string-name><given-names>A.</given-names><surname>Fry</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kamath</surname></string-name>, <string-name><given-names>E.</given-names><surname>McCann</surname></string-name>, <string-name><given-names>H.</given-names><surname>Mugalaasi</surname></string-name>, <string-name><given-names>C.</given-names><surname>Pottinger</surname></string-name>, <string-name><given-names>A.</given-names><surname>Procter</surname></string-name>, <string-name><given-names>J.</given-names><surname>Sampson</surname></string-name>, <string-name><given-names>F.</given-names><surname>Sansbury</surname></string-name>, <string-name><given-names>V.</given-names><surname>Varghese</surname></string-name>, <string-name><given-names>D.</given-names><surname>Baralle</surname></string-name>, <string-name><given-names>A.</given-names><surname>Callaway</surname></string-name>, <string-name><given-names>E. J.</given-names><surname>Cassidy</surname></string-name>, <string-name><given-names>S.</given-names><surname>Daniels</surname></string-name>, <string-name><given-names>A.</given-names><surname>Douglas</surname></string-name>, <string-name><given-names>N.</given-names><surname>Foulds</surname></string-name>, <string-name><given-names>D.</given-names><surname>Hunt</surname></string-name>, <string-name><given-names>M.</given-names><surname>Kharbanda</surname></string-name>, <string-name><given-names>K.</given-names><surname>Lachlan</surname></string-name>, <string-name><given-names>C.</given-names><surname>Mercer</surname></string-name>, <string-name><given-names>L.</given-names><surname>Side</surname></string-name>, <string-name><given-names>I. K.</given-names><surname>Temple</surname></string-name>, <string-name><given-names>D.</given-names><surname>Wellesley</surname></string-name>, <string-name><given-names>L. E. L. M.</given-names><surname>Vissers</surname></string-name>, <string-name><given-names>J.</given-names><surname>Juusola</surname></string-name>, <string-name><given-names>C. F.</given-names><surname>Wright</surname></string-name>, <string-name><given-names>H. G.</given-names><surname>Brunner</surname></string-name>, <string-name><given-names>H. V.</given-names><surname>Firth</surname></string-name>, <string-name><given-names>D. R.</given-names><surname>FitzPatrick</surname></string-name>, <string-name><given-names>J. C.</given-names><surname>Barrett</surname></string-name>, <string-name><given-names>M. E.</given-names><surname>Hurles</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gilissen</surname></string-name>, <string-name><given-names>K.</given-names><surname>Retterer</surname></string-name></person-group>, 
<article-title>Evidence for 28 genetic disorders discovered by combining healthcare and research data</article-title>. <source>Nature</source><volume>586</volume>, 
<fpage>757</fpage>–<lpage>762</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">33057194</pub-id></mixed-citation>
    </ref>
    <ref id="R12">
      <label>12</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>D. M.</given-names><surname>Hyman</surname></string-name>, <string-name><given-names>B. S.</given-names><surname>Taylor</surname></string-name>, <string-name><given-names>J.</given-names><surname>Baselga</surname></string-name></person-group>, 
<article-title>Implementing genome-driven oncology</article-title>. <source>Cell</source><volume>168</volume>, 
<fpage>584</fpage>–<lpage>599</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28187282</pub-id></mixed-citation>
    </ref>
    <ref id="R13">
      <label>13</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.</given-names><surname>Jumper</surname></string-name>, <string-name><given-names>R.</given-names><surname>Evans</surname></string-name>, <string-name><given-names>A.</given-names><surname>Pritzel</surname></string-name>, <string-name><given-names>T.</given-names><surname>Green</surname></string-name>, <string-name><given-names>M.</given-names><surname>Figurnov</surname></string-name>, <string-name><given-names>O.</given-names><surname>Ronneberger</surname></string-name>, <string-name><given-names>K.</given-names><surname>Tunyasuvunakool</surname></string-name>, <string-name><given-names>R.</given-names><surname>Bates</surname></string-name>, <string-name><given-names>A.</given-names><surname>Žídek</surname></string-name>, <string-name><given-names>A.</given-names><surname>Potapenko</surname></string-name>, <string-name><given-names>A.</given-names><surname>Bridgland</surname></string-name>, <string-name><given-names>C.</given-names><surname>Meyer</surname></string-name>, <string-name><given-names>S. A. A.</given-names><surname>Kohl</surname></string-name>, <string-name><given-names>A. J.</given-names><surname>Ballard</surname></string-name>, <string-name><given-names>A.</given-names><surname>Cowie</surname></string-name>, <string-name><given-names>B.</given-names><surname>Romera-Paredes</surname></string-name>, <string-name><given-names>S.</given-names><surname>Nikolov</surname></string-name>, <string-name><given-names>R.</given-names><surname>Jain</surname></string-name>, <string-name><given-names>J.</given-names><surname>Adler</surname></string-name>, <string-name><given-names>T.</given-names><surname>Back</surname></string-name>, <string-name><given-names>S.</given-names><surname>Petersen</surname></string-name>, <string-name><given-names>D.</given-names><surname>Reiman</surname></string-name>, <string-name><given-names>E.</given-names><surname>Clancy</surname></string-name>, <string-name><given-names>M.</given-names><surname>Zielinski</surname></string-name>, <string-name><given-names>M.</given-names><surname>Steinegger</surname></string-name>, <string-name><given-names>M.</given-names><surname>Pacholska</surname></string-name>, <string-name><given-names>T.</given-names><surname>Berghammer</surname></string-name>, <string-name><given-names>S.</given-names><surname>Bodenstein</surname></string-name>, <string-name><given-names>D.</given-names><surname>Silver</surname></string-name>, <string-name><given-names>O.</given-names><surname>Vinyals</surname></string-name>, <string-name><given-names>A. W.</given-names><surname>Senior</surname></string-name>, <string-name><given-names>K.</given-names><surname>Kavukcuoglu</surname></string-name>, <string-name><given-names>P.</given-names><surname>Kohli</surname></string-name>, <string-name><given-names>D.</given-names><surname>Hassabis</surname></string-name></person-group>, 
<article-title>Highly accurate protein structure prediction with AlphaFold</article-title>. <source>Nature</source><volume>596</volume>, 
<fpage>583</fpage>–<lpage>589</lpage> (<year>2021</year>).<pub-id pub-id-type="pmid">34265844</pub-id></mixed-citation>
    </ref>
    <ref id="R14">
      <label>14</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. G.</given-names><surname>Bick</surname></string-name>, <string-name><given-names>J. S.</given-names><surname>Weinstock</surname></string-name>, <string-name><given-names>S. K.</given-names><surname>Nandakumar</surname></string-name>, <string-name><given-names>C. P.</given-names><surname>Fulco</surname></string-name>, <string-name><given-names>E. L.</given-names><surname>Bao</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Zekavat</surname></string-name>, <string-name><given-names>M. D.</given-names><surname>Szeto</surname></string-name>, <string-name><given-names>X.</given-names><surname>Liao</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Leventhal</surname></string-name>, <string-name><given-names>J.</given-names><surname>Nasser</surname></string-name>, <string-name><given-names>K.</given-names><surname>Chang</surname></string-name>, <string-name><given-names>C.</given-names><surname>Laurie</surname></string-name>, <string-name><given-names>B. B.</given-names><surname>Burugula</surname></string-name>, <string-name><given-names>C. J.</given-names><surname>Gibson</surname></string-name>, <string-name><given-names>A.</given-names><surname>Niroula</surname></string-name>, <string-name><given-names>A. E.</given-names><surname>Lin</surname></string-name>, <string-name><given-names>M. A.</given-names><surname>Taub</surname></string-name>, <string-name><given-names>F.</given-names><surname>Aguet</surname></string-name>, <string-name><given-names>K.</given-names><surname>Ardlie</surname></string-name>, <string-name><given-names>B. D.</given-names><surname>Mitchell</surname></string-name>, <string-name><given-names>K. C.</given-names><surname>Barnes</surname></string-name>, <string-name><given-names>A.</given-names><surname>Moscati</surname></string-name>, <string-name><given-names>M.</given-names><surname>Fornage</surname></string-name>, <string-name><given-names>S.</given-names><surname>Redline</surname></string-name>, <string-name><given-names>B. M.</given-names><surname>Psaty</surname></string-name>, <string-name><given-names>E. K.</given-names><surname>Silverman</surname></string-name>, <string-name><given-names>S. T.</given-names><surname>Weiss</surname></string-name>, <string-name><given-names>N. D.</given-names><surname>Palmer</surname></string-name>, <string-name><given-names>R. S.</given-names><surname>Vasan</surname></string-name>, <string-name><given-names>E. G.</given-names><surname>Burchard</surname></string-name>, <string-name><given-names>S. L. R.</given-names><surname>Kardia</surname></string-name>, <string-name><given-names>J.</given-names><surname>He</surname></string-name>, <string-name><given-names>R. C.</given-names><surname>Kaplan</surname></string-name>, <string-name><given-names>N. L.</given-names><surname>Smith</surname></string-name>, <string-name><given-names>D. K.</given-names><surname>Arnett</surname></string-name>, <string-name><given-names>D. A.</given-names><surname>Schwartz</surname></string-name>, <string-name><given-names>A.</given-names><surname>Correa</surname></string-name>, <string-name><given-names>M.</given-names><surname>de Andrade</surname></string-name>, <string-name><given-names>X.</given-names><surname>Guo</surname></string-name>, <string-name><given-names>B. A.</given-names><surname>Konkle</surname></string-name>, <string-name><given-names>B.</given-names><surname>Custer</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Peralta</surname></string-name>, <string-name><given-names>H.</given-names><surname>Gui</surname></string-name>, <string-name><given-names>D. A.</given-names><surname>Meyers</surname></string-name>, <string-name><given-names>S. T.</given-names><surname>McGarvey</surname></string-name>, <string-name><given-names>I. Y. D.</given-names><surname>Chen</surname></string-name>, <string-name><given-names>M. B.</given-names><surname>Shoemaker</surname></string-name>, <string-name><given-names>P. A.</given-names><surname>Peyser</surname></string-name>, <string-name><given-names>J. G.</given-names><surname>Broome</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Gogarten</surname></string-name>, <string-name><given-names>F. F.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>Q.</given-names><surname>Wong</surname></string-name>, <string-name><given-names>M. E.</given-names><surname>Montasser</surname></string-name>, <string-name><given-names>M.</given-names><surname>Daya</surname></string-name>, <string-name><given-names>E. E.</given-names><surname>Kenny</surname></string-name>, <string-name><given-names>K. E.</given-names><surname>North</surname></string-name>, <string-name><given-names>L. J.</given-names><surname>Launer</surname></string-name>, <string-name><given-names>B. E.</given-names><surname>Cade</surname></string-name>, <string-name><given-names>J. C.</given-names><surname>Bis</surname></string-name>, <string-name><given-names>M. H.</given-names><surname>Cho</surname></string-name>, <string-name><given-names>J.</given-names><surname>Lasky-Su</surname></string-name>, <string-name><given-names>D. W.</given-names><surname>Bowden</surname></string-name>, <string-name><given-names>L. A.</given-names><surname>Cupples</surname></string-name>, <string-name><given-names>A. C. Y.</given-names><surname>Mak</surname></string-name>, <string-name><given-names>L. C.</given-names><surname>Becker</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Smith</surname></string-name>, <string-name><given-names>T. N.</given-names><surname>Kelly</surname></string-name>, <string-name><given-names>S.</given-names><surname>Aslibekyan</surname></string-name>, <string-name><given-names>S. R.</given-names><surname>Heckbert</surname></string-name>, <string-name><given-names>H. K.</given-names><surname>Tiwari</surname></string-name>, <string-name><given-names>I. V.</given-names><surname>Yang</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Heit</surname></string-name>, <string-name><given-names>S. A.</given-names><surname>Lubitz</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Johnsen</surname></string-name>, <string-name><given-names>J. E.</given-names><surname>Curran</surname></string-name>, <string-name><given-names>S. E.</given-names><surname>Wenzel</surname></string-name>, <string-name><given-names>D. E.</given-names><surname>Weeks</surname></string-name>, <string-name><given-names>D. C.</given-names><surname>Rao</surname></string-name>, <string-name><given-names>D.</given-names><surname>Darbar</surname></string-name>, <string-name><given-names>J. Y.</given-names><surname>Moon</surname></string-name>, <string-name><given-names>R. P.</given-names><surname>Tracy</surname></string-name>, <string-name><given-names>E. J.</given-names><surname>Buth</surname></string-name>, <string-name><given-names>N.</given-names><surname>Rafaels</surname></string-name>, <string-name><given-names>R. J. F.</given-names><surname>Loos</surname></string-name>, <string-name><given-names>P.</given-names><surname>Durda</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>L.</given-names><surname>Hou</surname></string-name>, <string-name><given-names>J.</given-names><surname>Lee</surname></string-name>, <string-name><given-names>P.</given-names><surname>Kachroo</surname></string-name>, <string-name><given-names>B. I.</given-names><surname>Freedman</surname></string-name>, <string-name><given-names>D.</given-names><surname>Levy</surname></string-name>, <string-name><given-names>L. F.</given-names><surname>Bielak</surname></string-name>, <string-name><given-names>J. E.</given-names><surname>Hixson</surname></string-name>, <string-name><given-names>J. S.</given-names><surname>Floyd</surname></string-name>, <string-name><given-names>E. A.</given-names><surname>Whitsel</surname></string-name>, <string-name><given-names>P. T.</given-names><surname>Ellinor</surname></string-name>, <string-name><given-names>M. R.</given-names><surname>Irvin</surname></string-name>, <string-name><given-names>T. E.</given-names><surname>Fingerlin</surname></string-name>, <string-name><given-names>L. M.</given-names><surname>Raffield</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Armasu</surname></string-name>, <string-name><given-names>M. M.</given-names><surname>Wheeler</surname></string-name>, <string-name><given-names>E. C.</given-names><surname>Sabino</surname></string-name>, <string-name><given-names>J.</given-names><surname>Blangero</surname></string-name>, <string-name><given-names>L. K.</given-names><surname>Williams</surname></string-name>, <string-name><given-names>B. D.</given-names><surname>Levy</surname></string-name>, <string-name><given-names>W. H. H.</given-names><surname>Sheu</surname></string-name>, <string-name><given-names>D. M.</given-names><surname>Roden</surname></string-name>, <string-name><given-names>E.</given-names><surname>Boerwinkle</surname></string-name>, <string-name><given-names>J. A. E.</given-names><surname>Manson</surname></string-name>, <string-name><given-names>R. A.</given-names><surname>Mathias</surname></string-name>, <string-name><given-names>P.</given-names><surname>Desai</surname></string-name>, <string-name><given-names>K. D.</given-names><surname>Taylor</surname></string-name>, <string-name><given-names>A. D.</given-names><surname>Johnson</surname></string-name>; <collab>NHLBI Trans-Omics for Precision Medicine Consortium</collab>, <string-name><given-names>N.</given-names><surname>Abe</surname></string-name>, <string-name><given-names>C.</given-names><surname>Albert</surname></string-name>, <string-name><given-names>L.</given-names><surname>Almasy</surname></string-name>, <string-name><given-names>A.</given-names><surname>Alonso</surname></string-name>, <string-name><given-names>S.</given-names><surname>Ament</surname></string-name>, <string-name><given-names>P.</given-names><surname>Anderson</surname></string-name>, <string-name><given-names>P.</given-names><surname>Anugu</surname></string-name>, <string-name><given-names>D.</given-names><surname>Applebaum-Bowden</surname></string-name>, <string-name><given-names>D.</given-names><surname>Arking</surname></string-name>, <string-name><given-names>A.</given-names><surname>Ashley-Koch</surname></string-name>, <string-name><given-names>S.</given-names><surname>Aslibekyan</surname></string-name>, <string-name><given-names>T.</given-names><surname>Assimes</surname></string-name>, <string-name><given-names>D.</given-names><surname>Avramopoulos</surname></string-name>, <string-name><given-names>J.</given-names><surname>Barnard</surname></string-name>, <string-name><given-names>R. G.</given-names><surname>Barr</surname></string-name>, <string-name><given-names>E.</given-names><surname>Barron-Casella</surname></string-name>, <string-name><given-names>L.</given-names><surname>Barwick</surname></string-name>, <string-name><given-names>T.</given-names><surname>Beaty</surname></string-name>, <string-name><given-names>G.</given-names><surname>Beck</surname></string-name>, <string-name><given-names>D.</given-names><surname>Becker</surname></string-name>, <string-name><given-names>R.</given-names><surname>Beer</surname></string-name>, <string-name><given-names>A.</given-names><surname>Beitelshees</surname></string-name>, <string-name><given-names>E.</given-names><surname>Benjamin</surname></string-name>, <string-name><given-names>P.</given-names><surname>Benos</surname></string-name>, <string-name><given-names>M.</given-names><surname>Bezerra</surname></string-name>, <string-name><given-names>L.</given-names><surname>Bielak</surname></string-name>, <string-name><given-names>R.</given-names><surname>Bowler</surname></string-name>, <string-name><given-names>J.</given-names><surname>Brody</surname></string-name>, <string-name><given-names>U.</given-names><surname>Broeckel</surname></string-name>, <string-name><given-names>K.</given-names><surname>Bunting</surname></string-name>, <string-name><given-names>C.</given-names><surname>Bustamante</surname></string-name>, <string-name><given-names>J.</given-names><surname>Cardwell</surname></string-name>, <string-name><given-names>V.</given-names><surname>Carey</surname></string-name>, <string-name><given-names>C.</given-names><surname>Carty</surname></string-name>, <string-name><given-names>R.</given-names><surname>Casaburi</surname></string-name>, <string-name><given-names>J.</given-names><surname>Casella</surname></string-name>, <string-name><given-names>P.</given-names><surname>Castaldi</surname></string-name>, <string-name><given-names>M.</given-names><surname>Chaffin</surname></string-name>, <string-name><given-names>C.</given-names><surname>Chang</surname></string-name>, <string-name><given-names>Y. C.</given-names><surname>Chang</surname></string-name>, <string-name><given-names>D.</given-names><surname>Chasman</surname></string-name>, <string-name><given-names>S.</given-names><surname>Chavan</surname></string-name>, <string-name><given-names>B. J.</given-names><surname>Chen</surname></string-name>, <string-name><given-names>W. M.</given-names><surname>Chen</surname></string-name>, <string-name><given-names>S. H.</given-names><surname>Choi</surname></string-name>, <string-name><given-names>L. M.</given-names><surname>Chuang</surname></string-name>, <string-name><given-names>M.</given-names><surname>Chung</surname></string-name>, <string-name><given-names>R. H.</given-names><surname>Chung</surname></string-name>, <string-name><given-names>C.</given-names><surname>Clish</surname></string-name>, <string-name><given-names>S.</given-names><surname>Comhair</surname></string-name>, <string-name><given-names>E.</given-names><surname>Cornell</surname></string-name>, <string-name><given-names>C.</given-names><surname>Crandall</surname></string-name>, <string-name><given-names>J.</given-names><surname>Crapo</surname></string-name>, <string-name><given-names>J.</given-names><surname>Curtis</surname></string-name>, <string-name><given-names>C.</given-names><surname>Damcott</surname></string-name>, <string-name><given-names>S.</given-names><surname>Das</surname></string-name>, <string-name><given-names>S.</given-names><surname>David</surname></string-name>, <string-name><given-names>C.</given-names><surname>Davis</surname></string-name>, <string-name><given-names>M.</given-names><surname>DeBaun</surname></string-name>, <string-name><given-names>R.</given-names><surname>Deka</surname></string-name>, <string-name><given-names>D.</given-names><surname>DeMeo</surname></string-name>, <string-name><given-names>S.</given-names><surname>Devine</surname></string-name>, <string-name><given-names>Q.</given-names><surname>Duan</surname></string-name>, <string-name><given-names>R.</given-names><surname>Duggirala</surname></string-name>, <string-name><given-names>S.</given-names><surname>Dutcher</surname></string-name>, <string-name><given-names>C.</given-names><surname>Eaton</surname></string-name>, <string-name><given-names>L.</given-names><surname>Ekunwe</surname></string-name>, <string-name><given-names>A. E.</given-names><surname>Boueiz</surname></string-name>, <string-name><given-names>L.</given-names><surname>Emery</surname></string-name>, <string-name><given-names>S.</given-names><surname>Erzurum</surname></string-name>, <string-name><given-names>C.</given-names><surname>Farber</surname></string-name>, <string-name><given-names>M.</given-names><surname>Flickinger</surname></string-name>, <string-name><given-names>N.</given-names><surname>Franceschini</surname></string-name>, <string-name><given-names>C.</given-names><surname>Frazar</surname></string-name>, <string-name><given-names>M.</given-names><surname>Fu</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Fullerton</surname></string-name>, <string-name><given-names>L.</given-names><surname>Fulton</surname></string-name>, <string-name><given-names>S.</given-names><surname>Gabriel</surname></string-name>, <string-name><given-names>W.</given-names><surname>Gan</surname></string-name>, <string-name><given-names>S.</given-names><surname>Gao</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Gao</surname></string-name>, <string-name><given-names>M.</given-names><surname>Gass</surname></string-name>, <string-name><given-names>B.</given-names><surname>Gelb</surname></string-name>, <string-name><given-names>X.</given-names><surname>Geng</surname></string-name>, <string-name><given-names>M.</given-names><surname>Geraci</surname></string-name>, <string-name><given-names>S.</given-names><surname>Germer</surname></string-name>, <string-name><given-names>R.</given-names><surname>Gerszten</surname></string-name>, <string-name><given-names>A.</given-names><surname>Ghosh</surname></string-name>, <string-name><given-names>R.</given-names><surname>Gibbs</surname></string-name>, <string-name><given-names>C.</given-names><surname>Gignoux</surname></string-name>, <string-name><given-names>M.</given-names><surname>Gladwin</surname></string-name>, <string-name><given-names>D.</given-names><surname>Glahn</surname></string-name>, <string-name><given-names>D. W.</given-names><surname>Gong</surname></string-name>, <string-name><given-names>H.</given-names><surname>Goring</surname></string-name>, <string-name><given-names>S.</given-names><surname>Graw</surname></string-name>, <string-name><given-names>D.</given-names><surname>Grine</surname></string-name>, <string-name><given-names>C. C.</given-names><surname>Gu</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Guan</surname></string-name>, <string-name><given-names>N.</given-names><surname>Gupta</surname></string-name>, <string-name><given-names>J.</given-names><surname>Haessler</surname></string-name>, <string-name><given-names>M.</given-names><surname>Hall</surname></string-name>, <string-name><given-names>D.</given-names><surname>Harris</surname></string-name>, <string-name><given-names>N. L.</given-names><surname>Hawley</surname></string-name>, <string-name><given-names>B.</given-names><surname>Heavner</surname></string-name>, <string-name><given-names>R.</given-names><surname>Hernandez</surname></string-name>, <string-name><given-names>D.</given-names><surname>Herrington</surname></string-name>, <string-name><given-names>C.</given-names><surname>Hersh</surname></string-name>, <string-name><given-names>B.</given-names><surname>Hidalgo</surname></string-name>, <string-name><given-names>B.</given-names><surname>Hobbs</surname></string-name>, <string-name><given-names>J.</given-names><surname>Hokanson</surname></string-name>, <string-name><given-names>E.</given-names><surname>Hong</surname></string-name>, <string-name><given-names>K.</given-names><surname>Hoth</surname></string-name>, <string-name><given-names>C.</given-names><surname>Hsiung</surname></string-name>, <string-name><given-names>Y. J.</given-names><surname>Hung</surname></string-name>, <string-name><given-names>H.</given-names><surname>Huston</surname></string-name>, <string-name><given-names>C. M.</given-names><surname>Hwu</surname></string-name>, <string-name><given-names>R.</given-names><surname>Jackson</surname></string-name>, <string-name><given-names>D.</given-names><surname>Jain</surname></string-name>, <string-name><given-names>C.</given-names><surname>Jaquish</surname></string-name>, <string-name><given-names>M. A.</given-names><surname>Jhun</surname></string-name>, <string-name><given-names>C.</given-names><surname>Johnson</surname></string-name>, <string-name><given-names>R.</given-names><surname>Johnston</surname></string-name>, <string-name><given-names>K.</given-names><surname>Jones</surname></string-name>, <string-name><given-names>H. M.</given-names><surname>Kang</surname></string-name>, <string-name><given-names>S.</given-names><surname>Kelly</surname></string-name>, <string-name><given-names>M.</given-names><surname>Kessler</surname></string-name>, <string-name><given-names>A.</given-names><surname>Khan</surname></string-name>, <string-name><given-names>W.</given-names><surname>Kim</surname></string-name>, <string-name><given-names>G.</given-names><surname>Kinney</surname></string-name>, <string-name><given-names>H.</given-names><surname>Kramer</surname></string-name>, <string-name><given-names>C.</given-names><surname>Lange</surname></string-name>, <string-name><given-names>M.</given-names><surname>LeBoff</surname></string-name>, <string-name><given-names>S. S.</given-names><surname>Lee</surname></string-name>, <string-name><given-names>W. J.</given-names><surname>Lee</surname></string-name>, <string-name><given-names>J.</given-names><surname>LeFaive</surname></string-name>, <string-name><given-names>D.</given-names><surname>Levine</surname></string-name>, <string-name><given-names>J.</given-names><surname>Lewis</surname></string-name>, <string-name><given-names>X.</given-names><surname>Li</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Li</surname></string-name>, <string-name><given-names>H.</given-names><surname>Lin</surname></string-name>, <string-name><given-names>H.</given-names><surname>Lin</surname></string-name>, <string-name><given-names>K. H.</given-names><surname>Lin</surname></string-name>, <string-name><given-names>X.</given-names><surname>Lin</surname></string-name>, <string-name><given-names>S.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>K.</given-names><surname>Lunetta</surname></string-name>, <string-name><given-names>J.</given-names><surname>Luo</surname></string-name>, <string-name><given-names>M.</given-names><surname>Mahaney</surname></string-name>, <string-name><given-names>B.</given-names><surname>Make</surname></string-name>, <string-name><given-names>A.</given-names><surname>Manichaikul</surname></string-name>, <string-name><given-names>L.</given-names><surname>Margolin</surname></string-name>, <string-name><given-names>L.</given-names><surname>Martin</surname></string-name>, <string-name><given-names>S.</given-names><surname>Mathai</surname></string-name>, <string-name><given-names>S.</given-names><surname>May</surname></string-name>, <string-name><given-names>P.</given-names><surname>McArdle</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>McDonald</surname></string-name>, <string-name><given-names>S.</given-names><surname>McFarland</surname></string-name>, <string-name><given-names>D.</given-names><surname>McGoldrick</surname></string-name>, <string-name><given-names>C.</given-names><surname>McHugh</surname></string-name>, <string-name><given-names>H.</given-names><surname>Mei</surname></string-name>, <string-name><given-names>L.</given-names><surname>Mestroni</surname></string-name>, <string-name><given-names>J.</given-names><surname>Mikulla</surname></string-name>, <string-name><given-names>N.</given-names><surname>Min</surname></string-name>, <string-name><given-names>M.</given-names><surname>Minear</surname></string-name>, <string-name><given-names>R. L.</given-names><surname>Minster</surname></string-name>, <string-name><given-names>M.</given-names><surname>Moll</surname></string-name>, <string-name><given-names>C.</given-names><surname>Montgomery</surname></string-name>, <string-name><given-names>S.</given-names><surname>Musani</surname></string-name>, <string-name><given-names>S.</given-names><surname>Mwasongwe</surname></string-name>, <string-name><given-names>J. C.</given-names><surname>Mychaleckyj</surname></string-name>, <string-name><given-names>G.</given-names><surname>Nadkarni</surname></string-name>, <string-name><given-names>R.</given-names><surname>Naik</surname></string-name>, <string-name><given-names>T.</given-names><surname>Naseri</surname></string-name>, <string-name><given-names>S.</given-names><surname>Nekhai</surname></string-name>, <string-name><given-names>S. C.</given-names><surname>Nelson</surname></string-name>, <string-name><given-names>B.</given-names><surname>Neltner</surname></string-name>, <string-name><given-names>D.</given-names><surname>Nickerson</surname></string-name>, <string-name><given-names>J.</given-names><surname>O’Connell</surname></string-name>, <string-name><given-names>T.</given-names><surname>O’Connor</surname></string-name>, <string-name><given-names>H.</given-names><surname>Ochs-Balcom</surname></string-name>, <string-name><given-names>D.</given-names><surname>Paik</surname></string-name>, <string-name><given-names>J.</given-names><surname>Pankow</surname></string-name>, <string-name><given-names>G.</given-names><surname>Papanicolaou</surname></string-name>, <string-name><given-names>A.</given-names><surname>Parsa</surname></string-name>, <string-name><given-names>M.</given-names><surname>Perez</surname></string-name>, <string-name><given-names>J.</given-names><surname>Perry</surname></string-name>, <string-name><given-names>U.</given-names><surname>Peters</surname></string-name>, <string-name><given-names>P.</given-names><surname>Peyser</surname></string-name>, <string-name><given-names>L. S.</given-names><surname>Phillips</surname></string-name>, <string-name><given-names>T.</given-names><surname>Pollin</surname></string-name>, <string-name><given-names>W.</given-names><surname>Post</surname></string-name>, <string-name><given-names>J. P.</given-names><surname>Becker</surname></string-name>, <string-name><given-names>M. P.</given-names><surname>Boorgula</surname></string-name>, <string-name><given-names>M.</given-names><surname>Preuss</surname></string-name>, <string-name><given-names>P.</given-names><surname>Qasba</surname></string-name>, <string-name><given-names>D.</given-names><surname>Qiao</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Qin</surname></string-name>, <string-name><given-names>L.</given-names><surname>Rasmussen-Torvik</surname></string-name>, <string-name><given-names>A.</given-names><surname>Ratan</surname></string-name>, <string-name><given-names>R.</given-names><surname>Reed</surname></string-name>, <string-name><given-names>E.</given-names><surname>Regan</surname></string-name>, <string-name><given-names>M.</given-names><surname>Sefuiva Reupena</surname></string-name>, <string-name><given-names>K.</given-names><surname>Rice</surname></string-name>, <string-name><given-names>C.</given-names><surname>Roselli</surname></string-name>, <string-name><given-names>I.</given-names><surname>Ruczinski</surname></string-name>, <string-name><given-names>P.</given-names><surname>Russell</surname></string-name>, <string-name><given-names>S.</given-names><surname>Ruuska</surname></string-name>, <string-name><given-names>K.</given-names><surname>Ryan</surname></string-name>, <string-name><given-names>D.</given-names><surname>Saleheen</surname></string-name>, <string-name><given-names>S.</given-names><surname>Salimi</surname></string-name>, <string-name><given-names>S.</given-names><surname>Salzberg</surname></string-name>, <string-name><given-names>K.</given-names><surname>Sandow</surname></string-name>, <string-name><given-names>C.</given-names><surname>Scheller</surname></string-name>, <string-name><given-names>E.</given-names><surname>Schmidt</surname></string-name>, <string-name><given-names>K.</given-names><surname>Schwander</surname></string-name>, <string-name><given-names>F.</given-names><surname>Sciurba</surname></string-name>, <string-name><given-names>C.</given-names><surname>Seidman</surname></string-name>, <string-name><given-names>J.</given-names><surname>Seidman</surname></string-name>, <string-name><given-names>V.</given-names><surname>Sheehan</surname></string-name>, <string-name><given-names>S. L.</given-names><surname>Sherman</surname></string-name>, <string-name><given-names>A.</given-names><surname>Shetty</surname></string-name>, <string-name><given-names>A.</given-names><surname>Shetty</surname></string-name>, <string-name><given-names>B.</given-names><surname>Silver</surname></string-name>, <string-name><given-names>J.</given-names><surname>Smith</surname></string-name>, <string-name><given-names>T.</given-names><surname>Smith</surname></string-name>, <string-name><given-names>S.</given-names><surname>Smoller</surname></string-name>, <string-name><given-names>B.</given-names><surname>Snively</surname></string-name>, <string-name><given-names>M.</given-names><surname>Snyder</surname></string-name>, <string-name><given-names>T.</given-names><surname>Sofer</surname></string-name>, <string-name><given-names>N.</given-names><surname>Sotoodehnia</surname></string-name>, <string-name><given-names>A. M.</given-names><surname>Stilp</surname></string-name>, <string-name><given-names>G.</given-names><surname>Storm</surname></string-name>, <string-name><given-names>E.</given-names><surname>Streeten</surname></string-name>, <string-name><given-names>J. L.</given-names><surname>Su</surname></string-name>, <string-name><given-names>Y. J.</given-names><surname>Sung</surname></string-name>, <string-name><given-names>J.</given-names><surname>Sylvia</surname></string-name>, <string-name><given-names>A.</given-names><surname>Szpiro</surname></string-name>, <string-name><given-names>C.</given-names><surname>Sztalryd</surname></string-name>, <string-name><given-names>D.</given-names><surname>Taliun</surname></string-name>, <string-name><given-names>H.</given-names><surname>Tang</surname></string-name>, <string-name><given-names>M.</given-names><surname>Taylor</surname></string-name>, <string-name><given-names>S.</given-names><surname>Taylor</surname></string-name>, <string-name><given-names>M.</given-names><surname>Telen</surname></string-name>, <string-name><given-names>T. A.</given-names><surname>Thornton</surname></string-name>, <string-name><given-names>M.</given-names><surname>Threlkeld</surname></string-name>, <string-name><given-names>L.</given-names><surname>Tinker</surname></string-name>, <string-name><given-names>D.</given-names><surname>Tirschwell</surname></string-name>, <string-name><given-names>S.</given-names><surname>Tishkoff</surname></string-name>, <string-name><given-names>H.</given-names><surname>Tiwari</surname></string-name>, <string-name><given-names>C.</given-names><surname>Tong</surname></string-name>, <string-name><given-names>M.</given-names><surname>Tsai</surname></string-name>, <string-name><given-names>D.</given-names><surname>Vaidya</surname></string-name>, <string-name><given-names>D. V. D.</given-names><surname>Berg</surname></string-name>, <string-name><given-names>P.</given-names><surname>VandeHaar</surname></string-name>, <string-name><given-names>S.</given-names><surname>Vrieze</surname></string-name>, <string-name><given-names>T.</given-names><surname>Walker</surname></string-name>, <string-name><given-names>R.</given-names><surname>Wallace</surname></string-name>, <string-name><given-names>A.</given-names><surname>Walts</surname></string-name>, <string-name><given-names>H.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>K.</given-names><surname>Watson</surname></string-name>, <string-name><given-names>B.</given-names><surname>Weir</surname></string-name>, <string-name><given-names>L. C.</given-names><surname>Weng</surname></string-name>, <string-name><given-names>J.</given-names><surname>Wessel</surname></string-name>, <string-name><given-names>C.</given-names><surname>Willer</surname></string-name>, <string-name><given-names>K.</given-names><surname>Williams</surname></string-name>, <string-name><given-names>C.</given-names><surname>Wilson</surname></string-name>, <string-name><given-names>J.</given-names><surname>Wu</surname></string-name>, <string-name><given-names>H.</given-names><surname>Xu</surname></string-name>, <string-name><given-names>L.</given-names><surname>Yanek</surname></string-name>, <string-name><given-names>R.</given-names><surname>Yang</surname></string-name>, <string-name><given-names>N.</given-names><surname>Zaghloul</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Zhang</surname></string-name>, <string-name><given-names>S. X.</given-names><surname>Zhao</surname></string-name>, <string-name><given-names>W.</given-names><surname>Zhao</surname></string-name>, <string-name><given-names>D.</given-names><surname>Zhi</surname></string-name>, <string-name><given-names>X.</given-names><surname>Zhou</surname></string-name>, <string-name><given-names>X.</given-names><surname>Zhu</surname></string-name>, <string-name><given-names>M.</given-names><surname>Zody</surname></string-name>, <string-name><given-names>S.</given-names><surname>Zoellner</surname></string-name>, <string-name><given-names>P. L.</given-names><surname>Auer</surname></string-name>, <string-name><given-names>C.</given-names><surname>Kooperberg</surname></string-name>, <string-name><given-names>C. C.</given-names><surname>Laurie</surname></string-name>, <string-name><given-names>T. W.</given-names><surname>Blackwell</surname></string-name>, <string-name><given-names>A. V.</given-names><surname>Smith</surname></string-name>, <string-name><given-names>H.</given-names><surname>Zhao</surname></string-name>, <string-name><given-names>E.</given-names><surname>Lange</surname></string-name>, <string-name><given-names>L.</given-names><surname>Lange</surname></string-name>, <string-name><given-names>S. S.</given-names><surname>Rich</surname></string-name>, <string-name><given-names>J. I.</given-names><surname>Rotter</surname></string-name>, <string-name><given-names>J. G.</given-names><surname>Wilson</surname></string-name>, <string-name><given-names>P.</given-names><surname>Scheet</surname></string-name>, <string-name><given-names>J. O.</given-names><surname>Kitzman</surname></string-name>, <string-name><given-names>E. S.</given-names><surname>Lander</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Engreitz</surname></string-name>, <string-name><given-names>B. L.</given-names><surname>Ebert</surname></string-name>, <string-name><given-names>A. P.</given-names><surname>Reiner</surname></string-name>, <string-name><given-names>S.</given-names><surname>Jaiswal</surname></string-name>, <string-name><given-names>G.</given-names><surname>Abecasis</surname></string-name>, <string-name><given-names>V. G.</given-names><surname>Sankaran</surname></string-name>, <string-name><given-names>S.</given-names><surname>Kathiresan</surname></string-name>, <string-name><given-names>P.</given-names><surname>Natarajan</surname></string-name></person-group>, 
<article-title>Inherited causes of clonal haematopoiesis in 97,691 whole genomes</article-title>. <source>Nature</source><volume>586</volume>, 
<fpage>763</fpage>–<lpage>768</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">33057201</pub-id></mixed-citation>
    </ref>
    <ref id="R15">
      <label>15</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M.</given-names><surname>Kircher</surname></string-name>, <string-name><given-names>D. M.</given-names><surname>Witten</surname></string-name>, <string-name><given-names>P.</given-names><surname>Jain</surname></string-name>, <string-name><given-names>B. J.</given-names><surname>O’Roak</surname></string-name>, <string-name><given-names>G. M.</given-names><surname>Cooper</surname></string-name>, <string-name><given-names>J.</given-names><surname>Shendure</surname></string-name></person-group>, 
<article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>. <source>Nat. Genet.</source><volume>46</volume>, 
<fpage>310</fpage>–<lpage>315</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
    </ref>
    <ref id="R16">
      <label>16</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A.</given-names><surname>Wells</surname></string-name>, <string-name><given-names>D.</given-names><surname>Heckerman</surname></string-name>, <string-name><given-names>A.</given-names><surname>Torkamani</surname></string-name>, <string-name><given-names>L.</given-names><surname>Yin</surname></string-name>, <string-name><given-names>J.</given-names><surname>Sebat</surname></string-name>, <string-name><given-names>B.</given-names><surname>Ren</surname></string-name>, <string-name><given-names>A.</given-names><surname>Telenti</surname></string-name>, <string-name><given-names>J.</given-names><surname>di Iulio</surname></string-name></person-group>, 
<article-title>Ranking of non-coding pathogenic variants and putative essential regions of the human genome</article-title>. <source>Nat. Commun.</source><volume>10</volume>, 
<fpage>5241</fpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31748530</pub-id></mixed-citation>
    </ref>
    <ref id="R17">
      <label>17</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Y.-F.</given-names><surname>Huang</surname></string-name>, <string-name><given-names>B.</given-names><surname>Gulko</surname></string-name>, <string-name><given-names>A.</given-names><surname>Siepel</surname></string-name></person-group>, 
<article-title>Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data</article-title>. <source>Nat. Genet.</source><volume>49</volume>, 
<fpage>618</fpage>–<lpage>624</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28288115</pub-id></mixed-citation>
    </ref>
    <ref id="R18">
      <label>18</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K. S.</given-names><surname>Pollard</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Hubisz</surname></string-name>, <string-name><given-names>K. R.</given-names><surname>Rosenbloom</surname></string-name>, <string-name><given-names>A.</given-names><surname>Siepel</surname></string-name></person-group>, 
<article-title>Detection of nonneutral substitution rates on mammalian phylogenies</article-title>. <source>Genome Res.</source><volume>20</volume>, 
<fpage>110</fpage>–<lpage>121</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">19858363</pub-id></mixed-citation>
    </ref>
    <ref id="R19">
      <label>19</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>F.</given-names><surname>Muiños</surname></string-name>, <string-name><given-names>F.</given-names><surname>Martínez-Jiménez</surname></string-name>, <string-name><given-names>O.</given-names><surname>Pich</surname></string-name>, <string-name><given-names>A.</given-names><surname>Gonzalez-Perez</surname></string-name>, <string-name><given-names>N.</given-names><surname>Lopez-Bigas</surname></string-name></person-group>, 
<article-title>In silico saturation mutagenesis of cancer genes</article-title>. <source>Nature</source><volume>596</volume>, 
<fpage>428</fpage>–<lpage>432</lpage> (<year>2021</year>).<pub-id pub-id-type="pmid">34321661</pub-id></mixed-citation>
    </ref>
    <ref id="R20">
      <label>20</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>F.</given-names><surname>Martínez-Jiménez</surname></string-name>, <string-name><given-names>F.</given-names><surname>Muiños</surname></string-name>, <string-name><given-names>I.</given-names><surname>Sentís</surname></string-name>, <string-name><given-names>J.</given-names><surname>Deu-Pons</surname></string-name>, <string-name><given-names>I.</given-names><surname>Reyes-Salazar</surname></string-name>, <string-name><given-names>C.</given-names><surname>Arnedo-Pac</surname></string-name>, <string-name><given-names>L.</given-names><surname>Mularoni</surname></string-name>, <string-name><given-names>O.</given-names><surname>Pich</surname></string-name>, <string-name><given-names>J.</given-names><surname>Bonet</surname></string-name>, <string-name><given-names>H.</given-names><surname>Kranas</surname></string-name>, <string-name><given-names>A.</given-names><surname>Gonzalez-Perez</surname></string-name>, <string-name><given-names>N.</given-names><surname>Lopez-Bigas</surname></string-name></person-group>, 
<article-title>A compendium of mutational cancer driver genes</article-title>. <source>Nat. Rev. Cancer</source><volume>20</volume>, 
<fpage>555</fpage>–<lpage>572</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32778778</pub-id></mixed-citation>
    </ref>
    <ref id="R21">
      <label>21</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K.</given-names><surname>Bhatia</surname></string-name>, <string-name><given-names>K.</given-names><surname>Huppi</surname></string-name>, <string-name><given-names>G.</given-names><surname>Spangler</surname></string-name>, <string-name><given-names>D.</given-names><surname>Siwarski</surname></string-name>, <string-name><given-names>R.</given-names><surname>Iyer</surname></string-name>, <string-name><given-names>I.</given-names><surname>Magrath</surname></string-name></person-group>, 
<article-title>Point mutations in the c-Myc transactivation domain are common in Burkitt’s lymphoma and mouse plasmacytomas</article-title>. <source>Nat. Genet.</source><volume>5</volume>, 
<fpage>56</fpage>–<lpage>61</lpage> (<year>1993</year>).<pub-id pub-id-type="pmid">8220424</pub-id></mixed-citation>
    </ref>
    <ref id="R22">
      <label>22</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>B.</given-names><surname>King</surname></string-name>, <string-name><given-names>T.</given-names><surname>Trimarchi</surname></string-name>, <string-name><given-names>L.</given-names><surname>Reavie</surname></string-name>, <string-name><given-names>L.</given-names><surname>Xu</surname></string-name>, <string-name><given-names>J.</given-names><surname>Mullenders</surname></string-name>, <string-name><given-names>P.</given-names><surname>Ntziachristos</surname></string-name>, <string-name><given-names>B.</given-names><surname>Aranda-Orgilles</surname></string-name>, <string-name><given-names>A.</given-names><surname>Perez-Garcia</surname></string-name>, <string-name><given-names>J.</given-names><surname>Shi</surname></string-name>, <string-name><given-names>C.</given-names><surname>Vakoc</surname></string-name>, <string-name><given-names>P.</given-names><surname>Sandy</surname></string-name>, <string-name><given-names>S. S.</given-names><surname>Shen</surname></string-name>, <string-name><given-names>A.</given-names><surname>Ferrando</surname></string-name>, <string-name><given-names>I.</given-names><surname>Aifantis</surname></string-name></person-group>, 
<article-title>The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability</article-title>. <source>Cell</source><volume>153</volume>, 
<fpage>1552</fpage>–<lpage>1566</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23791182</pub-id></mixed-citation>
    </ref>
    <ref id="R23">
      <label>23</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>D.</given-names><surname>Whiteside</surname></string-name>, <string-name><given-names>R.</given-names><surname>McLeod</surname></string-name>, <string-name><given-names>G.</given-names><surname>Graham</surname></string-name>, <string-name><given-names>J. L.</given-names><surname>Steckley</surname></string-name>, <string-name><given-names>K.</given-names><surname>Booth</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Somerville</surname></string-name>, <string-name><given-names>S. E.</given-names><surname>Andrew</surname></string-name></person-group>, 
<article-title>A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple café-au-lait spots</article-title>. <source>Cancer Res.</source><volume>62</volume>, 
<fpage>359</fpage>–<lpage>362</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">11809679</pub-id></mixed-citation>
    </ref>
    <ref id="R24">
      <label>24</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A.</given-names><surname>Yoda</surname></string-name>, <string-name><given-names>G.</given-names><surname>Adelmant</surname></string-name>, <string-name><given-names>J.</given-names><surname>Tamburini</surname></string-name>, <string-name><given-names>B.</given-names><surname>Chapuy</surname></string-name>, <string-name><given-names>N.</given-names><surname>Shindoh</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Yoda</surname></string-name>, <string-name><given-names>O.</given-names><surname>Weigert</surname></string-name>, <string-name><given-names>N.</given-names><surname>Kopp</surname></string-name>, <string-name><given-names>S. C.</given-names><surname>Wu</surname></string-name>, <string-name><given-names>S. S.</given-names><surname>Kim</surname></string-name>, <string-name><given-names>H.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>T.</given-names><surname>Tivey</surname></string-name>, <string-name><given-names>A. L.</given-names><surname>Christie</surname></string-name>, <string-name><given-names>K. G.</given-names><surname>Elpek</surname></string-name>, <string-name><given-names>J.</given-names><surname>Card</surname></string-name>, <string-name><given-names>K.</given-names><surname>Gritsman</surname></string-name>, <string-name><given-names>J.</given-names><surname>Gotlib</surname></string-name>, <string-name><given-names>M. W.</given-names><surname>Deininger</surname></string-name>, <string-name><given-names>H.</given-names><surname>Makishima</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Turley</surname></string-name>, <string-name><given-names>N.</given-names><surname>Javidi-Sharifi</surname></string-name>, <string-name><given-names>J. P.</given-names><surname>Maciejewski</surname></string-name>, <string-name><given-names>S.</given-names><surname>Jaiswal</surname></string-name>, <string-name><given-names>B. L.</given-names><surname>Ebert</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Rodig</surname></string-name>, <string-name><given-names>J. W.</given-names><surname>Tyner</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Marto</surname></string-name>, <string-name><given-names>D. M.</given-names><surname>Weinstock</surname></string-name>, <string-name><given-names>A. A.</given-names><surname>Lane</surname></string-name></person-group>, 
<article-title>Mutations in G protein β subunits promote transformation and kinase inhibitor resistance</article-title>. <source>Nat. Med.</source><volume>21</volume>, 
<fpage>71</fpage>–<lpage>75</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25485910</pub-id></mixed-citation>
    </ref>
    <ref id="R25">
      <label>25</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J. B.</given-names><surname>Oliveira</surname></string-name>, <string-name><given-names>N.</given-names><surname>Bidère</surname></string-name>, <string-name><given-names>J. E.</given-names><surname>Niemela</surname></string-name>, <string-name><given-names>L.</given-names><surname>Zheng</surname></string-name>, <string-name><given-names>K.</given-names><surname>Sakai</surname></string-name>, <string-name><given-names>C. P.</given-names><surname>Nix</surname></string-name>, <string-name><given-names>R. L.</given-names><surname>Danner</surname></string-name>, <string-name><given-names>J.</given-names><surname>Barb</surname></string-name>, <string-name><given-names>P. J.</given-names><surname>Munson</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Puck</surname></string-name>, <string-name><given-names>J.</given-names><surname>Dale</surname></string-name>, <string-name><given-names>S. E.</given-names><surname>Straus</surname></string-name>, <string-name><given-names>T. A.</given-names><surname>Fleisher</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Lenardo</surname></string-name></person-group>, 
<article-title>NRAS mutation causes a human autoimmune lymphoproliferative syndrome</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>104</volume>, 
<fpage>8953</fpage>–<lpage>8958</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17517660</pub-id></mixed-citation>
    </ref>
    <ref id="R26">
      <label>26</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>I. C.</given-names><surname>Cirstea</surname></string-name>, <string-name><given-names>K.</given-names><surname>Kutsche</surname></string-name>, <string-name><given-names>R.</given-names><surname>Dvorsky</surname></string-name>, <string-name><given-names>L.</given-names><surname>Gremer</surname></string-name>, <string-name><given-names>C.</given-names><surname>Carta</surname></string-name>, <string-name><given-names>D.</given-names><surname>Horn</surname></string-name>, <string-name><given-names>A. E.</given-names><surname>Roberts</surname></string-name>, <string-name><given-names>F.</given-names><surname>Lepri</surname></string-name>, <string-name><given-names>T.</given-names><surname>Merbitz-Zahradnik</surname></string-name>, <string-name><given-names>R.</given-names><surname>König</surname></string-name>, <string-name><given-names>C. P.</given-names><surname>Kratz</surname></string-name>, <string-name><given-names>F.</given-names><surname>Pantaleoni</surname></string-name>, <string-name><given-names>M. L.</given-names><surname>Dentici</surname></string-name>, <string-name><given-names>V. A.</given-names><surname>Joshi</surname></string-name>, <string-name><given-names>R. S.</given-names><surname>Kucherlapati</surname></string-name>, <string-name><given-names>L.</given-names><surname>Mazzanti</surname></string-name>, <string-name><given-names>S.</given-names><surname>Mundlos</surname></string-name>, <string-name><given-names>M. A.</given-names><surname>Patton</surname></string-name>, <string-name><given-names>M. C.</given-names><surname>Silengo</surname></string-name>, <string-name><given-names>C.</given-names><surname>Rossi</surname></string-name>, <string-name><given-names>G.</given-names><surname>Zampino</surname></string-name>, <string-name><given-names>C.</given-names><surname>Digilio</surname></string-name>, <string-name><given-names>L.</given-names><surname>Stuppia</surname></string-name>, <string-name><given-names>E.</given-names><surname>Seemanova</surname></string-name>, <string-name><given-names>L. A.</given-names><surname>Pennacchio</surname></string-name>, <string-name><given-names>B. D.</given-names><surname>Gelb</surname></string-name>, <string-name><given-names>B.</given-names><surname>Dallapiccola</surname></string-name>, <string-name><given-names>A.</given-names><surname>Wittinghofer</surname></string-name>, <string-name><given-names>M. R.</given-names><surname>Ahmadian</surname></string-name>, <string-name><given-names>M.</given-names><surname>Tartaglia</surname></string-name>, <string-name><given-names>M.</given-names><surname>Zenker</surname></string-name></person-group>, 
<article-title>A restricted spectrum of NRAS mutations causes Noonan syndrome</article-title>. <source>Nat. Genet.</source><volume>42</volume>, 
<fpage>27</fpage>–<lpage>29</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">19966803</pub-id></mixed-citation>
    </ref>
    <ref id="R27">
      <label>27</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K.</given-names><surname>Matsuda</surname></string-name>, <string-name><given-names>A.</given-names><surname>Shimada</surname></string-name>, <string-name><given-names>N.</given-names><surname>Yoshida</surname></string-name>, <string-name><given-names>A.</given-names><surname>Ogawa</surname></string-name>, <string-name><given-names>A.</given-names><surname>Watanabe</surname></string-name>, <string-name><given-names>S.</given-names><surname>Yajima</surname></string-name>, <string-name><given-names>S.</given-names><surname>Iizuka</surname></string-name>, <string-name><given-names>K.</given-names><surname>Koike</surname></string-name>, <string-name><given-names>F.</given-names><surname>Yanai</surname></string-name>, <string-name><given-names>K.</given-names><surname>Kawasaki</surname></string-name>, <string-name><given-names>M.</given-names><surname>Yanagimachi</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kikuchi</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Ohtsuka</surname></string-name>, <string-name><given-names>E.</given-names><surname>Hidaka</surname></string-name>, <string-name><given-names>K.</given-names><surname>Yamauchi</surname></string-name>, <string-name><given-names>M.</given-names><surname>Tanaka</surname></string-name>, <string-name><given-names>R.</given-names><surname>Yanagisawa</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Nakazawa</surname></string-name>, <string-name><given-names>M.</given-names><surname>Shiohara</surname></string-name>, <string-name><given-names>A.</given-names><surname>Manabe</surname></string-name>, <string-name><given-names>S.</given-names><surname>Kojima</surname></string-name>, <string-name><given-names>K.</given-names><surname>Koike</surname></string-name></person-group>, 
<article-title>Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations</article-title>. <source>Blood</source><volume>109</volume>, 
<fpage>5477</fpage>–<lpage>5480</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17332249</pub-id></mixed-citation>
    </ref>
    <ref id="R28">
      <label>28</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>R.</given-names><surname>Kosaki</surname></string-name>, <string-name><given-names>H.</given-names><surname>Terashima</surname></string-name>, <string-name><given-names>M.</given-names><surname>Kubota</surname></string-name>, <string-name><given-names>K.</given-names><surname>Kosaki</surname></string-name></person-group>, 
<article-title>Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation</article-title>. <source>Am. J. Med. Genet. A</source><volume>173</volume>, 
<fpage>250</fpage>–<lpage>253</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">27991732</pub-id></mixed-citation>
    </ref>
    <ref id="R29">
      <label>29</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names><surname>Jaiswal</surname></string-name>, <string-name><given-names>P.</given-names><surname>Natarajan</surname></string-name>, <string-name><given-names>A. J.</given-names><surname>Silver</surname></string-name>, <string-name><given-names>C. J.</given-names><surname>Gibson</surname></string-name>, <string-name><given-names>A. G.</given-names><surname>Bick</surname></string-name>, <string-name><given-names>E.</given-names><surname>Shvartz</surname></string-name>, <string-name><given-names>M. M.</given-names><surname>Conkey</surname></string-name>, <string-name><given-names>N.</given-names><surname>Gupta</surname></string-name>, <string-name><given-names>S.</given-names><surname>Gabriel</surname></string-name>, <string-name><given-names>D.</given-names><surname>Ardissino</surname></string-name>, <string-name><given-names>U.</given-names><surname>Baber</surname></string-name>, <string-name><given-names>R.</given-names><surname>Mehran</surname></string-name>, <string-name><given-names>V.</given-names><surname>Fuster</surname></string-name>, <string-name><given-names>J.</given-names><surname>Danesh</surname></string-name>, <string-name><given-names>P.</given-names><surname>Frossard</surname></string-name>, <string-name><given-names>D.</given-names><surname>Saleheen</surname></string-name>, <string-name><given-names>O.</given-names><surname>Melander</surname></string-name>, <string-name><given-names>G. K.</given-names><surname>Sukhova</surname></string-name>, <string-name><given-names>D.</given-names><surname>Neuberg</surname></string-name>, <string-name><given-names>P.</given-names><surname>Libby</surname></string-name>, <string-name><given-names>S.</given-names><surname>Kathiresan</surname></string-name>, <string-name><given-names>B. L.</given-names><surname>Ebert</surname></string-name></person-group>, 
<article-title>Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease</article-title>. <source>N. Engl. J. Med.</source><volume>377</volume>, 
<fpage>111</fpage>–<lpage>121</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28636844</pub-id></mixed-citation>
    </ref>
    <ref id="R30">
      <label>30</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K.</given-names><surname>Tatton-Brown</surname></string-name>, <string-name><given-names>S.</given-names><surname>Seal</surname></string-name>, <string-name><given-names>E.</given-names><surname>Ruark</surname></string-name>, <string-name><given-names>J.</given-names><surname>Harmer</surname></string-name>, <string-name><given-names>E.</given-names><surname>Ramsay</surname></string-name>, <string-name><given-names>S. D. V.</given-names><surname>Duarte</surname></string-name>, <string-name><given-names>A.</given-names><surname>Zachariou</surname></string-name>, <string-name><given-names>S.</given-names><surname>Hanks</surname></string-name>, <string-name><given-names>E.</given-names><surname>O’Brien</surname></string-name>, <string-name><given-names>L.</given-names><surname>Aksglaede</surname></string-name>, <string-name><given-names>D.</given-names><surname>Baralle</surname></string-name>, <string-name><given-names>T.</given-names><surname>Dabir</surname></string-name>, <string-name><given-names>B.</given-names><surname>Gener</surname></string-name>, <string-name><given-names>D.</given-names><surname>Goudie</surname></string-name>, <string-name><given-names>T.</given-names><surname>Homfray</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kumar</surname></string-name>, <string-name><given-names>D. T.</given-names><surname>Pilz</surname></string-name>, <string-name><given-names>A.</given-names><surname>Selicorni</surname></string-name>, <string-name><given-names>I. K.</given-names><surname>Temple</surname></string-name>, <string-name><given-names>L.</given-names><surname>Van Maldergem</surname></string-name>, <string-name><given-names>N.</given-names><surname>Yachelevich</surname></string-name>; <collab>Childhood Overgrowth Consortium</collab>, <string-name><given-names>R.</given-names><surname>van Montfort</surname></string-name>, <string-name><given-names>N.</given-names><surname>Rahman</surname></string-name></person-group>, 
<article-title>Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability</article-title>. <source>Nat. Genet.</source><volume>46</volume>, 
<fpage>385</fpage>–<lpage>388</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24614070</pub-id></mixed-citation>
    </ref>
    <ref id="R31">
      <label>31</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Z.-M.</given-names><surname>Zhang</surname></string-name>, <string-name><given-names>R.</given-names><surname>Lu</surname></string-name>, <string-name><given-names>P.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Yu</surname></string-name>, <string-name><given-names>D.</given-names><surname>Chen</surname></string-name>, <string-name><given-names>L.</given-names><surname>Gao</surname></string-name>, <string-name><given-names>S.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>D.</given-names><surname>Ji</surname></string-name>, <string-name><given-names>S. B.</given-names><surname>Rothbart</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>G. G.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>J.</given-names><surname>Song</surname></string-name></person-group>, 
<article-title>Structural basis for DNMT3A-mediated de novo DNA methylation</article-title>. <source>Nature</source><volume>554</volume>, 
<fpage>387</fpage>–<lpage>391</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29414941</pub-id></mixed-citation>
    </ref>
    <ref id="R32">
      <label>32</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M. T.</given-names><surname>Chang</surname></string-name>, <string-name><given-names>T. S.</given-names><surname>Bhattarai</surname></string-name>, <string-name><given-names>A. M.</given-names><surname>Schram</surname></string-name>, <string-name><given-names>C. M.</given-names><surname>Bielski</surname></string-name>, <string-name><given-names>M. T. A.</given-names><surname>Donoghue</surname></string-name>, <string-name><given-names>P.</given-names><surname>Jonsson</surname></string-name>, <string-name><given-names>D.</given-names><surname>Chakravarty</surname></string-name>, <string-name><given-names>S.</given-names><surname>Phillips</surname></string-name>, <string-name><given-names>C.</given-names><surname>Kandoth</surname></string-name>, <string-name><given-names>A.</given-names><surname>Penson</surname></string-name>, <string-name><given-names>A.</given-names><surname>Gorelick</surname></string-name>, <string-name><given-names>T.</given-names><surname>Shamu</surname></string-name>, <string-name><given-names>S.</given-names><surname>Patel</surname></string-name>, <string-name><given-names>C.</given-names><surname>Harris</surname></string-name>, <string-name><given-names>J. J.</given-names><surname>Gao</surname></string-name>, <string-name><given-names>S. O.</given-names><surname>Sumer</surname></string-name>, <string-name><given-names>R.</given-names><surname>Kundra</surname></string-name>, <string-name><given-names>P.</given-names><surname>Razavi</surname></string-name>, <string-name><given-names>B. T.</given-names><surname>Li</surname></string-name>, <string-name><given-names>D. N.</given-names><surname>Reales</surname></string-name>, <string-name><given-names>N. D.</given-names><surname>Socci</surname></string-name>, <string-name><given-names>G.</given-names><surname>Jayakumaran</surname></string-name>, <string-name><given-names>A.</given-names><surname>Zehir</surname></string-name>, <string-name><given-names>R.</given-names><surname>Benayed</surname></string-name>, <string-name><given-names>M. E.</given-names><surname>Arcila</surname></string-name>, <string-name><given-names>S.</given-names><surname>Chandarlapaty</surname></string-name>, <string-name><given-names>M.</given-names><surname>Ladanyi</surname></string-name>, <string-name><given-names>N.</given-names><surname>Schultz</surname></string-name>, <string-name><given-names>J.</given-names><surname>Baselga</surname></string-name>, <string-name><given-names>M. F.</given-names><surname>Berger</surname></string-name>, <string-name><given-names>N.</given-names><surname>Rosen</surname></string-name>, <string-name><given-names>D. B.</given-names><surname>Solit</surname></string-name>, <string-name><given-names>D. M.</given-names><surname>Hyman</surname></string-name>, <string-name><given-names>B. S.</given-names><surname>Taylor</surname></string-name></person-group>, 
<article-title>Accelerating discovery of functional mutant alleles in cancer</article-title>. <source>Cancer Discov.</source><volume>8</volume>, 
<fpage>174</fpage>–<lpage>183</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29247016</pub-id></mixed-citation>
    </ref>
    <ref id="R33">
      <label>33</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M.</given-names><surname>Cassandri</surname></string-name>, <string-name><given-names>A.</given-names><surname>Smirnov</surname></string-name>, <string-name><given-names>F.</given-names><surname>Novelli</surname></string-name>, <string-name><given-names>C.</given-names><surname>Pitolli</surname></string-name>, <string-name><given-names>M.</given-names><surname>Agostini</surname></string-name>, <string-name><given-names>M.</given-names><surname>Malewicz</surname></string-name>, <string-name><given-names>G.</given-names><surname>Melino</surname></string-name>, <string-name><given-names>G.</given-names><surname>Raschellà</surname></string-name></person-group>, 
<article-title>Zinc-finger proteins in health and disease</article-title>. <source>Cell Death Discov.</source><volume>3</volume>, 
<fpage>17071</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">29152378</pub-id></mixed-citation>
    </ref>
    <ref id="R34">
      <label>34</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names><surname>De Rubeis</surname></string-name>, <string-name><given-names>X.</given-names><surname>He</surname></string-name>, <string-name><given-names>A. P.</given-names><surname>Goldberg</surname></string-name>, <string-name><given-names>C. S.</given-names><surname>Poultney</surname></string-name>, <string-name><given-names>K.</given-names><surname>Samocha</surname></string-name>, <string-name><given-names>A. E.</given-names><surname>Cicek</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Kou</surname></string-name>, <string-name><given-names>L.</given-names><surname>Liu</surname></string-name>, <string-name><given-names>M.</given-names><surname>Fromer</surname></string-name>, <string-name><given-names>S.</given-names><surname>Walker</surname></string-name>, <string-name><given-names>T.</given-names><surname>Singh</surname></string-name>, <string-name><given-names>L.</given-names><surname>Klei</surname></string-name>, <string-name><given-names>J.</given-names><surname>Kosmicki</surname></string-name>, <string-name><given-names>F.</given-names><surname>Shih-Chen</surname></string-name>, <string-name><given-names>B.</given-names><surname>Aleksic</surname></string-name>, <string-name><given-names>M.</given-names><surname>Biscaldi</surname></string-name>, <string-name><given-names>P. F.</given-names><surname>Bolton</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Brownfeld</surname></string-name>, <string-name><given-names>J.</given-names><surname>Cai</surname></string-name>, <string-name><given-names>N. G.</given-names><surname>Campbell</surname></string-name>, <string-name><given-names>A.</given-names><surname>Carracedo</surname></string-name>, <string-name><given-names>M. H.</given-names><surname>Chahrour</surname></string-name>, <string-name><given-names>A. G.</given-names><surname>Chiocchetti</surname></string-name>, <string-name><given-names>H.</given-names><surname>Coon</surname></string-name>, <string-name><given-names>E. L.</given-names><surname>Crawford</surname></string-name>, <string-name><given-names>S. R.</given-names><surname>Curran</surname></string-name>, <string-name><given-names>G.</given-names><surname>Dawson</surname></string-name>, <string-name><given-names>E.</given-names><surname>Duketis</surname></string-name>, <string-name><given-names>B. A.</given-names><surname>Fernandez</surname></string-name>, <string-name><given-names>L.</given-names><surname>Gallagher</surname></string-name>, <string-name><given-names>E.</given-names><surname>Geller</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Guter</surname></string-name>, <string-name><given-names>R. S.</given-names><surname>Hill</surname></string-name>, <string-name><given-names>J.</given-names><surname>Ionita-Laza</surname></string-name>, <string-name><given-names>P. J.</given-names><surname>Gonzalez</surname></string-name>, <string-name><given-names>H.</given-names><surname>Kilpinen</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Klauck</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kolevzon</surname></string-name>, <string-name><given-names>I.</given-names><surname>Lee</surname></string-name>, <string-name><given-names>I.</given-names><surname>Lei</surname></string-name>, <string-name><given-names>J.</given-names><surname>Lei</surname></string-name>, <string-name><given-names>T.</given-names><surname>Lehtimäki</surname></string-name>, <string-name><given-names>C.-F.</given-names><surname>Lin</surname></string-name>, <string-name><given-names>A.</given-names><surname>Ma’ayan</surname></string-name>, <string-name><given-names>C. R.</given-names><surname>Marshall</surname></string-name>, <string-name><given-names>A. L.</given-names><surname>McInnes</surname></string-name>, <string-name><given-names>B.</given-names><surname>Neale</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Owen</surname></string-name>, <string-name><given-names>N.</given-names><surname>Ozaki</surname></string-name>, <string-name><given-names>M.</given-names><surname>Parellada</surname></string-name>, <string-name><given-names>J. R.</given-names><surname>Parr</surname></string-name>, <string-name><given-names>S.</given-names><surname>Purcell</surname></string-name>, <string-name><given-names>K.</given-names><surname>Puura</surname></string-name>, <string-name><given-names>D.</given-names><surname>Rajagopalan</surname></string-name>, <string-name><given-names>K.</given-names><surname>Rehnström</surname></string-name>, <string-name><given-names>A.</given-names><surname>Reichenberg</surname></string-name>, <string-name><given-names>A.</given-names><surname>Sabo</surname></string-name>, <string-name><given-names>M.</given-names><surname>Sachse</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Sanders</surname></string-name>, <string-name><given-names>C.</given-names><surname>Schafer</surname></string-name>, <string-name><given-names>M.</given-names><surname>Schulte-Rüther</surname></string-name>, <string-name><given-names>D.</given-names><surname>Skuse</surname></string-name>, <string-name><given-names>C.</given-names><surname>Stevens</surname></string-name>, <string-name><given-names>P.</given-names><surname>Szatmari</surname></string-name>, <string-name><given-names>K.</given-names><surname>Tammimies</surname></string-name>, <string-name><given-names>O.</given-names><surname>Valladares</surname></string-name>, <string-name><given-names>A.</given-names><surname>Voran</surname></string-name>, <string-name><given-names>W.</given-names><surname>Li-San</surname></string-name>, <string-name><given-names>L. A.</given-names><surname>Weiss</surname></string-name>, <string-name><given-names>A. J.</given-names><surname>Willsey</surname></string-name>, <string-name><given-names>T. W.</given-names><surname>Yu</surname></string-name>, <string-name><given-names>R. K. C.</given-names><surname>Yuen</surname></string-name>; <collab>DDD Study</collab>; <collab>Homozygosity Mapping Collaborative for Autism</collab>; <collab>UK10K Consortium</collab>; <collab>The Autism Sequencing Consortium</collab>, <string-name><given-names>E. H.</given-names><surname>Cook</surname></string-name>, <string-name><given-names>C. M.</given-names><surname>Freitag</surname></string-name>, <string-name><given-names>M.</given-names><surname>Gill</surname></string-name>, <string-name><given-names>C. M.</given-names><surname>Hultman</surname></string-name>, <string-name><given-names>T.</given-names><surname>Lehner</surname></string-name>, <string-name><given-names>A.</given-names><surname>Palotie</surname></string-name>, <string-name><given-names>G. D.</given-names><surname>Schellenberg</surname></string-name>, <string-name><given-names>P.</given-names><surname>Sklar</surname></string-name>, <string-name><given-names>M. W.</given-names><surname>State</surname></string-name>, <string-name><given-names>J. S.</given-names><surname>Sutcliffe</surname></string-name>, <string-name><given-names>C. A.</given-names><surname>Walsh</surname></string-name>, <string-name><given-names>S. W.</given-names><surname>Scherer</surname></string-name>, <string-name><given-names>M. E.</given-names><surname>Zwick</surname></string-name>, <string-name><given-names>J. C.</given-names><surname>Barett</surname></string-name>, <string-name><given-names>D. J.</given-names><surname>Cutler</surname></string-name>, <string-name><given-names>K.</given-names><surname>Roeder</surname></string-name>, <string-name><given-names>B.</given-names><surname>Devlin</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Daly</surname></string-name>, <string-name><given-names>J. D.</given-names><surname>Buxbaum</surname></string-name></person-group>, 
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>. <source>Nature</source><volume>515</volume>, 
<fpage>209</fpage>–<lpage>215</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
    </ref>
    <ref id="R35">
      <label>35</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>R. S.</given-names><surname>Dhindsa</surname></string-name>, <string-name><given-names>A. W.</given-names><surname>Zoghbi</surname></string-name>, <string-name><given-names>D. K.</given-names><surname>Krizay</surname></string-name>, <string-name><given-names>C.</given-names><surname>Vasavda</surname></string-name>, <string-name><given-names>D. B.</given-names><surname>Goldstein</surname></string-name></person-group>, 
<article-title>A transcriptome-based drug discovery paradigm for neurodevelopmental disorders</article-title>. <source>Ann. Neurol.</source><volume>89</volume>, 
<fpage>199</fpage>–<lpage>211</lpage> (<year>2021</year>).<pub-id pub-id-type="pmid">33159466</pub-id></mixed-citation>
    </ref>
    <ref id="R36">
      <label>36</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Y.-C. A.</given-names><surname>Feng</surname></string-name>, <string-name><given-names>D. P.</given-names><surname>Howrigan</surname></string-name>, <string-name><given-names>L. E.</given-names><surname>Abbott</surname></string-name>, <string-name><given-names>K.</given-names><surname>Tashman</surname></string-name>, <string-name><given-names>F.</given-names><surname>Cerrato</surname></string-name>, <string-name><given-names>T.</given-names><surname>Singh</surname></string-name>, <string-name><given-names>H.</given-names><surname>Heyne</surname></string-name>, <string-name><given-names>A.</given-names><surname>Byrnes</surname></string-name>, <string-name><given-names>C.</given-names><surname>Churchhouse</surname></string-name>, <string-name><given-names>N.</given-names><surname>Watts</surname></string-name>, <string-name><given-names>M.</given-names><surname>Solomonson</surname></string-name>, <string-name><given-names>D.</given-names><surname>Lal</surname></string-name>, <string-name><given-names>E. L.</given-names><surname>Heinzen</surname></string-name>, <string-name><given-names>R. S.</given-names><surname>Dhindsa</surname></string-name>, <string-name><given-names>K. E.</given-names><surname>Stanley</surname></string-name>, <string-name><given-names>G. L.</given-names><surname>Cavalleri</surname></string-name>, <string-name><given-names>H.</given-names><surname>Hakonarson</surname></string-name>, <string-name><given-names>I.</given-names><surname>Helbig</surname></string-name>, <string-name><given-names>R.</given-names><surname>Krause</surname></string-name>, <string-name><given-names>P.</given-names><surname>May</surname></string-name>, <string-name><given-names>S.</given-names><surname>Weckhuysen</surname></string-name>, <string-name><given-names>S.</given-names><surname>Petrovski</surname></string-name>, <string-name><given-names>S.</given-names><surname>Kamalakaran</surname></string-name>, <string-name><given-names>S. M.</given-names><surname>Sisodiya</surname></string-name>, <string-name><given-names>P.</given-names><surname>Cossette</surname></string-name>, <string-name><given-names>C.</given-names><surname>Cotsapas</surname></string-name>, <string-name><given-names>P.</given-names><surname>de Jonghe</surname></string-name>, <string-name><given-names>T.</given-names><surname>Dixon-Salazar</surname></string-name>, <string-name><given-names>R.</given-names><surname>Guerrini</surname></string-name>, <string-name><given-names>P.</given-names><surname>Kwan</surname></string-name>, <string-name><given-names>A. G.</given-names><surname>Marson</surname></string-name>, <string-name><given-names>R.</given-names><surname>Stewart</surname></string-name>, <string-name><given-names>C.</given-names><surname>Depondt</surname></string-name>, <string-name><given-names>D. J.</given-names><surname>Dlugos</surname></string-name>, <string-name><given-names>I. E.</given-names><surname>Scheffer</surname></string-name>, <string-name><given-names>P.</given-names><surname>Striano</surname></string-name>, <string-name><given-names>C.</given-names><surname>Freyer</surname></string-name>, <string-name><given-names>K.</given-names><surname>McKenna</surname></string-name>, <string-name><given-names>B. M.</given-names><surname>Regan</surname></string-name>, <string-name><given-names>S. T.</given-names><surname>Bellows</surname></string-name>, <string-name><given-names>C.</given-names><surname>Leu</surname></string-name>, <string-name><given-names>C. A.</given-names><surname>Bennett</surname></string-name>, <string-name><given-names>E. M. C.</given-names><surname>Johns</surname></string-name>, <string-name><given-names>A.</given-names><surname>Macdonald</surname></string-name>, <string-name><given-names>H.</given-names><surname>Shilling</surname></string-name>, <string-name><given-names>R.</given-names><surname>Burgess</surname></string-name>, <string-name><given-names>D.</given-names><surname>Weckhuysen</surname></string-name>, <string-name><given-names>M.</given-names><surname>Bahlo</surname></string-name>, <string-name><given-names>T. J.</given-names><surname>O’Brien</surname></string-name>, <string-name><given-names>M.</given-names><surname>Todaro</surname></string-name>, <string-name><given-names>H.</given-names><surname>Stamberger</surname></string-name>, <string-name><given-names>D. M.</given-names><surname>Andrade</surname></string-name>, <string-name><given-names>T. R.</given-names><surname>Sadoway</surname></string-name>, <string-name><given-names>K.</given-names><surname>Mo</surname></string-name>, <string-name><given-names>H.</given-names><surname>Krestel</surname></string-name>, <string-name><given-names>S.</given-names><surname>Gallati</surname></string-name>, <string-name><given-names>S. S.</given-names><surname>Papacostas</surname></string-name>, <string-name><given-names>I.</given-names><surname>Kousiappa</surname></string-name>, <string-name><given-names>G. A.</given-names><surname>Tanteles</surname></string-name>, <string-name><given-names>K.</given-names><surname>Štěrbová</surname></string-name>, <string-name><given-names>M.</given-names><surname>Vlčková</surname></string-name>, <string-name><given-names>L.</given-names><surname>Sedláčková</surname></string-name>, <string-name><given-names>P.</given-names><surname>Laššuthová</surname></string-name>, <string-name><given-names>K. M.</given-names><surname>Klein</surname></string-name>, <string-name><given-names>F.</given-names><surname>Rosenow</surname></string-name>, <string-name><given-names>P. S.</given-names><surname>Reif</surname></string-name>, <string-name><given-names>S.</given-names><surname>Knake</surname></string-name>, <string-name><given-names>W. S.</given-names><surname>Kunz</surname></string-name>, <string-name><given-names>G.</given-names><surname>Zsurka</surname></string-name>, <string-name><given-names>C. E.</given-names><surname>Elger</surname></string-name>, <string-name><given-names>J.</given-names><surname>Bauer</surname></string-name>, <string-name><given-names>M.</given-names><surname>Rademacher</surname></string-name>, <string-name><given-names>M.</given-names><surname>Pendziwiat</surname></string-name>, <string-name><given-names>H.</given-names><surname>Muhle</surname></string-name>, <string-name><given-names>A.</given-names><surname>Rademacher</surname></string-name>, <string-name><given-names>A.</given-names><surname>van Baalen</surname></string-name>, <string-name><given-names>S.</given-names><surname>von Spiczak</surname></string-name>, <string-name><given-names>U.</given-names><surname>Stephani</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Afawi</surname></string-name>, <string-name><given-names>A. D.</given-names><surname>Korczyn</surname></string-name>, <string-name><given-names>M.</given-names><surname>Kanaan</surname></string-name>, <string-name><given-names>C.</given-names><surname>Canavati</surname></string-name>, <string-name><given-names>G.</given-names><surname>Kurlemann</surname></string-name>, <string-name><given-names>K.</given-names><surname>Müller-Schlüter</surname></string-name>, <string-name><given-names>G.</given-names><surname>Kluger</surname></string-name>, <string-name><given-names>M.</given-names><surname>Häusler</surname></string-name>, <string-name><given-names>I.</given-names><surname>Blatt</surname></string-name>, <string-name><given-names>J. R.</given-names><surname>Lemke</surname></string-name>, <string-name><given-names>I.</given-names><surname>Krey</surname></string-name>, <string-name><given-names>Y. G.</given-names><surname>Weber</surname></string-name>, <string-name><given-names>S.</given-names><surname>Wolking</surname></string-name>, <string-name><given-names>F.</given-names><surname>Becker</surname></string-name>, <string-name><given-names>C.</given-names><surname>Hengsbach</surname></string-name>, <string-name><given-names>S.</given-names><surname>Rau</surname></string-name>, <string-name><given-names>A. F.</given-names><surname>Maisch</surname></string-name>, <string-name><given-names>B. J.</given-names><surname>Steinhoff</surname></string-name>, <string-name><given-names>A.</given-names><surname>Schulze-Bonhage</surname></string-name>, <string-name><given-names>S.</given-names><surname>Schubert-Bast</surname></string-name>, <string-name><given-names>H.</given-names><surname>Schreiber</surname></string-name>, <string-name><given-names>I.</given-names><surname>Borggräfe</surname></string-name>, <string-name><given-names>C. J.</given-names><surname>Schankin</surname></string-name>, <string-name><given-names>T.</given-names><surname>Mayer</surname></string-name>, <string-name><given-names>R.</given-names><surname>Korinthenberg</surname></string-name>, <string-name><given-names>K.</given-names><surname>Brockmann</surname></string-name>, <string-name><given-names>G.</given-names><surname>Kurlemann</surname></string-name>, <string-name><given-names>D.</given-names><surname>Dennig</surname></string-name>, <string-name><given-names>R.</given-names><surname>Madeleyn</surname></string-name>, <string-name><given-names>R.</given-names><surname>Kälviäinen</surname></string-name>, <string-name><given-names>P.</given-names><surname>Auvinen</surname></string-name>, <string-name><given-names>A.</given-names><surname>Saarela</surname></string-name>, <string-name><given-names>T.</given-names><surname>Linnankivi</surname></string-name>, <string-name><given-names>A. E.</given-names><surname>Lehesjoki</surname></string-name>, <string-name><given-names>M. I.</given-names><surname>Rees</surname></string-name>, <string-name><given-names>S. K.</given-names><surname>Chung</surname></string-name>, <string-name><given-names>W. O.</given-names><surname>Pickrell</surname></string-name>, <string-name><given-names>R.</given-names><surname>Powell</surname></string-name>, <string-name><given-names>N.</given-names><surname>Schneider</surname></string-name>, <string-name><given-names>S.</given-names><surname>Balestrini</surname></string-name>, <string-name><given-names>S.</given-names><surname>Zagaglia</surname></string-name>, <string-name><given-names>V.</given-names><surname>Braatz</surname></string-name>, <string-name><given-names>M. R.</given-names><surname>Johnson</surname></string-name>, <string-name><given-names>P.</given-names><surname>Auce</surname></string-name>, <string-name><given-names>G. J.</given-names><surname>Sills</surname></string-name>, <string-name><given-names>L. W.</given-names><surname>Baum</surname></string-name>, <string-name><given-names>P. C.</given-names><surname>Sham</surname></string-name>, <string-name><given-names>S. S.</given-names><surname>Cherny</surname></string-name>, <string-name><given-names>C. H. T.</given-names><surname>Lui</surname></string-name>, <string-name><given-names>N.</given-names><surname>Barišić</surname></string-name>, <string-name><given-names>N.</given-names><surname>Delanty</surname></string-name>, <string-name><given-names>C. P.</given-names><surname>Doherty</surname></string-name>, <string-name><given-names>A.</given-names><surname>Shukralla</surname></string-name>, <string-name><given-names>M.</given-names><surname>McCormack</surname></string-name>, <string-name><given-names>H.</given-names><surname>el-Naggar</surname></string-name>, <string-name><given-names>L.</given-names><surname>Canafoglia</surname></string-name>, <string-name><given-names>S.</given-names><surname>Franceschetti</surname></string-name>, <string-name><given-names>B.</given-names><surname>Castellotti</surname></string-name>, <string-name><given-names>T.</given-names><surname>Granata</surname></string-name>, <string-name><given-names>F.</given-names><surname>Zara</surname></string-name>, <string-name><given-names>M.</given-names><surname>Iacomino</surname></string-name>, <string-name><given-names>F.</given-names><surname>Madia</surname></string-name>, <string-name><given-names>M. S.</given-names><surname>Vari</surname></string-name>, <string-name><given-names>M. M.</given-names><surname>Mancardi</surname></string-name>, <string-name><given-names>V.</given-names><surname>Salpietro</surname></string-name>, <string-name><given-names>F.</given-names><surname>Bisulli</surname></string-name>, <string-name><given-names>P.</given-names><surname>Tinuper</surname></string-name>, <string-name><given-names>L.</given-names><surname>Licchetta</surname></string-name>, <string-name><given-names>T.</given-names><surname>Pippucci</surname></string-name>, <string-name><given-names>C.</given-names><surname>Stipa</surname></string-name>, <string-name><given-names>R.</given-names><surname>Minardi</surname></string-name>, <string-name><given-names>A.</given-names><surname>Gambardella</surname></string-name>, <string-name><given-names>A.</given-names><surname>Labate</surname></string-name>, <string-name><given-names>G.</given-names><surname>Annesi</surname></string-name>, <string-name><given-names>L.</given-names><surname>Manna</surname></string-name>, <string-name><given-names>M.</given-names><surname>Gagliardi</surname></string-name>, <string-name><given-names>E.</given-names><surname>Parrini</surname></string-name>, <string-name><given-names>D.</given-names><surname>Mei</surname></string-name>, <string-name><given-names>A.</given-names><surname>Vetro</surname></string-name>, <string-name><given-names>C.</given-names><surname>Bianchini</surname></string-name>, <string-name><given-names>M.</given-names><surname>Montomoli</surname></string-name>, <string-name><given-names>V.</given-names><surname>Doccini</surname></string-name>, <string-name><given-names>C.</given-names><surname>Marini</surname></string-name>, <string-name><given-names>T.</given-names><surname>Suzuki</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Inoue</surname></string-name>, <string-name><given-names>K.</given-names><surname>Yamakawa</surname></string-name>, <string-name><given-names>B.</given-names><surname>Tumiene</surname></string-name>, <string-name><given-names>L. G.</given-names><surname>Sadleir</surname></string-name>, <string-name><given-names>C.</given-names><surname>King</surname></string-name>, <string-name><given-names>E.</given-names><surname>Mountier</surname></string-name>, <string-name><given-names>S. H.</given-names><surname>Caglayan</surname></string-name>, <string-name><given-names>M.</given-names><surname>Arslan</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Yapıcı</surname></string-name>, <string-name><given-names>U.</given-names><surname>Yis</surname></string-name>, <string-name><given-names>P.</given-names><surname>Topaloglu</surname></string-name>, <string-name><given-names>B.</given-names><surname>Kara</surname></string-name>, <string-name><given-names>D.</given-names><surname>Turkdogan</surname></string-name>, <string-name><given-names>A.</given-names><surname>Gundogdu-Eken</surname></string-name>, <string-name><given-names>N.</given-names><surname>Bebek</surname></string-name>, <string-name><given-names>S.</given-names><surname>Uğur-İşeri</surname></string-name>, <string-name><given-names>B.</given-names><surname>Baykan</surname></string-name>, <string-name><given-names>B.</given-names><surname>Salman</surname></string-name>, <string-name><given-names>G.</given-names><surname>Haryanyan</surname></string-name>, <string-name><given-names>E.</given-names><surname>Yücesan</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Kesim</surname></string-name>, <string-name><given-names>Ç.</given-names><surname>Özkara</surname></string-name>, <string-name><given-names>A.</given-names><surname>Poduri</surname></string-name>, <string-name><given-names>B. R.</given-names><surname>Shiedley</surname></string-name>, <string-name><given-names>C.</given-names><surname>Shain</surname></string-name>, <string-name><given-names>R. J.</given-names><surname>Buono</surname></string-name>, <string-name><given-names>T. N.</given-names><surname>Ferraro</surname></string-name>, <string-name><given-names>M. R.</given-names><surname>Sperling</surname></string-name>, <string-name><given-names>W.</given-names><surname>Lo</surname></string-name>, <string-name><given-names>M.</given-names><surname>Privitera</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>French</surname></string-name>, <string-name><given-names>S.</given-names><surname>Schachter</surname></string-name>, <string-name><given-names>R. I.</given-names><surname>Kuzniecky</surname></string-name>, <string-name><given-names>O.</given-names><surname>Devinsky</surname></string-name>, <string-name><given-names>M.</given-names><surname>Hegde</surname></string-name>, <string-name><given-names>P.</given-names><surname>Khankhanian</surname></string-name>, <string-name><given-names>K. L.</given-names><surname>Helbig</surname></string-name>, <string-name><given-names>C. A.</given-names><surname>Ellis</surname></string-name>, <string-name><given-names>G.</given-names><surname>Spalletta</surname></string-name>, <string-name><given-names>F.</given-names><surname>Piras</surname></string-name>, <string-name><given-names>F.</given-names><surname>Piras</surname></string-name>, <string-name><given-names>T.</given-names><surname>Gili</surname></string-name>, <string-name><given-names>V.</given-names><surname>Ciullo</surname></string-name>, <string-name><given-names>A.</given-names><surname>Reif</surname></string-name>, <string-name><given-names>A.</given-names><surname>McQuillin</surname></string-name>, <string-name><given-names>N.</given-names><surname>Bass</surname></string-name>, <string-name><given-names>A.</given-names><surname>McIntosh</surname></string-name>, <string-name><given-names>D.</given-names><surname>Blackwood</surname></string-name>, <string-name><given-names>M.</given-names><surname>Johnstone</surname></string-name>, <string-name><given-names>A.</given-names><surname>Palotie</surname></string-name>, <string-name><given-names>M. T.</given-names><surname>Pato</surname></string-name>, <string-name><given-names>C. N.</given-names><surname>Pato</surname></string-name>, <string-name><given-names>E. J.</given-names><surname>Bromet</surname></string-name>, <string-name><given-names>C. B.</given-names><surname>Carvalho</surname></string-name>, <string-name><given-names>E. D.</given-names><surname>Achtyes</surname></string-name>, <string-name><given-names>M. H.</given-names><surname>Azevedo</surname></string-name>, <string-name><given-names>R.</given-names><surname>Kotov</surname></string-name>, <string-name><given-names>D. S.</given-names><surname>Lehrer</surname></string-name>, <string-name><given-names>D.</given-names><surname>Malaspina</surname></string-name>, <string-name><given-names>S. R.</given-names><surname>Marder</surname></string-name>, <string-name><given-names>H.</given-names><surname>Medeiros</surname></string-name>, <string-name><given-names>C. P.</given-names><surname>Morley</surname></string-name>, <string-name><given-names>D. O.</given-names><surname>Perkins</surname></string-name>, <string-name><given-names>J. L.</given-names><surname>Sobell</surname></string-name>, <string-name><given-names>P. F.</given-names><surname>Buckley</surname></string-name>, <string-name><given-names>F.</given-names><surname>Macciardi</surname></string-name>, <string-name><given-names>M. H.</given-names><surname>Rapaport</surname></string-name>, <string-name><given-names>J. A.</given-names><surname>Knowles</surname></string-name>, <string-name><given-names>A. H.</given-names><surname>Fanous</surname></string-name>, <string-name><given-names>S. A.</given-names><surname>McCarroll</surname></string-name>, <string-name><given-names>N.</given-names><surname>Gupta</surname></string-name>, <string-name><given-names>S. B.</given-names><surname>Gabriel</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Daly</surname></string-name>, <string-name><given-names>E. S.</given-names><surname>Lander</surname></string-name>, <string-name><given-names>D. H.</given-names><surname>Lowenstein</surname></string-name>, <string-name><given-names>D. B.</given-names><surname>Goldstein</surname></string-name>, <string-name><given-names>H.</given-names><surname>Lerche</surname></string-name>, <string-name><given-names>S. F.</given-names><surname>Berkovic</surname></string-name>, <string-name><given-names>B. M.</given-names><surname>Neale</surname></string-name></person-group>, 
<article-title>Ultra-rare genetic variation in the epilepsies: A whole-exome sequencing study of 17,606 individuals</article-title>. <source>Am. J. Hum. Genet.</source><volume>105</volume>, 
<fpage>267</fpage>–<lpage>282</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31327507</pub-id></mixed-citation>
    </ref>
    <ref id="R37">
      <label>37</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>E.</given-names><surname>Porta-Pardo</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kamburov</surname></string-name>, <string-name><given-names>D.</given-names><surname>Tamborero</surname></string-name>, <string-name><given-names>T.</given-names><surname>Pons</surname></string-name>, <string-name><given-names>D.</given-names><surname>Grases</surname></string-name>, <string-name><given-names>A.</given-names><surname>Valencia</surname></string-name>, <string-name><given-names>N.</given-names><surname>Lopez-Bigas</surname></string-name>, <string-name><given-names>G.</given-names><surname>Getz</surname></string-name>, <string-name><given-names>A.</given-names><surname>Godzik</surname></string-name></person-group>, 
<article-title>Comparison of algorithms for the detection of cancer drivers at subgene resolution</article-title>. <source>Nat. Methods</source><volume>14</volume>, 
<fpage>782</fpage>–<lpage>788</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28714987</pub-id></mixed-citation>
    </ref>
    <ref id="R38">
      <label>38</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>T.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>S.</given-names><surname>Ruan</surname></string-name>, <string-name><given-names>X.</given-names><surname>Zhao</surname></string-name>, <string-name><given-names>X.</given-names><surname>Shi</surname></string-name>, <string-name><given-names>H.</given-names><surname>Teng</surname></string-name>, <string-name><given-names>J.</given-names><surname>Zhong</surname></string-name>, <string-name><given-names>M.</given-names><surname>You</surname></string-name>, <string-name><given-names>K.</given-names><surname>Xia</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Sun</surname></string-name>, <string-name><given-names>F.</given-names><surname>Mao</surname></string-name></person-group>, 
<article-title>OncoVar: An integrated database and analysis platform for oncogenic driver variants in cancers</article-title>. <source>Nucleic Acids Res.</source><volume>49</volume>, 
<fpage>D1289</fpage>–<lpage>D1301</lpage> (<year>2021</year>).<pub-id pub-id-type="pmid">33179738</pub-id></mixed-citation>
    </ref>
    <ref id="R39">
      <label>39</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>D.</given-names><surname>Vitsios</surname></string-name>, <string-name><given-names>R. S.</given-names><surname>Dhindsa</surname></string-name>, <string-name><given-names>L.</given-names><surname>Middleton</surname></string-name>, <string-name><given-names>A. B.</given-names><surname>Gussow</surname></string-name>, <string-name><given-names>S.</given-names><surname>Petrovski</surname></string-name></person-group>, 
<article-title>Prioritizing non-coding regions based on human genomic constraint and sequence context with deep learning</article-title>. <source>Nat. Commun.</source><volume>12</volume>, 
<fpage>1504</fpage> (<year>2021</year>).<pub-id pub-id-type="pmid">33686085</pub-id></mixed-citation>
    </ref>
    <ref id="R40">
      <label>40</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. B.</given-names><surname>Gussow</surname></string-name>, <string-name><given-names>B. R.</given-names><surname>Copeland</surname></string-name>, <string-name><given-names>R. S.</given-names><surname>Dhindsa</surname></string-name>, <string-name><given-names>Q.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>S.</given-names><surname>Petrovski</surname></string-name>, <string-name><given-names>W. H.</given-names><surname>Majoros</surname></string-name>, <string-name><given-names>A. S.</given-names><surname>Allen</surname></string-name>, <string-name><given-names>D. B.</given-names><surname>Goldstein</surname></string-name></person-group>, 
<article-title>Orion: Detecting regions of the human non-coding genome that are intolerant to variation using population genetics</article-title>. <source>PLOS ONE</source><volume>12</volume>, 
<fpage>e0181604</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28797091</pub-id></mixed-citation>
    </ref>
    <ref id="R41">
      <label>41</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names><surname>Jaiswal</surname></string-name>, <string-name><given-names>P.</given-names><surname>Fontanillas</surname></string-name>, <string-name><given-names>J.</given-names><surname>Flannick</surname></string-name>, <string-name><given-names>A.</given-names><surname>Manning</surname></string-name>, <string-name><given-names>P. V.</given-names><surname>Grauman</surname></string-name>, <string-name><given-names>B. G.</given-names><surname>Mar</surname></string-name>, <string-name><given-names>R. C.</given-names><surname>Lindsley</surname></string-name>, <string-name><given-names>C. H.</given-names><surname>Mermel</surname></string-name>, <string-name><given-names>N.</given-names><surname>Burtt</surname></string-name>, <string-name><given-names>A.</given-names><surname>Chavez</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Higgins</surname></string-name>, <string-name><given-names>V.</given-names><surname>Moltchanov</surname></string-name>, <string-name><given-names>F. C.</given-names><surname>Kuo</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Kluk</surname></string-name>, <string-name><given-names>B.</given-names><surname>Henderson</surname></string-name>, <string-name><given-names>L.</given-names><surname>Kinnunen</surname></string-name>, <string-name><given-names>H. A.</given-names><surname>Koistinen</surname></string-name>, <string-name><given-names>C.</given-names><surname>Ladenvall</surname></string-name>, <string-name><given-names>G.</given-names><surname>Getz</surname></string-name>, <string-name><given-names>A.</given-names><surname>Correa</surname></string-name>, <string-name><given-names>B. F.</given-names><surname>Banahan</surname></string-name>, <string-name><given-names>S.</given-names><surname>Gabriel</surname></string-name>, <string-name><given-names>S.</given-names><surname>Kathiresan</surname></string-name>, <string-name><given-names>H. M.</given-names><surname>Stringham</surname></string-name>, <string-name><given-names>M. I.</given-names><surname>McCarthy</surname></string-name>, <string-name><given-names>M.</given-names><surname>Boehnke</surname></string-name>, <string-name><given-names>J.</given-names><surname>Tuomilehto</surname></string-name>, <string-name><given-names>C.</given-names><surname>Haiman</surname></string-name>, <string-name><given-names>L.</given-names><surname>Groop</surname></string-name>, <string-name><given-names>G.</given-names><surname>Atzmon</surname></string-name>, <string-name><given-names>J. G.</given-names><surname>Wilson</surname></string-name>, <string-name><given-names>D.</given-names><surname>Neuberg</surname></string-name>, <string-name><given-names>D.</given-names><surname>Altshuler</surname></string-name>, <string-name><given-names>B. L.</given-names><surname>Ebert</surname></string-name></person-group>, 
<article-title>Age-related clonal hematopoiesis associated with adverse outcomes</article-title>. <source>N. Eng. J. Med.</source><volume>371</volume>, 
<fpage>2488</fpage>–<lpage>2498</lpage> (<year>2014</year>).</mixed-citation>
    </ref>
    <ref id="R42">
      <label>42</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>D.</given-names><surname>Tamborero</surname></string-name>, <string-name><given-names>C.</given-names><surname>Rubio-Perez</surname></string-name>, <string-name><given-names>J.</given-names><surname>Deu-Pons</surname></string-name>, <string-name><given-names>M. P.</given-names><surname>Schroeder</surname></string-name>, <string-name><given-names>A.</given-names><surname>Vivancos</surname></string-name>, <string-name><given-names>A.</given-names><surname>Rovira</surname></string-name>, <string-name><given-names>I.</given-names><surname>Tusquets</surname></string-name>, <string-name><given-names>J.</given-names><surname>Albanell</surname></string-name>, <string-name><given-names>J.</given-names><surname>Rodon</surname></string-name>, <string-name><given-names>J.</given-names><surname>Tabernero</surname></string-name>, <string-name><given-names>C.</given-names><surname>de Torres</surname></string-name>, <string-name><given-names>R.</given-names><surname>Dienstmann</surname></string-name>, <string-name><given-names>A.</given-names><surname>Gonzalez-Perez</surname></string-name>, <string-name><given-names>N.</given-names><surname>Lopez-Bigas</surname></string-name></person-group>, 
<article-title>Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations</article-title>. <source>Genome Med.</source><volume>10</volume>, 
<fpage>25</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29592813</pub-id></mixed-citation>
    </ref>
    <ref id="R43">
      <label>43</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J. S.</given-names><surname>Amberger</surname></string-name>, <string-name><given-names>C. A.</given-names><surname>Bocchini</surname></string-name>, <string-name><given-names>F.</given-names><surname>Schiettecatte</surname></string-name>, <string-name><given-names>A. F.</given-names><surname>Scott</surname></string-name>, <string-name><given-names>A.</given-names><surname>Hamosh</surname></string-name></person-group>, 
<article-title>OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders</article-title>. <source>Nucleic Acids Res.</source><volume>43</volume>, 
<fpage>D789</fpage>–<lpage>D798</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25428349</pub-id></mixed-citation>
    </ref>
    <ref id="R44">
      <label>44</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names><surname>Bahrami</surname></string-name>, <string-name><given-names>R.</given-names><surname>Ehsani</surname></string-name>, <string-name><given-names>F.</given-names><surname>Drabløs</surname></string-name></person-group>, 
<article-title>A property-based analysis of human transcription factors</article-title>. <source>BMC. Res. Notes</source><volume>8</volume>, 
<fpage>82</fpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25890365</pub-id></mixed-citation>
    </ref>
    <ref id="R45">
      <label>45</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>C.</given-names><surname>Bycroft</surname></string-name>, <string-name><given-names>C.</given-names><surname>Freeman</surname></string-name>, <string-name><given-names>D.</given-names><surname>Petkova</surname></string-name>, <string-name><given-names>G.</given-names><surname>Band</surname></string-name>, <string-name><given-names>L. T.</given-names><surname>Elliott</surname></string-name>, <string-name><given-names>K.</given-names><surname>Sharp</surname></string-name>, <string-name><given-names>A.</given-names><surname>Motyer</surname></string-name>, <string-name><given-names>D.</given-names><surname>Vukcevic</surname></string-name>, <string-name><given-names>O.</given-names><surname>Delaneau</surname></string-name>, <string-name><given-names>J.</given-names><surname>O’Connell</surname></string-name>, <string-name><given-names>A.</given-names><surname>Cortes</surname></string-name>, <string-name><given-names>S.</given-names><surname>Welsh</surname></string-name>, <string-name><given-names>A.</given-names><surname>Young</surname></string-name>, <string-name><given-names>M.</given-names><surname>Effingham</surname></string-name>, <string-name><given-names>G.</given-names><surname>McVean</surname></string-name>, <string-name><given-names>S.</given-names><surname>Leslie</surname></string-name>, <string-name><given-names>N.</given-names><surname>Allen</surname></string-name>, <string-name><given-names>P.</given-names><surname>Donnelly</surname></string-name>, <string-name><given-names>J.</given-names><surname>Marchini</surname></string-name></person-group>, 
<article-title>The UK Biobank resource with deep phenotyping and genomic data</article-title>. <source>Nature</source><volume>562</volume>, 
<fpage>203</fpage>–<lpage>209</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">30305743</pub-id></mixed-citation>
    </ref>
    <ref id="R46">
      <label>46</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>P.</given-names><surname>Cingolani</surname></string-name>, <string-name><given-names>A.</given-names><surname>Platts</surname></string-name>, <string-name><given-names>L. L.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>M.</given-names><surname>Coon</surname></string-name>, <string-name><given-names>T.</given-names><surname>Nguyen</surname></string-name>, <string-name><given-names>L.</given-names><surname>Wang</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Land</surname></string-name>, <string-name><given-names>X.</given-names><surname>Lu</surname></string-name>, <string-name><given-names>D. M.</given-names><surname>Ruden</surname></string-name></person-group>, 
<article-title>A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3</article-title>. <source>Fly (Austin)</source><volume>6</volume>, 
<fpage>80</fpage>–<lpage>92</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22728672</pub-id></mixed-citation>
    </ref>
    <ref id="R47">
      <label>47</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>N. M.</given-names><surname>Ioannidis</surname></string-name>, <string-name><given-names>J. H.</given-names><surname>Rothstein</surname></string-name>, <string-name><given-names>V.</given-names><surname>Pejaver</surname></string-name>, <string-name><given-names>S.</given-names><surname>Middha</surname></string-name>, <string-name><given-names>S. K.</given-names><surname>McDonnell</surname></string-name>, <string-name><given-names>S.</given-names><surname>Baheti</surname></string-name>, <string-name><given-names>A.</given-names><surname>Musolf</surname></string-name>, <string-name><given-names>Q.</given-names><surname>Li</surname></string-name>, <string-name><given-names>E.</given-names><surname>Holzinger</surname></string-name>, <string-name><given-names>D.</given-names><surname>Karyadi</surname></string-name>, <string-name><given-names>L. A.</given-names><surname>Cannon-Albright</surname></string-name>, <string-name><given-names>C. C.</given-names><surname>Teerlink</surname></string-name>, <string-name><given-names>J. L.</given-names><surname>Stanford</surname></string-name>, <string-name><given-names>W. B.</given-names><surname>Isaacs</surname></string-name>, <string-name><given-names>J.</given-names><surname>Xu</surname></string-name>, <string-name><given-names>K. A.</given-names><surname>Cooney</surname></string-name>, <string-name><given-names>E. M.</given-names><surname>Lange</surname></string-name>, <string-name><given-names>J.</given-names><surname>Schleutker</surname></string-name>, <string-name><given-names>J. D.</given-names><surname>Carpten</surname></string-name>, <string-name><given-names>I. J.</given-names><surname>Powell</surname></string-name>, <string-name><given-names>O.</given-names><surname>Cussenot</surname></string-name>, <string-name><given-names>G.</given-names><surname>Cancel-Tassin</surname></string-name>, <string-name><given-names>G. G.</given-names><surname>Giles</surname></string-name>, <string-name><given-names>R. J.</given-names><surname>MacInnis</surname></string-name>, <string-name><given-names>C.</given-names><surname>Maier</surname></string-name>, <string-name><given-names>C. L.</given-names><surname>Hsieh</surname></string-name>, <string-name><given-names>F.</given-names><surname>Wiklund</surname></string-name>, <string-name><given-names>W. J.</given-names><surname>Catalona</surname></string-name>, <string-name><given-names>W. D.</given-names><surname>Foulkes</surname></string-name>, <string-name><given-names>D.</given-names><surname>Mandal</surname></string-name>, <string-name><given-names>R. A.</given-names><surname>Eeles</surname></string-name>, <string-name><given-names>Z.</given-names><surname>Kote-Jarai</surname></string-name>, <string-name><given-names>C. D.</given-names><surname>Bustamante</surname></string-name>, <string-name><given-names>D. J.</given-names><surname>Schaid</surname></string-name>, <string-name><given-names>T.</given-names><surname>Hastie</surname></string-name>, <string-name><given-names>E. A.</given-names><surname>Ostrander</surname></string-name>, <string-name><given-names>J. E.</given-names><surname>Bailey-Wilson</surname></string-name>, <string-name><given-names>P.</given-names><surname>Radivojac</surname></string-name>, <string-name><given-names>S. N.</given-names><surname>Thibodeau</surname></string-name>, <string-name><given-names>A. S.</given-names><surname>Whittemore</surname></string-name>, <string-name><given-names>W.</given-names><surname>Sieh</surname></string-name></person-group>, 
<article-title>REVEL: An ensemble method for predicting the pathogenicity of rare missense variants</article-title>. <source>Am. J. Hum. Genet.</source><volume>99</volume>, 
<fpage>877</fpage>–<lpage>885</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27666373</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
